QUARTERLY REPORT

Q2 2020 — Quarterly report on Form 10-Q

Q2 2020PDF · 89 pages642 KB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 26, 2020
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from 	to
Commission File Number 001-02217
COCA COLA CO
(Exact name of Registrant as specified in its charter)
Delaware 	58-0628465
(State or other jurisdiction of incorporation or organization) 	(I.R.S. Employer Identification No.)
One Coca-Cola Plaza
Atlanta Georgia 	30313
(Address of principal executive offices) 	(Zip Code)
Registrant's telephone number, including area code: (404) 676-2121
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock, $0.25 Par Value 	KO 	New York Stock Exchange
0.000% Notes Due 2021 	KO21B 	New York Stock Exchange
Floating Rate Notes Due 2021 	KO21C 	New York Stock Exchange
1.125% Notes Due 2022 	KO22 	New York Stock Exchange
0.125% Notes Due 2022 	KO22B 	New York Stock Exchange
0.75% Notes Due 2023 	KO23B 	New York Stock Exchange
0.500% Notes Due 2024 	KO24 	New York Stock Exchange
1.875% Notes Due 2026 	KO26 	New York Stock Exchange
0.750% Notes Due 2026 	KO26C 	New York Stock Exchange
1.125% Notes Due 2027 	KO27 	New York Stock Exchange
1.250% Notes Due 2031 	KO31 	New York Stock Exchange
1.625% Notes Due 2035 	KO35 	New York Stock Exchange
1.100% Notes Due 2036 	KO36 	New York Stock Exchange
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐

-- 1 of 89 --

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth
company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer 	☒ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 	☐
Indicate by check mark if the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐ No ☒
Indicate the number of shares outstanding of each of the issuer's classes of common stock as of the latest practicable date.
Class of Common Stock 	Shares Outstanding as of July 20, 2020
$0.25 Par Value 	4,295,438,919

-- 2 of 89 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Table of Contents
Page
Forward-Looking Statements 	1
Part I. Financial Information
Item 1. 	Financial Statements (Unaudited) 	2
Condensed Consolidated Statements of Income
Three and Six Months Ended June 26, 2020 and June 28, 2019 	2
Condensed Consolidated Statements of Comprehensive Income
Three and Six Months Ended June 26, 2020 and June 28, 2019 	3
Condensed Consolidated Balance Sheets
June 26, 2020 and December 31, 2019 	4
Condensed Consolidated Statements of Cash Flows
Six Months Ended June 26, 2020 and June 28, 2019 	5
Notes to Condensed Consolidated Financial Statements 	6
Item 2. 	Management's Discussion and Analysis of Financial Condition and Results of Operations 	32
Item 3. 	Quantitative and Qualitative Disclosures About Market Risk 	50
Item 4. 	Controls and Procedures 	50
Part II. Other Information
Item 1. 	Legal Proceedings 	50
Item 1A. 	Risk Factors 	51
Item 2. 	Unregistered Sales of Equity Securities and Use of Proceeds 	53
Item 6. 	Exhibits 	53
Signatures 	57

-- 3 of 89 --

FORWARD-LOOKING STATEMENTS
This report contains information that may constitute "forward-looking statements." Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will"
and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not
mean that a statement is not forward-looking. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future —
including statements relating to volume growth, share of sales and earnings per share growth, and statements expressing general views about future operating results — are
forward-looking statements. Management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to place
undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We undertake no obligation to publicly update or revise
any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are
subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or projections. These
risks and uncertainties include, but are not limited to, those described in Part II, "Item 1A. Risk Factors" and elsewhere in this report and in our Annual Report on Form 10-K
for the year ended December 31, 2019, and those described from time to time in our future reports filed with the Securities and Exchange Commission.
1

-- 4 of 89 --

Part I. Financial Information
Item 1. Financial Statements (Unaudited)
THE COCA-COLA COMPANY AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED)
(In millions except per share data)
Three Months Ended 	Six Months Ended
June 26,
2020
June 28,
2019
June 26,
2020
June 28,
2019
Net Operating Revenues 	$ 	7,150 $ 	9,997 	$ 	15,751 $ 	18,691
Cost of goods sold 	3,013 	3,921 	6,384 	7,286
Gross Profit 	4,137 	6,076 	9,367 	11,405
Selling, general and administrative expenses 	1,983 	2,996 	4,631 	5,763
Other operating charges 	173 	92 	375 	219
Operating Income 	1,981 	2,988 	4,361 	5,423
Interest income 	100 	142 	212 	275
Interest expense 	274 	236 	467 	481
Equity income (loss) — net 	176 	329 	343 	462
Other income (loss) — net 	214 	(174) 	758 	(405)
Income Before Income Taxes 	2,197 	3,049 	5,207 	5,274
Income taxes 	438 	421 	653 	943
Consolidated Net Income 	1,759 	2,628 	4,554 	4,331
Less: Net income (loss) attributable to noncontrolling interests 	(20) 	21 	— 	46
Net Income Attributable to Shareowners of The Coca-Cola
Company 	$ 	1,779 $ 	2,607 	$ 	4,554 $ 	4,285
Basic Net Income Per Share1 	$ 	0.41 $ 	0.61 	$ 	1.06 $ 	1.00
Diluted Net Income Per Share1
$ 	0.41 $ 	0.61 	$ 	1.05 $ 	1.00
Average Shares Outstanding 	4,295 	4,269 	4,292 	4,270
Effect of dilutive securities 	21 	36 	29 	35
Average Shares Outstanding Assuming Dilution 	4,316 	4,305 	4,321 	4,305
1 Calculated based on net income attributable to shareowners of The Coca-Cola Company.
Refer to Notes to Condensed Consolidated Financial Statements.
2

-- 5 of 89 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(UNAUDITED)
(In millions)
Three Months Ended 	Six Months Ended
June 26,
2020
June 28,
2019
June 26,
2020
June 28,
2019
Consolidated Net Income 	$ 	1,759 $ 	2,628 	$ 	4,554 $ 	4,331
Other Comprehensive Income:
Net foreign currency translation adjustments 	(714) 	(645) 	(3,335) 	281
Net gains (losses) on derivatives 	(26) 	(24) 	(10) 	(16)
Net change in unrealized gains (losses) on available-for-sale debt
securities 	(11) 	15 	(19) 	30
Net change in pension and other benefit liabilities 	41 	37 	47 	68
Total Comprehensive Income 	1,049 	2,011 	1,237 	4,694
Less: Comprehensive income (loss) attributable to noncontrolling interests 	34 	60 	(401) 	57
Total Comprehensive Income Attributable to Shareowners
of The Coca-Cola Company 	$ 	1,015 $ 	1,951 	$ 	1,638 $ 	4,637
Refer to Notes to Condensed Consolidated Financial Statements.
3

-- 6 of 89 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(In millions except par value)
June 26,
2020
December 31,
2019
ASSETS
Current Assets
Cash and cash equivalents 	$ 	10,037 $ 	6,480
Short-term investments 	7,551 	1,467
Total Cash, Cash Equivalents and Short-Term Investments 	17,588 	7,947
Marketable securities 	2,228 	3,228
Trade accounts receivable, less allowances of $549 and $524, respectively 	3,849 	3,971
Inventories 	3,501 	3,379
Prepaid expenses and other assets 	2,205 	1,886
Total Current Assets 	29,371 	20,411
Equity method investments 	18,189 	19,025
Other investments 	746 	854
Other assets 	5,875 	6,075
Deferred income tax assets 	2,366 	2,412
Property, plant and equipment, less accumulated depreciation of
$8,539 and $8,083, respectively 	10,695 	10,838
Trademarks with indefinite lives 	10,172 	9,266
Bottlers' franchise rights with indefinite lives 	103 	109
Goodwill 	16,617 	16,764
Other intangible assets 	555 	627
Total Assets 	$ 	94,689 $ 	86,381
LIABILITIES AND EQUITY
Current Liabilities
Accounts payable and accrued expenses 	$ 	11,668 $ 	11,312
Loans and notes payable 	9,423 	10,994
Current maturities of long-term debt 	5,181 	4,253
Accrued income taxes 	576 	414
Total Current Liabilities 	26,848 	26,973
Long-term debt 	37,729 	27,516
Other liabilities 	8,954 	8,510
Deferred income tax liabilities 	1,969 	2,284
The Coca-Cola Company Shareowners' Equity
Common stock, $0.25 par value; authorized — 11,200 shares; issued — 7,040 shares 	1,760 	1,760
Capital surplus 	17,367 	17,154
Reinvested earnings 	66,888 	65,855
Accumulated other comprehensive income (loss) 	(16,460) 	(13,544)
Treasury stock, at cost — 2,745 and 2,760 shares, respectively 	(52,071) 	(52,244)
Equity Attributable to Shareowners of The Coca-Cola Company 	17,484 	18,981
Equity attributable to noncontrolling interests 	1,705 	2,117
Total Equity 	19,189 	21,098
Total Liabilities and Equity 	$ 	94,689 $ 	86,381
Refer to Notes to Condensed Consolidated Financial Statements.
4

-- 7 of 89 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(In millions)
Six Months Ended
June 26,
2020
June 28,
2019
Operating Activities
Consolidated net income 	$ 	4,554 $ 	4,331
Depreciation and amortization 	748 	602
Stock-based compensation expense 	36 	88
Deferred income taxes 	(39) 	(163)
Equity (income) loss — net of dividends 	(212) 	(254)
Foreign currency adjustments 	(67) 	37
Significant (gains) losses — net 	(901) 	247
Other operating charges 	341 	93
Other items 	52 	180
Net change in operating assets and liabilities 	(1,726) 	(660)
Net Cash Provided by Operating Activities 	2,786 	4,501
Investing Activities
Purchases of investments 	(8,294) 	(2,935)
Proceeds from disposals of investments 	2,649 	3,395
Acquisitions of businesses, equity method investments and nonmarketable securities 	(984) 	(5,353)
Proceeds from disposals of businesses, equity method investments and nonmarketable securities 	46 	265
Purchases of property, plant and equipment 	(536) 	(767)
Proceeds from disposals of property, plant and equipment 	112 	43
Other investing activities 	40 	(10)
Net Cash Provided by (Used in) Investing Activities 	(6,967) 	(5,362)
Financing Activities
Issuances of debt 	19,775 	14,518
Payments of debt 	(10,304) 	(14,278)
Issuances of stock 	444 	602
Purchases of stock for treasury 	(93) 	(689)
Dividends 	(1,761) 	(1,709)
Other financing activities 	(16) 	124
Net Cash Provided by (Used in) Financing Activities 	8,045 	(1,432)
Effect of Exchange Rate Changes on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 	(172) 	2
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents
during the period 	3,692 	(2,291)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 	6,737 	9,318
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at End of Period 	10,429 	7,027
Less: Restricted cash and restricted cash equivalents at end of period 	392 	296
Cash and Cash Equivalents at End of Period 	$ 	10,037 $ 	6,731
Refer to Notes to Condensed Consolidated Financial Statements.
5

-- 8 of 89 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States
("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all information and notes
required by U.S. GAAP for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to
Consolidated Financial Statements included in the Annual Report on Form 10-K of The Coca-Cola Company for the year ended December 31, 2019.
When used in these notes, the terms "The Coca-Cola Company," "Company," "we," "us" and "our" mean The Coca-Cola Company and all entities included in our condensed
consolidated financial statements. In the opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been
included. Operating results for the three and six months ended June 26, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31,
2020. Sales of our nonalcoholic ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting for the highest sales volumes.
The volume of sales in the beverage business may be affected by weather conditions.
Each of our interim reporting periods, other than the fourth interim reporting period, ends on the Friday closest to the last day of the corresponding quarterly calendar period.
The second quarter of 2020 and the second quarter of 2019 ended on June 26, 2020 and June 28, 2019, respectively. Our fourth interim reporting period and our fiscal year end
on December 31 regardless of the day of the week on which December 31 falls.
Advertising Costs
The Company's accounting policy related to advertising costs for annual reporting purposes is to expense production costs of print, radio, television and other advertisements as
of the first date the advertisements take place. All other marketing expenditures are expensed in the annual period in which the expenditure is incurred.
For interim reporting purposes, we allocate our estimated full year marketing expenditures that benefit multiple interim periods to each of our interim reporting periods. We use
the proportion of each interim period's actual unit case volume to the estimated full year unit case volume as the basis for the allocation. This methodology results in our
marketing expenditures being recognized at a standard rate per unit case. At the end of each interim reporting period, we review our estimated full year unit case volume and
our estimated full year marketing expenditures that benefit multiple interim periods in order to evaluate if a change in estimate is necessary. The impact of any changes in these
full year estimates is recognized in the interim period in which the change in estimate occurs. Our full year marketing expenditures are not impacted by this interim accounting
policy.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of purchase as cash equivalents or restricted cash
equivalents, as applicable. Restricted cash and restricted cash equivalents generally consist of amounts held by our captive insurance companies, which are included in the line
item other assets in our consolidated balance sheet. We manage our exposure to counterparty credit risk through specific minimum credit standards, diversification of
counterparties and procedures to monitor our concentrations of credit risk.
6

-- 9 of 89 --

The following tables provide a summary of cash, cash equivalents, restricted cash and restricted cash equivalents that constitute the total amounts shown in the condensed
consolidated statements of cash flows (in millions):
June 26,
2020
December 31,
2019
Cash and cash equivalents 	$ 	10,037 $ 	6,480
Cash and cash equivalents included in other assets1 	392 	257
Cash, cash equivalents, restricted cash and restricted cash equivalents 	$ 	10,429 $ 	6,737
1 Amounts represent cash and cash equivalents in our solvency capital portfolio set aside primarily to cover pension obligations in certain of
our European and Canadian pension plans. Refer to Note 4.
June 28,
2019
December 31,
2018
Cash and cash equivalents 	$ 	6,731 $ 	9,077
Cash and cash equivalents included in other assets1 	296 	241
Cash, cash equivalents, restricted cash and restricted cash equivalents 	$ 	7,027 $ 	9,318
1 Amounts represent cash and cash equivalents in our solvency capital portfolio set aside primarily to cover pension obligations in certain of our European and Canadian pension plans. Refer to
Note 4.
Recently Issued Accounting Guidance
In December 2019, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2019-12,Simplifying the Accounting for Income Taxes,
which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating taxes during the quarters and the recognition of
deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and changes in tax laws or rates, as well as
clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for the Company beginning January 1, 2021 and would
require us to recognize a cumulative effect adjustment to the opening balance of reinvested earnings, if applicable. We are currently evaluating the impact that ASU 2019-12
may have on our consolidated financial statements.
NOTE 2: ACQUISITIONS AND DIVESTITURES
Acquisitions
During the six months ended June 26, 2020, our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $984 million, which
primarily related to the acquisition of the remaining equity ownership interest in fairlife, LLC ("fairlife").
During the six months ended June 28, 2019, our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $5,353 million, which
primarily related to the acquisition of Costa Limited ("Costa"), the remaining equity ownership interest in C.H.I. Limited ("CHI") and controlling interests in bottling operations
in Zambia.
fairlife, LLC
In January 2020, the Company acquired the remaining 57.5 percent interest in, and now owns100 percent of, fairlife. fairlife offers a broad portfolio of products in the value-
added dairy category across North America. A significant portion of fairlife's revenues was already reflected in our consolidated financial statements, as we have operated as the
sales and distribution organization for certain fairlife products. Upon consolidation, we recognized a gain of $902 million resulting from the remeasurement of our previously
held equity interest in fairlife to fair value. The fair value of our previously held interest was determined using a discounted cash flow model based on Level 3 inputs. The gain
was recorded in the line item other income (loss) — net in our condensed consolidated statement of income. We acquired the remaining interest in exchange for $979 million of
cash, net of cash acquired, and effectively settled our $306 million note receivable from fairlife at the recorded amount. Under the terms of the agreement, we are subject to
making future milestone payments which are contingent on fairlife achieving certain financial targets through 2024, and if achieved, are payable in 2021, 2023 and 2025. These
milestone payments are based on agreed-upon formulas related to fairlife's operating results, the resulting value of which is not subject to a ceiling. Under the applicable
accounting guidance, we recorded a $270 million liability representing our best estimate of the fair value of this contingent consideration. The fair value of this contingent
consideration was determined using a Monte Carlo valuation model based on Level 3 inputs. We will be required to remeasure this liability to fair value quarterly with any
changes in the fair value recorded in income until the final milestone payments are made. During the three and six months ended June 26, 2020, we recorded charges of $18
million and $29 million, respectively, related to this remeasurement in the line item other operating charges in our condensed consolidated statements of income. As of June 26,
2020, $1.3 billion of the purchase price was preliminarily allocated to the fairlife trademark and $0.8 billion was preliminarily allocated to goodwill. The goodwill
7

-- 10 of 89 --

recognized as part of this acquisition is primarily related to synergistic value created from the opportunity for additional expansion. It also includes certain other intangible
assets that do not qualify for separate recognition, such as an assembled workforce. The goodwill is not tax deductible and has been preliminarily assigned to the North America
operating segment. The preliminary allocation of the purchase price is subject to refinement when valuations are finalized. As of June 26, 2020, the valuations that have not
been finalized primarily relate to the trademark and other intangible assets; and operating lease right-of-use ("ROU") assets and operating lease liabilities. The final purchase
price allocation will be completed no later than the first quarter of 2021.
Costa Limited
In January 2019, the Company acquired Costa in exchange for $4.9 billion of cash, net of cash acquired. Costa is a coffee business with retail outlets in more than 30 countries,
the Costa Express vending system and a state-of-the-art roastery. We believe this acquisition will allow us to increase our presence in the hot beverage market as Costa has a
scalable platform across multiple formats and channels, including opportunities to introduce ready-to-drink products. Upon finalization of purchase accounting, $2.4 billion of
the purchase price was allocated to the Costa trademark and $2.5 billion was allocated to goodwill. The goodwill recognized as part of this acquisition is primarily related to
synergistic value created from the opportunity for additional expansion as well as our ability to market and distribute Costa in ready-to-drink form throughout our bottling
system. It also includes certain other intangible assets that do not qualify for separate recognition, such as an assembled workforce. The goodwill is not tax deductible and has
been assigned to the Global Ventures operating segment, except for $108 million, which has been assigned to the Europe, Middle East and Africa operating segment.
C.H.I. Limited
In January 2019, the Company acquired the remaining 60 percent interest in CHI, a Nigerian producer of value-added dairy and juice beverages and iced tea, in exchange for
$260 million of cash, net of cash acquired, under the terms of the agreement for our original investment in CHI. Upon consolidation, we recognized a net charge of $121 million
during the six months ended June 28, 2019, which included the remeasurement of our previously held equity interest in CHI to fair value and the reversal of the related
cumulative translation adjustments. The fair value of our previously held equity investment was determined using a discounted cash flow model based on Level 3 inputs. The
net charge was recorded in the line item other income (loss) — net in our condensed consolidated statement of income.
Divestitures
During the six months ended June 26, 2020, proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $46 million, which
primarily related to the sale of a portion of our ownership interest in one of our equity method investments. We recognized a net gain of $18 million as a result of the sale, which
was recorded in the line item other income (loss) — net in our condensed consolidated statement of income.
During the six months ended June 28, 2019, proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $265 million, which
primarily related to the sale of a portion of our equity method investment in Embotelladora Andina S.A. ("Andina"). We recognized a gain of $39 million as a result of the sale,
which was recorded in the line item other income (loss) — net in our condensed consolidated statement of income. We continue to account for our remaining interest in Andina
as an equity method investment as a result of our representation on Andina's Board of Directors and other governance rights.
Coca-Cola Beverages Africa Proprietary Limited
Due to the Company's original intent to refranchise Coca-Cola Beverages Africa Proprietary Limited ("CCBA"), CCBA was accounted for as held for sale and a discontinued
operation from October 2017, when the Company became the controlling shareowner of CCBA, through the first quarter of 2019. While the Company had discussions with a
number of potential partners throughout the period CCBA was held for sale, during the second quarter of 2019, the Company updated its plans for CCBA and now intends to
maintain its controlling stake in CCBA for the foreseeable future. As a result, CCBA no longer qualifies as held for sale or as a discontinued operation, and CCBA's financial
results are now presented within the Company's continuing operations. The financial results for prior periods have also been retrospectively reclassified herein. As of the date
we changed our plans, the Company was required to measure CCBA's property, plant and equipment and definite-lived intangible assets at the lower of their current fair values
or their carrying amounts before they were classified as held for sale, adjusted for depreciation and amortization expense that would have been recognized had the business been
classified as held and used during the period that CCBA was classified as held for sale. As a result, the Company reallocated the allowance for reduction of assets held for sale
balance that was originally recorded during the third quarter of 2018 to reduce the carrying value of CCBA's property, plant and equipment by $225 million and CCBA's
definite-lived intangible assets by $329 million based on the relative amount of depreciation and amortization that would have been recognized during the periods they were
held for sale. We also recorded a $160 million adjustment to reduce the carrying value of CCBA's property, plant and equipment and definite-lived intangible assets by an
additional $34 million and $126 million, respectively, during the three and
8

-- 11 of 89 --

six months ended June 28, 2019. These additional adjustments were included in the line item other income (loss) — net in our condensed consolidated statements of income.
NOTE 3: REVENUE RECOGNITION
The following tables present net operating revenues disaggregated between the United States and International and further by line of business (in millions):
United States 	International 	Total
Three Months Ended June 26, 2020
Concentrate operations 	$ 	1,270 $ 	2,945 $ 	4,215
Finished product operations 	1,313 	1,622 	2,935
Total 	$ 	2,583 $ 	4,567 $ 	7,150
Three Months Ended June 28, 2019
Concentrate operations 	$ 	1,415 $ 	4,163 $ 	5,578
Finished product operations 	1,688 	2,731 	4,419
Total 	$ 	3,103 $ 	6,894 $ 	9,997
United States 	International 	Total
Six Months Ended June 26, 2020
Concentrate operations 	$ 	2,594 $ 	6,410 $ 	9,004
Finished product operations 	2,796 	3,951 	6,747
Total 	$ 	5,390 $ 	10,361 $ 	15,751
Six Months Ended June 28, 2019
Concentrate operations 	$ 	2,600 $ 	7,756 $ 	10,356
Finished product operations 	3,148 	5,187 	8,335
Total 	$ 	5,748 $ 	12,943 $ 	18,691
Refer to Note 16 for additional revenue disclosures by operating segment and Corporate.
NOTE 4: INVESTMENTS
Equity Securities
The carrying values of our equity securities were included in the following line items in our condensed consolidated balance sheets (in millions):
Fair Value with Changes
Recognized in Income
Measurement Alternative —
No Readily Determinable Fair
Value
June 26, 2020
Marketable securities 	$ 	276 $ 	—
Other investments 	699 	47
Other assets 	998 	—
Total equity securities 	$ 	1,973 $ 	47
December 31, 2019
Marketable securities 	$ 	329 $ 	—
Other investments 	772 	82
Other assets 	1,118 	—
Total equity securities 	$ 	2,219 $ 	82
9

-- 12 of 89 --

The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of the period is as follows (in millions):
Three Months Ended
June 26, 2020 	June 28, 2019
Net gains (losses) recognized during the period related to equity securities 	$ 	242 $ 	(13)
Less: Net gains (losses) recognized during the period related to equity securities sold
during the period 	13 	1
Net unrealized gains (losses) recognized during the period related to equity securities
still held at the end of the period 	$ 	229 $ 	(14)
Six Months Ended
June 26, 2020 	June 28, 2019
Net gains (losses) recognized during the period related to equity securities 	$ 	(154) $ 	134
Less: Net gains (losses) recognized during the period related to equity securities sold
during the period 	(31) 	13
Net unrealized gains (losses) recognized during the period related to equity securities
still held at the end of the period 	$ 	(123) $ 	121
Debt Securities
Our debt securities consisted of the following (in millions):
Gross Unrealized 	Estimated Fair
Value	Cost 	Gains 	Losses
June 26, 2020
Trading securities $ 	34 $ 	1 $ 	(1) $ 	34
Available-for-sale securities 2,176 	79 	(2) 	2,253
Total debt securities $ 	2,210 $ 	80 $ 	(3) $ 	2,287
December 31, 2019
Trading securities $ 	46 $ 	1 $ 	— $ 	47
Available-for-sale securities 3,172 	113 	(4) 	3,281
Total debt securities $ 	3,218 $ 	114 $ 	(4) $ 	3,328
The carrying values of our debt securities were included in the following line items in our condensed consolidated balance sheets (in millions):
June 26, 2020 	December 31, 2019
Trading
Securities
Available-for-
Sale Securities
Trading
Securities
Available-for-
Sale Securities
Cash and cash equivalents $ 	— $ 	59 	$ 	— $ 	123
Marketable securities 34 	1,918 	47 	2,852
Other assets — 	276 	— 	306
Total debt securities 	$ 	34 $ 	2,253 	$ 	47 $ 	3,281
The contractual maturities of these available-for-sale debt securities as of June 26, 2020 were as follows (in millions):
Cost
Estimated
Fair Value
Within 1 year 	$ 	1,242 $ 	1,243
After 1 year through 5 years 	713 	759
After 5 years through 10 years 	50 	63
After 10 years 	171 	188
Total 	$ 	2,176 $ 	2,253
The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right to call or prepay certain obligations.
10

-- 13 of 89 --

The sale and/or maturity of available-for-sale debt securities resulted in the following realized activity (in millions):
Three Months Ended 	Six Months Ended
June 26, 2020 	June 28, 2019 	June 26, 2020 	June 28, 2019
Gross gains 	$ 	9 $ 	23 	$ 	17 $ 	28
Gross losses 	(6) 	(1) 	(8) 	(4)
Proceeds 	280 	1,068 	1,186 	1,790
Captive Insurance Companies
In accordance with local insurance regulations, our captive insurance companies are required to meet and maintain minimum solvency capital requirements. The Company
elected to invest a majority of its solvency capital in a portfolio of marketable equity and debt securities. These securities are included in the disclosures above. The Company
uses one of its consolidated captive insurance companies to reinsure group annuity insurance contracts that cover the pension obligations of certain of our European and
Canadian pension plans. This captive's solvency capital funds included equity and debt securities of $1,123 million as of June 26, 2020 and $1,266 million as of December 31,
2019, which are classified in the line item other assets in our condensed consolidated balance sheets because the assets are not available to satisfy our current obligations.
NOTE 5: INVENTORIES
Inventories consisted of the following (in millions):
June 26,
2020
December 31,
2019
Raw materials and packaging 	$ 	2,265 $ 	2,180
Finished goods 	794 	851
Other 	442 	348
Total inventories 	$ 	3,501 $ 	3,379
NOTE 6: HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The following table presents the fair values of the Company's derivative instruments that were designated and qualified as part of a hedging relationship (in millions):
Fair Value1,2
Derivatives Designated as Hedging Instruments 	Balance Sheet Location1
June 26,
2020 	December 31, 2019
Assets:
Foreign currency contracts 	Prepaid expenses and other assets 	$ 	66 $ 	24
Foreign currency contracts 	Other assets 	130 	91
Interest rate contracts 	Prepaid expenses and other assets 	10 	10
Interest rate contracts 	Other assets 	596 	427
Total assets 	$ 	802 $ 	552
Liabilities:
Foreign currency contracts 	Accounts payable and accrued expenses 	$ 	50 $ 	40
Foreign currency contracts 	Other liabilities 	158 	48
Interest rate contracts 	Other liabilities 	17 	21
Total liabilities 	$ 	225 $ 	109
1 All of the Company's derivative instruments are carried at fair value in our condensed consolidated balance sheets after considering the impact of legally enforceable master netting
agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting
the impact of master netting agreements and cash collateral. Refer to Note 15 for the net presentation of the Company's derivative instruments.
2 Refer to Note 15 for additional information related to the estimated fair value.
11

-- 14 of 89 --

The following table presents the fair values of the Company's derivative instruments that were not designated as hedging instruments (in millions):
Fair Value1,2
Derivatives Not Designated as Hedging Instruments 	Balance Sheet Location1
June 26,
2020 	December 31, 2019
Assets:
Foreign currency contracts 	Prepaid expenses and other assets 	$ 	44 $ 	13
Foreign currency contracts 	Other assets 	4 	—
Commodity contracts 	Prepaid expenses and other assets 	4 	8
Commodity contracts 	Other assets 	2 	2
Other derivative instruments 	Prepaid expenses and other assets 	— 	12
Other derivative instruments 	Other assets 	3 	1
Total assets 	$ 	57 $ 	36
Liabilities:
Foreign currency contracts 	Accounts payable and accrued expenses 	$ 	72 $ 	39
Foreign currency contracts 	Other liabilities 	2 	—
Commodity contracts 	Accounts payable and accrued expenses 	57 	13
Commodity contracts 	Other liabilities 	18 	1
Other derivative instruments 	Accounts payable and accrued expenses 	11 	—
Total liabilities 	$ 	160 $ 	53
1 All of the Company's derivative instruments are carried at fair value in our condensed consolidated balance sheets after considering the impact of legally enforceable master netting
agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting
the impact of master netting agreements and cash collateral. Refer to Note 15 for the net presentation of the Company's derivative instruments.
2 Refer to Note 15 for additional information related to the estimated fair value.
Credit Risk Associated with Derivatives
We have established strict counterparty credit guidelines and enter into transactions only with financial institutions of investment grade or better. We monitor counterparty
exposures regularly and review any downgrade in credit rating immediately. If a downgrade in the credit rating of a counterparty were to occur, we have provisions requiring
collateral for substantially all of our transactions. To mitigate presettlement risk, minimum credit standards become more stringent as the duration of the derivative financial
instrument increases. In addition, the Company's master netting agreements reduce credit risk by permitting the Company to net settle for transactions with the same
counterparty. To minimize the concentration of credit risk, we enter into derivative transactions with a portfolio of financial institutions. Based on these factors, we consider the
risk of counterparty default to be minimal.
Cash Flow Hedging Strategy
The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions caused by fluctuations in foreign currency
exchange rates, commodity prices or interest rates. The changes in the fair values of derivatives designated as cash flow hedges are recorded in accumulated other
comprehensive income (loss) ("AOCI") and are reclassified into the line item in our consolidated statement of income in which the hedged items are recorded in the same period
the hedged items affect earnings. The changes in the fair values of hedges that are determined to be ineffective are immediately reclassified from AOCI into earnings. The
maximum length of time for which the Company hedges its exposure to the variability in future cash flows is typically four years.
The Company maintains a foreign currency cash flow hedging program to reduce the risk that our eventual U.S. dollar net cash inflows from sales outside the United States and
U.S. dollar net cash outflows from procurement activities will be adversely affected by fluctuations in foreign currency exchange rates. We enter into forward contracts and
purchase foreign currency options and collars (principally euro, British pound sterling and Japanese yen) to hedge certain portions of forecasted cash flows denominated in
foreign currencies. When the U.S. dollar strengthens against the foreign currencies, the decline in the present value of future foreign currency cash flows is partially offset by
gains in the fair value of the derivative instruments. Conversely, when the U.S. dollar weakens, the increase in the present value of future foreign currency cash flows is partially
offset by losses in the fair value of the derivative instruments. The total notional values of derivatives that were designated and qualify for the Company's foreign currency cash
flow hedging program were $9,044 million and $6,957 million as of June 26, 2020 and December 31, 2019, respectively.
12

-- 15 of 89 --

The Company uses cross-currency swaps to hedge the changes in cash flows of certain of its foreign currency denominated debt and other monetary assets or liabilities due to
changes in foreign currency exchange rates. For this hedging program, the Company records the change in carrying value of these foreign currency denominated assets and
liabilities due to changes in exchange rates into earnings each period. The changes in fair value of the cross-currency swap derivatives are recorded in AOCI with an immediate
reclassification into earnings for the change in fair value attributable to fluctuations in foreign currency exchange rates. The total notional values of derivatives that have been
designated as cash flow hedges for the Company's foreign currency denominated assets and liabilities were $2,700 million and $3,028 million as of June 26, 2020 and
December 31, 2019, respectively.
The Company has entered into commodity futures contracts and other derivative instruments on various commodities to mitigate the price risk associated with forecasted
purchases of materials used in our manufacturing process. These derivative instruments have been designated and qualify as part of the Company's commodity cash flow
hedging program. The objective of this hedging program is to reduce the variability of cash flows associated with future purchases of certain commodities. The total notional
values of derivatives that have been designated and qualify for this program were $3 million and $2 million as of June 26, 2020 and December 31, 2019, respectively.
Our Company monitors our mix of short-term debt and long-term debt regularly. From time to time, we manage our risk to interest rate fluctuations through the use of
derivative financial instruments. The Company has entered into interest rate swap agreements and has designated these instruments as part of the Company's interest rate cash
flow hedging program. The objective of this hedging program is to mitigate the risk of adverse changes in benchmark interest rates on the Company's future interest payments.
The total notional values of these interest rate swap agreements that were designated and qualified for the Company's interest rate cash flow hedging program were $550 million
as of June 26, 2020. As of December 31, 2019, we did not have any interest rate swaps designated as a cash flow hedge.
The following tables present the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on other comprehensive income ("OCI"), AOCI
and earnings (in millions):
Gain (Loss)
Recognized in OCI 	Location of Gain (Loss) Recognized in Income
Gain (Loss) Reclassified
from AOCI into Income
Three Months Ended June 26, 2020
Foreign currency contracts 	$ 	(80) Net operating revenues 	$ 	3
Foreign currency contracts 	(1) Cost of goods sold 	4
Foreign currency contracts 	— Interest expense 	(2)
Foreign currency contracts 	(11) Other income (loss) — net 	(44)
Interest rate contracts 	4 Interest expense 	(10)
Total 	$ 	(88) 	$ 	(49)
Three Months Ended June 28, 2019
Foreign currency contracts 	$ 	(25) Net operating revenues 	$ 	1
Foreign currency contracts 	(3) Cost of goods sold 	3
Foreign currency contracts 	— Interest expense 	(2)
Foreign currency contracts 	(31) Other income (loss) — net 	(43)
Interest rate contracts 	(17) Interest expense 	(10)
Total 	$ 	(76) 	$ 	(51)
13

-- 16 of 89 --

Gain (Loss)
Recognized in OCI 	Location of Gain (Loss) Recognized in Income
Gain (Loss) Reclassified
from AOCI into Income
Six Months Ended June 26, 2020
Foreign currency contracts 	$ 	23 Net operating revenues 	$ 	(1)
Foreign currency contracts 	10 Cost of goods sold 	5
Foreign currency contracts 	— Interest expense 	(4)
Foreign currency contracts 	(101) Other income (loss) — net 	(29)
Interest rate contracts 	12 Interest expense 	(21)
Total 	$ 	(56) 	$ 	(50)
Six Months Ended June 28, 2019
Foreign currency contracts 	$ 	(27) Net operating revenues 	$ 	7
Foreign currency contracts 	(2) Cost of goods sold 	7
Foreign currency contracts 	— Interest expense 	(4)
Foreign currency contracts 	(53) Other income (loss) — net 	(93)
Interest rate contracts 	(17) Interest expense 	(20)
Total 	$ 	(99) 	$ 	(103)
As of June 26, 2020, the Company estimates that it will reclassify into earnings during the next 12 months net losses of $73 million from the pretax amount recorded in AOCI
as the anticipated cash flows occur.
Fair Value Hedging Strategy
The Company uses interest rate swap agreements designated as fair value hedges to minimize exposure to changes in the fair value of fixed-rate debt that results from
fluctuations in benchmark interest rates. The Company also uses cross-currency interest rate swaps to hedge the changes in the fair value of foreign currency denominated debt
relating to changes in foreign currency exchange rates and benchmark interest rates. The changes in the fair values of derivatives designated as fair value hedges and the
offsetting changes in fair values of the hedged items are recognized in earnings. The ineffective portions of these hedges are immediately recognized in earnings. When a
derivative is no longer designated as a fair value hedge for any reason, including termination and maturity, the remaining unamortized difference between the carrying value of
the hedged item at that time and the face value of the hedged item is amortized to earnings over the remaining life of the hedged item, or immediately if the hedged item has
matured. The total notional values of derivatives related to our fair value hedges of this type were $12,420 million and $12,523 million as of June 26, 2020 and December 31,
2019, respectively.
The following tables summarize the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on earnings (in millions):
Hedging Instruments and Hedged Items 	Location of Gain (Loss) Recognized in Income
Gain (Loss)
Recognized in Income
Three Months Ended
June 26,
2020
June 28,
2019
Interest rate contracts 	Interest expense 	$ 	78 $ 	229
Fixed-rate debt 	Interest expense 	(81) 	(227)
Net impact to interest expense 	$ 	(3) $ 	2
Net impact of fair value hedging instruments 	$ 	(3) $ 	2
Hedging Instruments and Hedged Items 	Location of Gain (Loss) Recognized in Income
Gain (Loss)
Recognized in Income
Six Months Ended
June 26,
2020
June 28,
2019
Interest rate contracts 	Interest expense 	$ 	190 $ 	441
Fixed-rate debt 	Interest expense 	(184) 	(437)
Net impact to interest expense 	$ 	6 $ 	4
Net impact of fair value hedging instruments 	$ 	6 $ 	4
14

-- 17 of 89 --

The following table summarizes the amounts recorded in the condensed consolidated balance sheets related to hedged items in fair value hedging relationships (in millions):
Carrying Value of Hedged Items
Cumulative Amount of Fair Value Hedging
Adjustments Included in Carrying Value of Hedged
Items1
Balance Sheet Location of Hedged Items
June 26,
2020
December 31,
2019
June 26,
2020
December 31,
2019
Current maturities of long-term debt 	$ 	1,004 $ 	1,004 	$ 	5 $ 	5
Long-term debt 	12,286 	12,087 	619 	448
1 Cumulative amount of fair value hedging adjustments does not include changes due to foreign currency exchange rates.
Hedges of Net Investments in Foreign Operations Strategy
The Company uses forward contracts and a portion of its foreign currency denominated debt, a non-derivative financial instrument, to protect the value of our net investments in
a number of foreign operations. For derivative instruments that are designated and qualify as hedges of net investments in foreign operations, the changes in the fair values of
the derivative instruments are recognized in net foreign currency translation adjustments, a component of AOCI, to offset the changes in the values of the net investments being
hedged. For non-derivative financial instruments that are designated and qualify as hedges of net investments in foreign operations, the change in the carrying value of the
designated portion of the non-derivative financial instrument due to changes in foreign currency exchange rates is recorded in net foreign currency translation adjustments. Any
ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change.
The following table summarizes the notional values and pretax impact of changes in the fair values of instruments designated as net investment hedges (in millions):
Notional Amount 	Gain (Loss) Recognized in OCI
as of 	Three Months Ended 	Six Months Ended
June 26,
2020 December 31, 2019
June 26,
2020
June 28,
2019
June 26,
2020
June 28,
2019
Foreign currency contracts 	$ 	537 $ 	— 	$ 	22 $ 	7 	$ 	19 $ 	29
Foreign currency denominated debt 	12,341 	12,334 	(86) 	(163) 	(7) 	(32)
Total 	$ 	12,878 $ 	12,334 	$ 	(64) $ 	(156) $ 	12 $ 	(3)
The Company did not reclassify any gains or losses related to net investment hedges from AOCI into earnings during the three and six months ended June 26, 2020 and June 28,
2019. In addition, the Company did not have any ineffectiveness related to net investment hedges during the three and six months ended June 26, 2020 and June 28, 2019. The
cash inflows and outflows associated with the Company's derivative contracts designated as net investment hedges are classified in the line item other investing activities in our
consolidated statement of cash flows.
Economic (Non-Designated) Hedging Strategy
In addition to derivative instruments that are designated and qualify for hedge accounting, the Company also uses certain derivatives as economic hedges of foreign currency,
interest rate and commodity exposure. Although these derivatives were not designated and/or did not qualify for hedge accounting, they are effective economic hedges. The
changes in the fair values of economic hedges are immediately recognized in earnings.
The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and
liabilities denominated in nonfunctional currencies. The changes in the fair values of economic hedges used to offset those monetary assets and liabilities are immediately
recognized in earnings in the line item other income (loss) — net in our consolidated statement of income. In addition, we use foreign currency economic hedges to minimize
the variability in cash flows associated with fluctuations in foreign currency exchange rates, including those related to certain acquisition and divestiture activities. The changes
in the fair values of economic hedges used to offset the variability in U.S. dollar net cash flows are recognized in earnings in the line items net operating revenues, cost of goods
sold or other income (loss) — net in our consolidated statement of income, as applicable. The total notional values of derivatives related to our foreign currency economic
hedges were $4,693 million and $4,291 million as of June 26, 2020 and December 31, 2019, respectively.
The Company also uses certain derivatives as economic hedges to mitigate the price risk associated with the purchase of materials used in the manufacturing process and vehicle
fuel. The changes in the fair values of these economic hedges are immediately recognized in earnings in the line items net operating revenues, cost of goods sold, or selling,
general and
15

-- 18 of 89 --

administrative expenses in our consolidated statement of income, as applicable. The total notional values of derivatives related to our economic hedges of this type were $441
million and $425 million as of June 26, 2020 and December 31, 2019, respectively.
The following tables present the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on earnings (in millions):
Derivatives Not Designated as Hedging Instruments 	Location of Gain (Loss) Recognized in Income
Gain (Loss)
Recognized in Income
Three Months Ended
June 26,
2020
June 28,
2019
Foreign currency contracts 	Net operating revenues 	$ 	38 $ 	(2)
Foreign currency contracts 	Cost of goods sold 	13 	4
Foreign currency contracts 	Other income (loss) — net 	5 	(46)
Commodity contracts 	Cost of goods sold 	18 	(18)
Other derivative instruments 	Selling, general and administrative expenses 	24 	11
Other derivative instruments 	Other income (loss) — net 	2 	—
Total 	$ 	100 $ 	(51)
Derivatives Not Designated as Hedging Instruments 	Location of Gain (Loss) Recognized in Income
Gain (Loss)
Recognized in Income
Six Months Ended
June 26,
2020
June 28,
2019
Foreign currency contracts 	Net operating revenues 	$ 	62 $ 	(13)
Foreign currency contracts 	Cost of goods sold 	27 	2
Foreign currency contracts 	Other income (loss) — net 	(86) 	(25)
Commodity contracts 	Cost of goods sold 	(67) 	2
Other derivative instruments 	Selling, general and administrative expenses 	(32) 	28
Other derivative instruments 	Other income (loss) — net 	(55) 	34
Total 	$ 	(151) $ 	28
NOTE 7: DEBT AND BORROWING ARRANGEMENTS
During the six months ended June 26, 2020, the Company issued U.S. dollar-denominated debt of $11,500 million. The carrying value of this debt as of June 26, 2020 was
$11,396 million. The general terms of the notes issued are as follows:
• 	$1,000 million total principal amount of notes due March 25, 2025, at a fixed interest rate of2.950 percent;
• 	$1,000 million total principal amount of notes due March 25, 2027, at a fixed interest rate of3.375 percent;
• 	$1,500 million total principal amount of notes due June 1, 2027, at a fixed interest rate of1.450 percent;
• 	$1,250 million total principal amount of notes due March 25, 2030, at a fixed interest rate of3.450 percent;
• 	$1,500 million total principal amount of notes due June 1, 2030, at a fixed interest rate of1.650 percent;
• 	$500 million total principal amount of notes due March 25, 2040, at a fixed interest rate of4.125 percent;
• 	$1,000 million total principal amount of notes due June 1, 2040, at a fixed interest rate of2.500 percent;
• 	$1,250 million total principal amount of notes due March 25, 2050, at a fixed interest rate of4.200 percent;
• 	$1,500 million total principal amount of notes due June 1, 2050, at a fixed interest rate of2.600 percent; and
• 	$1,000 million total principal amount of notes due June 1, 2060, at a fixed interest rate of2.750 percent.
During the six months ended June 26, 2020, the Company retired upon maturity:
• 	AUD450 million total principal amount of notes due June 9, 2020, at a fixed interest rate of2.600 percent; and
• 	$171 million total principal amount of zero coupon notes due June 20, 2020.
16

-- 19 of 89 --

NOTE 8: COMMITMENTS AND CONTINGENCIES
Guarantees
As of June 26, 2020, we were contingently liable for guarantees of indebtedness owed by third parties of $480 million, of which $135 million was related to variable interest
entities. Our guarantees are primarily related to third-party customers, bottlers and vendors and have arisen through the normal course of business. These guarantees have
various terms, and none of these guarantees is individually significant. These amounts represent the maximum potential future payments that we could be required to make
under the guarantees; however, we do not consider it probable that we will be required to satisfy these guarantees.
We believe our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations.
Legal Contingencies
The Company is involved in various legal proceedings. We establish reserves for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is
probable and the amount of loss can be reasonably estimated. Management has also identified certain other legal matters where we believe an unfavorable outcome is
reasonably possible and/or for which no estimate of possible losses can be made. Management believes that the total liabilities of the Company that may arise as a result of
currently pending legal proceedings will not have a material adverse effect on the Company taken as a whole.
Tax Audits
The Company is involved in various tax matters, some of which have an uncertain outcome. We establish reserves to remove some or all of the tax benefit of any of our tax
positions at the time we determine that it becomes uncertain based upon one of the following conditions: (1) the tax position is not "more likely than not" to be sustained; (2) the
tax position is "more likely than not" to be sustained but for a lesser amount; or (3) the tax position is "more likely than not" to be sustained but not in the financial period in
which the tax position was originally taken. For purposes of evaluating whether or not a tax position is uncertain, (1) we presume the tax position will be examined by the
relevant taxing authority that has full knowledge of all relevant information; (2) the technical merits of a tax position are derived from authorities such as legislation and
statutes, legislative intent, regulations, rulings and case law and their applicability to the facts and circumstances of the tax position; and (3) each tax position is evaluated
without consideration of the possibility of offset or aggregation with other tax positions taken. A number of years may elapse before a particular uncertain tax position is
audited and finally resolved. The number of years subject to tax audits or tax assessments varies depending on the tax jurisdiction. The tax benefit that has been previously
reserved because of a failure to meet the "more likely than not" recognition threshold would be recognized in our income tax expense in the first interim period when the
uncertainty disappears under any one of the following conditions: (1) the tax position is "more likely than not" to be sustained; (2) the tax position, amount, and/or timing is
ultimately settled through negotiation or litigation; or (3) the statute of limitations for the tax position has expired. Refer to Note 14.
On September 17, 2015, the Company received a Statutory Notice of Deficiency (the "Notice") from the Internal Revenue Service ("IRS") for the tax years 2007 through 2009
after a five-year audit. In the Notice, the IRS claimed that the Company's U.S. taxable income should be increased by an amount that creates a potential additional federal
income tax liability of approximately $3.3 billion for the period plus interest. No penalties were asserted in the Notice. The disputed amounts largely relate to a transfer pricing
matter involving the appropriate amount of taxable income the Company should report in the United States in connection with its licensing of intangible property to certain
related foreign licensees regarding the manufacturing, distribution, sale, marketing, and promotion of products in certain foreign markets.
During the 2007-2009 audit period, the Company followed the same transfer pricing methodology for these licenses that had consistently been followed since the methodology
was agreed with the IRS in a 1996 closing agreement (the "Closing Agreement") that applied back to 1987. The Closing Agreement provided prospective penalty protection
conditioned on the Company's continued adherence to the prescribed methodology absent a change in material facts or circumstances or relevant federal tax law. Although the
IRS subsequently asserted, without explanation, that material facts and circumstances and relevant federal tax law had changed, it has not asserted penalties. The Company's
compliance with the Closing Agreement was audited and confirmed by the IRS in five successive audit cycles covering the subsequent 11 years through 2006, with the last audit
concluding as recently as 2009.
The Notice represents a repudiation of the methodology previously adopted in the Closing Agreement. The IRS designated the matter for litigation on October 15, 2015. Due to
the fact that the matter remains designated, the Company is prevented from pursuing any administrative settlement at IRS Appeals or under the IRS Advance Pricing and
Mutual Agreement Program.
The Company firmly believes that the IRS' claims are without merit and is pursuing, and will continue to pursue, all available administrative and judicial remedies necessary to
vigorously defend its position. To that end, the Company filed a petition in the U.S. Tax Court on December 14, 2015, and the IRS filed its answer on February 12, 2016. On
October 4, 2017, the IRS
17

-- 20 of 89 --

filed an amended answer to the Company's petition in which it increased its transfer pricing adjustment by $385 million resulting in an additional tax adjustment of $135
million.
On June 20, 2017, the Company filed a motion for summary judgment on the portion of the IRS' adjustments related to our licensee in Mexico. On December 14, 2017, the U.S.
Tax Court issued a decision on the summary judgment motion in favor of the Company. This decision effectively reduced the IRS' potential tax adjustment by
approximately $138 million.
The U.S. Tax Court trial was held from March 8, 2018 through May 11, 2018. The Company and the IRS filed and exchanged final post-trial briefs in April 2019. It is not
known how much time will elapse thereafter prior to the issuance of the court's opinion. In the interim, or subsequent to the court's opinion, the IRS may propose similar
adjustments for years subsequent to the 2007-2009 litigation period. While the Company continues to strongly disagree with the IRS' position, there is no assurance that the
court will rule in the Company's favor, and it is possible that all or some portion of the adjustment proposed by the Notice ultimately could be sustained. In that event, the
Company may be subject to significant additional liabilities for the years at issue and potentially also for subsequent periods, which could have a material adverse impact on the
Company's financial position, results of operations, and cash flows.
The Company regularly assesses the likelihood of adverse outcomes resulting from tax disputes such as this and other examinations for all open years to determine the adequacy
of its tax reserves. Any such adjustments related to years prior to 2018, either in the litigation period or later, may have an impact on the transition tax payable as part of the Tax
Cuts and Jobs Act of 2017 ("Tax Reform Act").
Risk Management Programs
The Company has numerous global insurance programs in place to help protect the Company from the risk of loss. In general, we are self-insured for large portions of many
different types of claims; however, we do use commercial insurance above our self-insured retentions to reduce the Company's risk of catastrophic loss. Our reserves for the
Company's self-insured losses are estimated using actuarial methods and assumptions of the insurance industry, adjusted for our specific expectations based on our claim
history. Our self-insurance reserves totaled $276 million and $301 million as of June 26, 2020 and December 31, 2019, respectively.
18

-- 21 of 89 --

NOTE 9: OTHER COMPREHENSIVE INCOME
AOCI attributable to shareowners of The Coca-Cola Company is separately presented in our condensed consolidated balance sheets as a component of The Coca-Cola
Company's shareowners' equity, which also includes our proportionate share of equity method investees' AOCI. OCI attributable to noncontrolling interests is allocated to, and
included in, our condensed consolidated balance sheets as part of the line item equity attributable to noncontrolling interests.
AOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions):
June 26,
2020 	December 31, 2019
Foreign currency translation adjustments 	$ 	(14,204) 	$ 	(11,270)
Accumulated derivative net gains (losses) 	(219) 	(209)
Unrealized net gains (losses) on available-for-sale debt securities 	56 	75
Adjustments to pension and other benefit liabilities 	(2,093) 	(2,140)
Accumulated other comprehensive income (loss) 	$ 	(16,460) 	$ 	(13,544)
The following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):
Six Months Ended June 26, 2020
Shareowners of
The Coca-Cola Company
Noncontrolling
Interests 	Total
Consolidated net income 	$ 	4,554 $ 	— $ 	4,554
Other comprehensive income:
Net foreign currency translation adjustments 	(2,934) 	(401) 	(3,335)
Net gains (losses) on derivatives1 	(10) 	— 	(10)
Net change in unrealized gains (losses) on available-for-sale debt
securities2 	(19) 	— 	(19)
Net change in pension and other benefit liabilities 	47 	— 	47
Total comprehensive income (loss) 	$ 	1,638 $ 	(401) $ 	1,237
1 Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
2 Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
19

-- 22 of 89 --

The following tables present OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees' OCI (in millions):
Three Months Ended June 26, 2020
Before-Tax
Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	(894) 	$ 	14 	$ 	(880)
Reclassification adjustments recognized in net income 	— 	— 	—
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	160 	— 	160
Gains (losses) on net investment hedges arising during the period1 	(64) 	16 	(48)
Net foreign currency translation adjustments 	$ 	(798) 	$ 	30 	$ 	(768)
Derivatives:
Gains (losses) arising during the period 	$ 	(88) 	$ 	25 	$ 	(63)
Reclassification adjustments recognized in net income 	49 	(12) 	37
Net gains (losses) on derivatives1 	$ 	(39) 	$ 	13 	$ 	(26)
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period 	$ 	(14) 	$ 	5 	$ 	(9)
Reclassification adjustments recognized in net income 	(3) 	1 	(2)
Net change in unrealized gains (losses) on available-for-sale debt securities2 	$ 	(17) 	$ 	6 	$ 	(11)
Pension and other benefit liabilities:
Net pension and other benefit liabilities arising during the period 	$ 	1 	$ 	7 	$ 	8
Reclassification adjustments recognized in net income 	43 	(10) 	33
Net change in pension and other benefit liabilities 	$ 	44 	$ 	(3) 	$ 	41
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	(810) 	$ 	46 	$ 	(764)
1 Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
2 Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
Six Months Ended June 26, 2020
Before-Tax
Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	(3,175) 	$ 	226 	$ 	(2,949)
Reclassification adjustments recognized in net income 	3 	— 	3
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	3 	— 	3
Gains (losses) on net investment hedges arising during the period1 	12 	(3) 	9
Net foreign currency translation adjustments 	$ 	(3,157) 	$ 	223 	$ 	(2,934)
Derivatives:
Gains (losses) arising during the period 	$ 	(65) 	$ 	17 	$ 	(48)
Reclassification adjustments recognized in net income 	50 	(12) 	38
Net gains (losses) on derivatives1 	$ 	(15) 	$ 	5 	$ 	(10)
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period 	$ 	(22) 	$ 	10 	$ 	(12)
Reclassification adjustments recognized in net income 	(9) 	2 	(7)
Net change in unrealized gains (losses) on available-for-sale debt securities2 	$ 	(31) 	$ 	12 	$ 	(19)
Pension and other benefit liabilities:
Net pension and other benefit liabilities arising during the period 	$ 	(24) 	$ 	6 	$ 	(18)
Reclassification adjustments recognized in net income 	86 	(21) 	65
Net change in pension and other benefit liabilities 	$ 	62 	$ 	(15) 	$ 	47
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	(3,141) 	$ 	225 	$ 	(2,916)
1 Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
2 Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
20

-- 23 of 89 --

Three Months Ended June 28, 2019
Before-Tax
Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	(882) 	$ 	2 	$ 	(880)
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	323 	— 	323
Gains (losses) on net investment hedges arising during the period1 	(156) 	29 	(127)
Net foreign currency translation adjustments 	$ 	(715) 	$ 	31 	$ 	(684)
Derivatives:
Gains (losses) arising during the period 	$ 	(81) 	$ 	19 	$ 	(62)
Reclassification adjustments recognized in net income 	51 	(13) 	38
Net gains (losses) on derivatives1 	$ 	(30) 	$ 	6 	$ 	(24)
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period 	$ 	35 	$ 	(3) 	$ 	32
Reclassification adjustments recognized in net income 	(22) 	5 	(17)
Net change in unrealized gains (losses) on available-for-sale debt securities2 	$ 	13 	$ 	2 	$ 	15
Pension and other benefit liabilities:
Net pension and other benefit liabilities arising during the period 	$ 	8 	$ 	1 	$ 	9
Reclassification adjustments recognized in net income 	37 	(9) 	28
Net change in pension and other benefit liabilities 	$ 	45 	$ 	(8) 	$ 	37
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	(687) 	$ 	31 	$ 	(656)
1 Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
2 Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
Six Months Ended June 28, 2019
Before-Tax
Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	115 	$ 	(71) 	$ 	44
Reclassification adjustments recognized in net income 	192 	— 	192
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	36 	— 	36
Gains (losses) on net investment hedges arising during the period1 	(3) 	1 	(2)
Net foreign currency translation adjustments 	$ 	340 	$ 	(70) 	$ 	270
Derivatives:
Gains (losses) arising during the period 	$ 	(117) 	$ 	23 	$ 	(94)
Reclassification adjustments recognized in net income 	104 	(26) 	78
Net gains (losses) on derivatives1 	$ 	(13) 	$ 	(3) 	$ 	(16)
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period 	$ 	59 	$ 	(10) 	$ 	49
Reclassification adjustments recognized in net income 	(24) 	5 	(19)
Net change in unrealized gains (losses) on available-for-sale debt securities2 	$ 	35 	$ 	(5) 	$ 	30
Pension and other benefit liabilities:
Net pension and other benefit liabilities arising during the period 	$ 	7 	$ 	5 	$ 	12
Reclassification adjustments recognized in net income 	74 	(18) 	56
Net change in pension and other benefit liabilities 	$ 	81 	$ 	(13) 	$ 	68
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	443 	$ 	(91) 	$ 	352
1 Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
2 Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
21

-- 24 of 89 --

The following table presents the amounts and line items in our condensed consolidated statements of income where adjustments reclassified from AOCI into income were
recorded (in millions):
Amount Reclassified from AOCI
into Income
Description of AOCI Component 	Financial Statement Line Item
Three Months Ended June
26, 2020
Six Months Ended June 26,
2020
Foreign currency translation adjustments:
Divestitures, deconsolidations and other1 	Other income (loss) — net 	$ 	— 	$ 	3
Income before income taxes 	— 	3
Income taxes 	— 	—
Consolidated net income 	$ 	— 	$ 	3
Derivatives:
Foreign currency contracts 	Net operating revenues 	$ 	(3) 	$ 	1
Foreign currency contracts 	Cost of goods sold 	(4) 	(5)
Foreign currency contracts 	Other income (loss) — net 	44 	29
Foreign currency and interest rate contracts 	Interest expense 	12 	25
Income before income taxes 	49 	50
Income taxes 	(12) 	(12)
Consolidated net income 	$ 	37 	$ 	38
Available-for-sale debt securities:
Sale of debt securities 	Other income (loss) — net 	$ 	(3) 	$ 	(9)
Income before income taxes 	(3) 	(9)
Income taxes 	1 	2
Consolidated net income 	$ 	(2) 	$ 	(7)
Pension and other benefit liabilities:
Recognized net actuarial loss 	Other income (loss) — net 	$ 	43 	$ 	87
Recognized prior service cost (credit) 	Other income (loss) — net 	— 	(1)
Income before income taxes 	43 	86
Income taxes 	(10) 	(21)
Consolidated net income 	$ 	33 	$ 	65
1 Related to the sale of a portion of our ownership interest in one of our equity method investments. Refer to Note 2.
NOTE 10: CHANGES IN EQUITY
The following tables provide a reconciliation of the beginning and ending carrying amounts of total equity, equity attributable to shareowners of The Coca-Cola Company and
equity attributable to noncontrolling interests (in millions):
Shareowners of The Coca-Cola Company
Three Months Ended June 26, 2020
Common Shares
Outstanding 	Total
Reinvested
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Common
Stock
Capital
Surplus
Treasury
Stock
Non-
controlling
Interests
March 27, 2020 	4,294 $ 19,834 $ 66,870 $ 	(15,696) $ 	1,760 $ 17,312 $ 	(52,088) $ 	1,676
Comprehensive income (loss) 	— 	1,049 	1,779 	(764) 	— 	— 	— 	34
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.41 per share) 	— 	(1,761) 	(1,761) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling
interests 	— 	(5) 	— 	— 	— 	— 	— 	(5)
Impact related to stock-based
compensation plans 	1 	72 	— 	— 	— 	55 	17 	—
June 26, 2020 	4,295 $ 19,189 $ 66,888 $ 	(16,460) $ 	1,760 $ 17,367 $ 	(52,071) $ 	1,705
22

-- 25 of 89 --

Shareowners of The Coca-Cola Company
Six Months Ended June 26, 2020
Common Shares
Outstanding 	Total
Reinvested
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Common
Stock
Capital
Surplus
Treasury
Stock
Non-
controlling
Interests
December 31, 2019 	4,280 $ 21,098 $ 65,855 $ 	(13,544) $ 	1,760 $ 17,154 $ 	(52,244) $ 	2,117
Comprehensive income (loss) 	— 	1,237 	4,554 	(2,916) 	— 	— 	— 	(401)
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.82 per share) 	— 	(3,521) 	(3,521) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling
interests 	— 	(11) 	— 	— 	— 	— 	— 	(11)
Impact related to stock-based
compensation plans 	15 	386 	— 	— 	— 	213 	173 	—
June 26, 2020 	4,295 $ 19,189 $ 66,888 $ 	(16,460) $ 	1,760 $ 17,367 $ 	(52,071) $ 	1,705
Shareowners of The Coca-Cola Company
Three Months Ended June 28, 2019
Common Shares
Outstanding 	Total
Reinvested
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Common
Stock
Capital
Surplus
Treasury
Stock
Non-
controlling
Interests
March 29, 2019 	4,268 $ 19,804 $ 63,704 $ 	(12,325) $ 	1,760 $ 16,577 $ 	(51,981) $ 	2,069
Comprehensive income (loss) 	— 	2,011 	2,607 	(656) 	— 	— 	— 	60
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.40 per share) 	— 	(1,709) 	(1,709) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling
interests 	— 	(15) 	— 	— 	— 	— 	— 	(15)
Purchases of treasury stock 	(5) 	(237) 	— 	— 	— 	— 	(237) 	—
Impact related to stock-based
compensation plans 	12 	441 	— 	— 	— 	256 	185 	—
June 28, 2019 	4,275 $ 20,295 $ 64,602 $ 	(12,981) $ 	1,760 $ 16,833 $ 	(52,033) $ 	2,114
Shareowners of The Coca-Cola Company
Six Months Ended June 28, 2019
Common Shares
Outstanding 	Total
Reinvested
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Common
Stock
Capital
Surplus
Treasury
Stock
Non-
controlling
Interests
December 31, 2018 	4,268 $ 19,058 $ 63,234 $ 	(12,814) $ 	1,760 $ 16,520 $ 	(51,719) $ 	2,077
Adoption of accounting standards 	— 	(18) 	501 	(519) 	— 	— 	— 	—
Comprehensive income (loss) 	— 	4,694 	4,285 	352 	— 	— 	— 	57
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.80 per share) 	— 	(3,418) 	(3,418) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling
interests 	— 	(20) 	— 	— 	— 	— 	— 	(20)
Purchases of treasury stock 	(14) 	(635) 	— 	— 	— 	— 	(635) 	—
Impact related to stock-based
compensation plans 	21 	634 	— 	— 	— 	313 	321 	—
June 28, 2019 	4,275 $ 20,295 $ 64,602 $ 	(12,981) $ 	1,760 $ 16,833 $ 	(52,033) $ 	2,114
23

-- 26 of 89 --

NOTE 11: SIGNIFICANT OPERATING AND NONOPERATING ITEMS
Other Operating Charges
During the three months ended June 26, 2020, the Company recorded other operating charges of $173 million. These charges included an impairment charge of $55 million
related to a trademark in North America, which was primarily driven by the impact of the COVID-19 pandemic, revised projections of future operating results and a change in
brand focus in the Company's portfolio. Also included were charges of $35 million related to discontinuing the Odwalla juice business and an impairment charge of $8 million
related to the Odwalla trademark. Other operating charges also included $22 million related to the Company's productivity and reinvestment program, $18 million related to the
remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition and $12 million related to the restructuring of our water
manufacturing operations in the United States. Refer to Note 2 for additional information on the fairlife acquisition. Refer to Note 12 for additional information on the
Company's productivity and reinvestment program. Refer to Note 15 for additional information on the impairment charges. Refer to Note 16 for the impact these charges had on
our operating segments and Corporate.
During the six months ended June 26, 2020, the Company recorded other operating charges of $375 million. These charges included an impairment charge of $160 million
related to the Odwalla trademark and charges of $35 million related to discontinuing the Odwalla juice business. These charges also included an impairment charge of $55
million related to a trademark in North America, which was primarily driven by the impact of the COVID-19 pandemic, revised projections of future operating results and a
change in brand focus in the Company's portfolio. Other operating charges also included $61 million related to the Company's productivity and reinvestment program, $29
million related to the remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition and $12 million related to the restructuring
of our water manufacturing operations in the United States. Refer to Note 2 for additional information on the fairlife acquisition. Refer to Note 12 for additional information on
the Company's productivity and reinvestment program. Refer to Note 15 for additional information on the impairment charges. Refer to Note 16 for the impact these charges
had on our operating segments and Corporate.
During the three months ended June 28, 2019, the Company recorded other operating charges of $92 million. These charges primarily consisted of $55 million related to the
Company's productivity and reinvestment program. In addition, other operating charges included $29 million for costs incurred to refranchise certain of our North America
bottling operations. Costs related to refranchising include, among other items, internal and external costs for individuals directly working on the refranchising efforts, severance,
and costs associated with the implementation of information technology systems to facilitate consistent data standards and availability throughout our North America bottling
system. Refer to Note 12 for additional information on the Company's productivity and reinvestment program. Refer to Note 16 for the impact these charges had on our
operating segments and Corporate.
During the six months ended June 28, 2019, the Company recorded other operating charges of $219 million. These charges primarily consisted of $123 million related to the
Company's productivity and reinvestment program. In addition, other operating charges included $46 million of transaction costs associated with the purchase of Costa, which
we acquired in January 2019, and $40 million for costs incurred to refranchise certain of our North America bottling operations. Other operating charges also included $2
million related to tax litigation expense. Refer to Note 2 for additional information on the acquisition of Costa. Refer to Note 8 for additional information related to the tax
litigation. Refer to Note 12 for additional information on the Company's productivity and reinvestment program. Refer to Note 16 for the impact these charges had on our
operating segments and Corporate.
Other Nonoperating Items
Equity Income (Loss) — Net
During the three and six months ended June 26, 2020, the Company recorded net charges of $63 million and $101 million, respectively. During the three and six months ended
June 28, 2019, the Company recorded net charges of $26 million and $68 million, respectively. These amounts represent the Company's proportionate share of significant
operating and nonoperating items recorded by certain of our equity method investees. Refer to Note 16 for the impact these items had on our operating segments and Corporate.
24

-- 27 of 89 --

Other Income (Loss) — Net
During the three months ended June 26, 2020, the Company recognized a net gain of $247 million related to realized and unrealized gains and losses on equity securities and
trading debt securities as well as realized gains and losses on available-for-sale debt securities. The Company also recorded an other-than-temporary impairment charge of
$38 million related to one of our equity method investees in Latin America and a charge of $19 million related to asset write-offs associated with the restructuring of our water
manufacturing operations in the United States. Refer to Note 4 for additional information on equity and debt securities. Refer to Note 15 for additional information on the
impairment charge. Refer to Note 16 for the impact these items had on our operating segments and Corporate.
During the six months ended June 26, 2020, the Company recognized a gain of $902 million in conjunction with the fairlife acquisition, which resulted from the remeasurement
of our previously held equity interest in fairlife to fair value, and a gain of $18 million related to the sale of a portion of our ownership interest in one of our equity method
investments. These gains were partially offset by an other-than-temporary impairment charge of $38 million related to one of our equity method investees in Latin America, a
charge of $19 million related to asset write-offs associated with the restructuring of our water manufacturing operations in the United States, a net loss of $144 million related to
realized and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities, and a net loss of
$55 million related to economic hedging activities. Refer to Note 2 for additional information on the fairlife acquisition. Refer to Note 4 for additional information on equity and
debt securities. Refer to Note 6 for additional information on our economic hedging activities. Refer to Note 15 for additional information on the impairment charge. Refer to
Note 16 for the impact these items had on our operating segments and Corporate.
During the three months ended June 28, 2019, the Company recorded an adjustment to reduce the carrying amount of CCBA's fixed assets and definite-lived intangible assets
by $160 million. The Company also recorded an other-than-temporary impairment charge of $49 million related to one of our equity method investees in Latin America and a
net gain of $10 million related to realized and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-
sale debt securities. Refer to Note 2 for additional information on the CCBA asset adjustment. Refer to Note 4 for additional information on equity and debt securities. Refer to
Note 15 for information on the impairment charge. Refer to Note 16 for the impact these items had on our operating segments and Corporate.
During the six months ended June 28, 2019, the Company recognized other-than-temporary impairment charges of $286 million related to Coca-Cola Bottlers Japan Holdings
Inc. ("CCBJHI"), an equity method investee, $57 million related to one of our equity method investees in North America, and $49 million related to one of our other equity
method investees. The Company also recorded an adjustment to reduce the carrying amount of CCBA's fixed assets and definite-lived intangible assets by $160 million and
recognized a $121 million loss in conjunction with our acquisition of the remaining equity ownership interest in CHI. These charges were partially offset by a net gain of $159
million related to realized and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities
and a gain of $39 million related to the sale of a portion of our equity ownership interest in Andina. Refer to Note 2 for additional information on the CCBA asset adjustment,
the acquisition of the remaining equity ownership interest in CHI and the sale of a portion of our equity ownership interest in Andina. Refer to Note 4 for additional information
on equity and debt securities. Refer to Note 15 for additional information on the impairment charges and the loss recognized in conjunction with our acquisition of the
remaining equity ownership interest in CHI. Refer to Note 16 for the impact these items had on our operating segments and Corporate.
NOTE 12: PRODUCTIVITY AND REINVESTMENT PROGRAM
In February 2012, the Company announced a productivity and reinvestment program designed to further enable our efforts to strengthen our brands and reinvest our resources to
drive long-term profitable growth. This program is focused on the following initiatives: global supply chain optimization; global marketing and innovation effectiveness;
operating expense leverage and operational excellence; data and information technology systems standardization; and the integration of Coca-Cola Enterprises Inc.'s former
North America business.
In February 2014, the Company announced the expansion of our productivity and reinvestment program to drive incremental productivity that will primarily be redirected into
increased media investments. Our incremental productivity goal consists of two relatively equal components. First, we will expand savings through global supply chain
optimization, data and information technology systems standardization, and resource and cost reallocation. Second, we will increase the effectiveness of our marketing
investments by transforming our marketing and commercial model to redeploy resources into more consumer-facing marketing investments to accelerate growth.
In October 2014, the Company announced that we were further expanding our productivity and reinvestment program and extending it through 2019. The expansion of the
productivity initiatives focused on four key areas: restructuring the Company's global supply chain; implementing zero-based work, an evolution of zero-based budget
principles, across the organization;
25

-- 28 of 89 --

streamlining and simplifying the Company's operating model; and further driving increased discipline and efficiency in direct marketing investments.
In April 2017, the Company announced another expansion of our productivity and reinvestment program. This expansion is focused on achieving additional efficiencies in both
our supply chain and our marketing expenditures as well as transitioning to a new, more agile operating model to enable growth. Under this operating model, our business units
will be supported by an expanded enabling services organization and a corporate center focused on a few strategic initiatives, policy and governance. The expanded enabling
services organization will focus on both simplifying and standardizing key transactional processes and providing support to business units through global centers of excellence.
Certain productivity initiatives included in this program, primarily related to our enabling services organization, will continue until the initiatives have been completed.
The Company has incurred total pretax expenses of $3,891 million related to our productivity and reinvestment program since it commenced. These expenses were recorded in
the line items other operating charges and other income (loss) — net in our condensed consolidated statements of income. Refer to Note 16 for the impact these charges had on
our operating segments and Corporate. Outside services reported in the tables below primarily relate to expenses in connection with legal, outplacement and consulting
activities. Other direct costs reported in the tables below include, among other items, internal and external costs associated with the development, communication,
administration and implementation of these initiatives; accelerated depreciation on certain fixed assets; contract termination fees; and relocation costs.
The following tables summarize the balance of accrued expenses related to these productivity and reinvestment initiatives and the changes in the accrued amounts as of and for
the three and six months ended June 26, 2020 (in millions):
Accrued Balance
March 27, 2020
Costs
Incurred 	Payments
Noncash
and
Exchange
Accrued Balance
June 26, 2020
Severance pay and benefits 	$ 	50 $ 	— $ 	(6) $ 	2 $ 	46
Outside services 	1 	10 	(11) 	— 	—
Other direct costs 	3 	12 	(13) 	(1) 	1
Total 	$ 	54 $ 	22 $ 	(30) $ 	1 $ 	47
Accrued Balance
December 31, 2019
Costs
Incurred 	Payments
Noncash
and
Exchange
Accrued Balance
June 26, 2020
Severance pay and benefits 	$ 	58 $ 	1 $ 	(13) $ 	— $ 	46
Outside services 	1 	37 	(38) 	— 	—
Other direct costs 	7 	23 	(24) 	(5) 	1
Total 	$ 	66 $ 	61 $ 	(75) $ 	(5) $ 	47
NOTE 13: PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
Net periodic benefit cost (income) for our pension and other postretirement benefit plans consisted of the following (in millions):
Pension Benefit Plans
Other Postretirement
Benefit Plans
Three Months Ended
June 26,
2020
June 28,
2019
June 26,
2020
June 28,
2019
Service cost 	$ 	28 $ 	26 	$ 	3 $ 	3
Interest cost 	59 	73 	5 	6
Expected return on plan assets1 	(145) 	(138) 	(4) 	(4)
Amortization of prior service credit 	— 	(1) 	— 	—
Amortization of net actuarial loss 	42 	38 	1 	—
Net periodic benefit cost (income) 	$ 	(16) $ 	(2) 	$ 	5 $ 	5
1 The weighted-average expected long-term rates of return on plan assets used in computing 2020 net periodic benefit cost (income) are 7.50 percent for pension benefit plans and 4.50 percent
for other postretirement benefit plans.
26

-- 29 of 89 --

Pension Benefit Plans
Other Postretirement
Benefit Plans
Six Months Ended
June 26,
2020
June 28,
2019
June 26,
2020
June 28,
2019
Service cost 	$ 	56 $ 	52 	$ 	6 $ 	5
Interest cost 	118 	145 	11 	13
Expected return on plan assets1 	(292) 	(276) 	(8) 	(7)
Amortization of prior service credit 	— 	(2) 	(1) 	(1)
Amortization of net actuarial loss 	85 	76 	2 	1
Net periodic benefit cost (income) 	$ 	(33) $ 	(5) 	$ 	10 $ 	11
1 The weighted-average expected long-term rates of return on plan assets used in computing 2020 net periodic benefit cost (income) are 7.50 percent for pension benefit plans and 4.50 percent
for other postretirement benefit plans.
All of the amounts in the tables above, other than service cost, were recorded in the line item other income (loss) — net in our condensed consolidated statements of income.
During the six months ended June 26, 2020, the Company contributed $8 million to our pension trusts, and we anticipate making additional contributions of approximately $18
million during the remainder of 2020. The Company contributed $22 million to our pension trusts during the six months ended June 28, 2019.
NOTE 14: INCOME TAXES
The Company recorded income taxes of $438 million (19.9 percent effective tax rate) and $421 million (13.8 percent effective tax rate) during the three months ended June 26,
2020 and June 28, 2019, respectively. The Company recorded income taxes of $653 million (12.5 percent effective tax rate) and $943 million (17.9 percent effective tax rate)
during the six months ended June 26, 2020 and June 28, 2019, respectively.
The Company's effective tax rates for the three and six months ended June 26, 2020 and June 28, 2019 vary from the statutory U.S. federal income tax rate of21.0 percent
primarily due to the tax impact of significant operating and nonoperating items, along with the tax benefits of having significant operations outside the United States and
significant earnings generated in investments accounted for under the equity method, both of which are generally taxed at rates lower than the statutory U.S. rate.
The Company's effective tax rate for the six months ended June 26, 2020 included the favorable impact of a $40 million tax benefit associated with the gain recorded upon the
acquisition of the remaining interest in fairlife and also included the net tax benefit of various discrete tax items. Refer to Note 2 for additional information on the fairlife
acquisition.
The Company's effective tax rates for the three and six months ended June 28, 2019 included $199 million of tax benefit recorded as a result of CCBA no longer qualifying as a
discontinued operation. Refer to Note 2.
On September 17, 2015, the Company received a Statutory Notice of Deficiency from the IRS for the tax years 2007 through 2009, after a five-year audit. The Company
contested the proposed adjustments in U.S. Tax Court and is currently awaiting a decision. Refer to Note 8.
27

-- 30 of 89 --

NOTE 15: FAIR VALUE MEASUREMENTS
Recurring Fair Value Measurements
The following tables summarize assets and liabilities measured at fair value on a recurring basis (in millions):
June 26, 2020 	Level 1 	Level 2 	Level 3 	Other3
Netting
Adjustment 4
Fair Value
Measurements
Assets:
Equity securities with readily determinable values1 	$ 	1,685 $ 	183 $ 	11 	$ 	94 $ 	— 	$ 	1,973
Debt securities1 	— 	2,242 	45 	— 	— 	2,287
Derivatives2 	3 	856 	— 	— 	(582) 6 	277 	8
Total assets 	$ 	1,688 $ 	3,281 $ 	56 	$ 	94 $ 	(582) 	$ 	4,537
Liabilities:
Contingent consideration liability 	$ 	— $ 	— $ 	(299) 	5 $ 	— $ 	— 	$ 	(299)
Derivatives2 	(8) 	(377) 	— 	— 	317 	7 	(68) 8
Total liabilities 	$ 	(8) $ 	(377) $ 	(299) 	$ 	— $ 	317 	$ 	(367)
1 Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
2 Refer to Note 6 for additional information related to the composition of our derivative portfolio.
3 Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are
included to reconcile to the amounts presented in Note 4.
4 Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with
the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting
requirements. Refer to Note 6.
5 Refer to Note 2 for additional information related to the contingent consideration liability resulting from the fairlife acquisition.
6 The Company is obligated to return $ 289 million in cash collateral it has netted against its derivative position.
7 The Company has the right to reclaim $ 18 million in cash collateral it has netted against its derivative position.
8 The Company's derivative financial instruments are recorded at fair value in our condensed consolidated balance sheet as follows:
$277 million in the line item other assets and $68 million in the line item other liabilities. Refer to Note 6 for additional information related
to the composition of our derivative portfolio.
December 31, 2019 	Level 1 	Level 2 	Level 3 	Other3
Netting
Adjustment 4
Fair Value
Measurements
Assets:
Equity securities with readily determinable values1 	$ 	1,877 $ 	219 $ 	14 	$ 	109 $ 	— 	$ 	2,219
Debt securities1 	— 	3,291 	37 	— 	— 	3,328
Derivatives2 	9 	579 	— 	— 	(392) 5 	196 	6
Total assets 	$ 	1,886 $ 	4,089 $ 	51 	$ 	109 $ 	(392) 	$ 	5,743
Liabilities:
Derivatives2 	$ 	— $ 	(162) $ 	— 	$ 	— $ 	130 	$ 	(32) 6
Total liabilities 	$ 	— $ 	(162) $ 	— 	$ 	— $ 	130 	$ 	(32)
1 Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
2 Refer to Note 6 for additional information related to the composition of our derivative portfolio.
3 Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are
included to reconcile to the amounts presented in Note 4.
4 Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with
the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting
requirements. Refer to Note 6.
5 The Company is obligated to return $ 261 million in cash collateral it has netted against its derivative position.
6 The Company's derivative financial instruments are recorded at fair value in our condensed consolidated balance sheet as follows: $ 196 million in the line item other assets and $32 million in
the line item other liabilities. Refer to Note 6 for additional information related to the composition of our derivative portfolio.
28

-- 31 of 89 --

Gross realized and unrealized gains and losses on Level 3 assets and liabilities were not significant for the three and six months ended June 26, 2020 and June 28, 2019.
The Company recognizes transfers between levels within the hierarchy as of the beginning of the reporting period. Gross transfers between levels within the hierarchy were not
significant for the three and six months ended June 26, 2020 and June 28, 2019.
Nonrecurring Fair Value Measurements
The gains and losses on assets measured at fair value on a nonrecurring basis are summarized in the table below (in millions):
Gains (Losses)
Three Months Ended 	Six Months Ended
June 26,
2020
June 28,
2019
June 26,
2020
June 28,
2019
Impairment of intangible assets 	$ 	(63) 1 $ 	— 	$ 	(215) 1 $ 	—
Other-than-temporary impairment charges 	(38) 2 	(49) 2 	(38) 2 	(392) 2
Impairment of equity investment without a readily
determinable fair value 	— 	— 	(26) 4 	—
CCBA asset adjustments 	— 	(160) 3 	— 	(160) 3
Total 	$ 	(101) 	$ 	(209) 	$ 	(279) 	$ 	(552)
1 The Company recorded impairment charges of $8 million and $160 million during the three and six months ended June 26, 2020, respectively, related to its Odwalla trademark in North
America, as the Company decided in June 2020 to discontinue its Odwalla juice business. The Company recorded an impairment charge of $55 million during the three and six months ended
June 26, 2020 related to a trademark in North America, which was primarily driven by the impact of the COVID-19 pandemic, revised projections of future operating results and a change in
brand focus in the Company's portfolio. The fair value of this trademark was derived using discounted cash flow analyses based on Level 3 inputs.
2 The Company recognized other-than-temporary impairment charges of $ 38 million during the three and six months ended June 26, 2020 and $49 million during the three and six months
ended June 28, 2019 related to certain of our equity method investees in Latin America, primarily driven by revised projections of future operating results. The fair values of these investments
were derived using discounted cash flow analyses based on Level 3 inputs. During the six months ended June 28, 2019, the Company recognized an other-than-temporary impairment charge
of $286 million related to our investment in CCBJHI, an equity method investee. Based on the length of time and the extent to which the market value of our investment in CCBJHI had been
less than our carrying value as well as the financial condition and near-term prospects of the issuer, management determined that the decline in fair value was other than temporary in nature.
This impairment charge was determined using the quoted market price (a Level 1 measurement) of CCBJHI. During the six months ended June 28, 2019, the Company also recognized an
other-than-temporary impairment charge of $57 million related to one of our equity method investees in North America. This impairment charge was derived using Level 3 inputs and was
primarily driven by revised projections of future operating results.
3 The Company was required to measure CCBA's property, plant and equipment and definite-lived intangible assets at the lower of their current fair values or their carrying amounts before
they were classified as held for sale, adjusted for depreciation and amortization expense that would have been recognized had the business been classified as held and used during the period
that CCBA was classified as held for sale. As a result, we reduced the carrying value of CCBA's property, plant and equipment and definite-lived intangible assets by $34 million and $126
million, respectively, based on Level 3 inputs. Refer to Note 2.
4 The Company recorded an impairment charge of $26 million related to an investment in an equity security without a readily determinable fair value. This impairment charge was derived
using Level 3 inputs and was primarily driven by revised projections of future operating results.
Other Fair Value Disclosures
The carrying amounts of cash and cash equivalents; short-term investments; trade accounts receivable; accounts payable and accrued expenses; and loans and notes payable
approximate their fair values because of the relatively short-term maturities of these financial instruments. The fair value of our long-term debt is estimated using Level 2 inputs
based on quoted prices for those instruments. Where quoted prices are not available, fair value is estimated using discounted cash flows and market-based expectations for
interest rates, credit risk and the contractual terms of the debt instruments. As of June 26, 2020, the carrying amount and fair value of our long-term debt, including the current
portion, were $42,910 million and $45,465 million, respectively. As of December 31, 2019, the carrying amount and fair value of our long-term debt, including the current
portion, were $31,769 million and $32,725 million, respectively.
29

-- 32 of 89 --

NOTE 16: OPERATING SEGMENTS
Information about our Company's operations by operating segment and Corporate is as follows (in millions):
Europe, Middle
East & Africa
Latin
America
North
America 	Asia Pacific
Global
Ventures
Bottling
Investments 	Corporate 	Eliminations 	Consolidated
As of and for the Three Months Ended June 26,
2020
Net operating revenues:
Third party 	$ 1,135 	$ 	755 $ 	2,647 $ 1,068 	$ 	295 	$ 	1,262 	$ 	(12) $ 	— $ 	7,150
Intersegment 	75 	— 	1 	115 	— 	1 	— 	(192) 	—
Total net operating revenues 	1,210 	755 	2,648 	1,183 	295 	1,263 	(12) 	(192) 	7,150
Operating income (loss) 	715 	504 	489 	652 	(102) 	12 	(289) 	— 	1,981
Income (loss) before income taxes 	736 	444 	483 	661 	(103) 	166 	(190) 	— 	2,197
Identifiable operating assets 	8,065 1 	1,643 	20,320 	2,131 	2 	6,983 	9,817 1,2 	26,795 	— 	75,754
Investments3 	534 	573 	356 	226 	5 	13,199 	4,042 	— 	18,935
As of and for the Three Months Ended June 28,
2019
Net operating revenues:
Third party 	$ 1,804 	$ 1,003 $ 	3,158 $ 1,350 	$ 	635 	$ 	2,024 	$ 	23 $ 	— $ 	9,997
Intersegment 	126 	— 	4 	190 	— 	2 	— 	(322) 	—
Total net operating revenues 	1,930 	1,003 	3,162 	1,540 	635 	2,026 	23 	(322) 	9,997
Operating income (loss) 	1,038 	588 	711 	731 	73 	119 	(272) 	— 	2,988
Income (loss) before income taxes 	1,062 	540 	729 	738 	75 	393 	(488) 	— 	3,049
Identifiable operating assets 	8,511 1 	2,008 	18,512 	2,266 	7,236 	10,727 1 	20,424 	— 	69,684
Investments3 	731 	728 	364 	223 	16 	14,420 	3,830 	— 	20,312
As of December 31, 2019
Identifiable operating assets 	$ 8,143 1 $ 1,801 $ 17,687 $ 2,060 	$ 7,265 	$ 	11,170 1 	$ 18,376 $ 	— $ 	66,502
Investments3 	543 	716 	358 	224 	14 	14,093 	3,931 	— 	19,879
1 Property, plant and equipment — net in South Africa represented 14 percent, 14 percent and 16 percent of consolidated property, plant and equipment — net as of June 26, 2020, June 28,
2019 and December 31, 2019, respectively.
2 Property, plant and equipment — net in the Philippines represented 10 percent of consolidated property, plant and equipment — net as of June 26, 2020.
3 Principally equity method investments and other investments in bottling companies.
During the three months ended June 26, 2020, the results of our operating segments and Corporate were impacted by the following items:
• Operating income (loss) and income (loss) before income taxes were reduced by $55 million for North America related to the impairment of a trademark, which was
primarily driven by the impact of the COVID-19 pandemic, revised projections of future operating results and a change in brand focus in the Company's portfolio.
• Operating income (loss) and income (loss) before income taxes were reduced by $39 million for North America for charges related to the cost of discontinuing the Odwalla
juice business and $8 million related to the impairment of the Odwalla trademark.
• Operating income (loss) and income (loss) before income taxes were reduced by $25 million and $44 million, respectively, for North America related to the restructuring of
our water manufacturing operations in the United States.
• Operating income (loss) and income (loss) before income taxes were reduced by $22 million for Corporate due to the Company's productivity and reinvestment program.
Refer to Note 12.
• Operating income (loss) and income (loss) before income taxes were reduced by $18 million for Corporate related to the remeasurement of our contingent consideration
liability to fair value in conjunction with the fairlife acquisition. Refer to Note 2.
30

-- 33 of 89 --

• Income (loss) before income taxes was increased by $247 million for Corporate related to realized and unrealized gains and losses on equity securities and trading debt
securities as well as realized gains and losses on available-for-sale debt securities. Refer to Note 4.
• Income (loss) before income taxes was reduced by $28 million for Latin America, $1 million for North America and $34 million for Bottling Investments due to the
Company's proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees.
• Income (loss) before income taxes was reduced by $38 million for Latin America due to an other-than-temporary impairment charge related to one of our equity method
investees.
During the three months ended June 28, 2019, the results of our operating segments and Corporate were impacted by the following items:
• Operating income (loss) and income (loss) before income taxes were reduced by $29 million for Bottling Investments related to costs incurred to refranchise certain of our
North America bottling operations. Refer to Note 11.
• Operating income (loss) and income (loss) before income taxes were reduced by $13 million for North America, $1 million for Bottling Investments and $41 million for
Corporate due to the Company's productivity and reinvestment program. Refer to Note 12.
• Income (loss) before income taxes was reduced by $160 million for Corporate as a result of CCBA asset adjustments. Refer to Note 2.
• Income (loss) before income taxes was reduced by $49 million for Latin America due to an other-than-temporary impairment charge related to one of our equity method
investees.
• Income (loss) before income taxes was reduced by $24 million for Bottling Investments and $2 million for Corporate due to the Company's proportionate share of
significant operating and nonoperating items recorded by certain of our equity method investees.
Europe, Middle
East & Africa
Latin
America
North
America 	Asia Pacific
Global
Ventures
Bottling
Investments 	Corporate 	Eliminations 	Consolidated
Six Months Ended June 26, 2020
Net operating revenues:
Third party 	$ 2,708 	$ 1,685 $ 	5,496 $ 2,057 	$ 	868 	$ 	2,918 	$ 	19 $ 	— $ 	15,751
Intersegment 	227 	— 	2 	254 	— 	3 	— 	(486) 	—
Total net operating revenues 	2,935 	1,685 	5,498 	2,311 	868 	2,921 	19 	(486) 	15,751
Operating income (loss) 	1,675 	1,043 	876 	1,163 	(83) 	75 	(388) 	— 	4,361
Income (loss) before income taxes 	1,707 	979 	885 	1,174 	(85) 	364 	183 	— 	5,207
Six Months Ended June 28, 2019
Net operating revenues:
Third party 	$ 3,438 	$ 1,899 $ 	5,839 $ 2,410 	$ 1,218 	$ 	3,832 	$ 	55 $ 	— $ 	18,691
Intersegment 	264 	— 	6 	317 	2 	4 	— 	(593) 	—
Total net operating revenues 	3,702 	1,899 	5,845 	2,727 	1,220 	3,836 	55 	(593) 	18,691
Operating income (loss) 	2,016 	1,084 	1,297 	1,273 	139 	219 	(605) 	— 	5,423
Income (loss) before income taxes 	2,050 	1,031 	1,266 	1,288 	143 	293 	(797) 	— 	5,274
During the six months ended June 26, 2020, the results of our operating segments and Corporate were impacted by the following items:
• Operating income (loss) and income (loss) before income taxes were reduced by $160 million for North America related to the impairment of the Odwalla trademark and
$39 million related to the cost of discontinuing the Odwalla juice business.
• Operating income (loss) and income (loss) before income taxes were reduced by $61 million for Corporate due to the Company's productivity and reinvestment program.
Refer to Note 12.
• Operating income (loss) and income (loss) before income taxes were reduced by $55 million for North America related to the impairment of a trademark, which was
primarily driven by the impact of the COVID-19 pandemic, revised projections of future operating results and a change in brand focus in the Company's portfolio.
• Operating income (loss) and income (loss) before income taxes were reduced by $25 million and $44 million,
31

-- 34 of 89 --

respectively, for North America related to the restructuring of our water manufacturing operations in the United States.
• Operating income (loss) and income (loss) before income taxes were reduced by $29 million for Corporate related to the remeasurement of our contingent consideration
liability to fair value in conjunction with the fairlife acquisition. Refer to Note 2.
• Income (loss) before income taxes was increased by $902 million for Corporate in conjunction with our fairlife acquisition, which resulted from the remeasurement of our
previously held equity interest in fairlife to fair value. Refer to Note 2.
• Income (loss) before income taxes was increased by $18 million for Corporate related to the sale of a portion of our ownership interest in one of our equity method
investments.
• Income (loss) before income taxes was reduced by $144 million for Corporate related to realized and unrealized gains and losses on equity securities and trading debt
securities as well as realized gains and losses on available-for-sale debt securities. Refer to Note 4.
• Income (loss) before income taxes was reduced by $28 million for Latin America, $1 million for North America and $72 million for Bottling Investments due to the
Company's proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees.
• Income (loss) before income taxes was reduced by $38 million for Latin America due to an other-than-temporary impairment charge related to one of our equity method
investees.
During the six months ended June 28, 2019, the results of our operating segments and Corporate were impacted by the following items:
• Operating income (loss) and income (loss) before income taxes were reduced by $1 million for Europe, Middle East and Africa, $30 million for North America, $3 million
for Bottling Investments and $89 million for Corporate due to the Company's productivity and reinvestment program. Refer to Note 12.
• Operating income (loss) and income (loss) before income taxes were reduced by $46 million for Corporate related to transaction costs associated with the purchase of Costa,
which we acquired in January 2019. Refer to Note 2.
• Operating income (loss) and income (loss) before income taxes were reduced by $40 million for Bottling Investments related to costs incurred to refranchise certain of our
North America bottling operations. Refer to Note 11.
• Income (loss) before income taxes was increased by $39 million for Corporate related to the sale of a portion of our equity ownership interest in Andina.
• Income (loss) before income taxes was reduced by $286 million for Bottling Investments due to an other-than-temporary impairment charge related to CCBJHI, an equity
method investee. Refer to Note 15.
• Income (loss) before income taxes was reduced by $160 million for Corporate as result of CCBA asset adjustments. Refer to Note 2.
• Income (loss) before income taxes was reduced by $121 million for Corporate resulting from a loss in conjunction with our acquisition of the remaining equity ownership
interest in CHI. Refer to Note 2.
• Income (loss) before income taxes was reduced by $66 million for Bottling Investments and $2 million for Corporate due to the Company's proportionate share of
significant operating and nonoperating items recorded by certain of our equity method investees.
• Income (loss) before income taxes was reduced by $57 million for North America due to an other-than-temporary impairment charge related to one of our equity method
investees.
• Income (loss) before income taxes was reduced by $49 million for Latin America due to an other-than-temporary impairment charge related to one of our equity method
investees.
32

-- 35 of 89 --

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
When used in this report, the terms "The Coca-Cola Company," "Company," "we," "us" and "our" mean The Coca-Cola Company and all entities included in our condensed
consolidated financial statements.
During the six months ended June 26, 2020, the effects of a novel strain of coronavirus ("COVID-19") pandemic and the related actions by governments around the world to
attempt to contain the spread of the virus have impacted our business globally. In particular, the outbreak and preventive measures taken to contain COVID-19 negatively
impacted our unit case volume and our price, product and geographic mix in all of our operating segments, primarily due to unfavorable channel and product mix as consumer
demand has shifted to more at-home consumption versus away from home.
In response to the COVID-19 outbreak and business disruption, we have five priorities:
• 	To ensure the health and safety of Coca-Cola system employees
• To support and make a difference in the communities we serve
• To keep our brands in supply and to maintain the quality and safety of our products
• To best serve our customers across all channels as they adapt to the shifting demands of consumers during the crisis
• 	To best position ourselves to emerge stronger when this crisis ends
We have deployed global and regional teams to monitor the rapidly evolving situation in each of our local markets and recommend risk mitigation actions; we have
implemented travel restrictions; and we are following social distancing practices. Around the world, we are endeavoring to follow guidance from authorities and health officials
including, but not limited to, checking the temperature of associates when entering our facilities, requiring associates to wear masks and other protective clothing as appropriate,
and implementing additional cleaning and sanitization routines at system facilities. In addition, nearly all office-based employees around the world are required to work
remotely.
We are grateful to the people throughout the world who are providing essential services, keeping communities safe and ensuring access to food, medicine and many other
essential goods. We have made contributions of money, product and materials to support relief efforts in impacted local communities across the globe.
During times of crisis, business continuity and adapting to the needs of our customers is critical. We have developed systemwide knowledge-sharing routines and processes
which include the management of any supply chain challenges. As of the date of this filing, there has been no material impact and we do not foresee a material impact on our
and our bottling partners' ability to manufacture or distribute our products. We are moving with speed to best serve our customers impacted by COVID-19. In partnership with
our bottlers and retail customers, we are working to ensure adequate inventory levels in key channels while prioritizing core brands, key packages and consumer affordability.
We are increasing investments in e-commerce to support retailer and meal delivery services, shifting toward package sizes that are fit-for-purpose for online sales, and shifting
consumer and trade promotion to digital.
Although we are experiencing a time of crisis, we are not losing sight of long-term opportunities for our business. We believe that we will come out of this situation a better and
stronger company. We are leveraging the crisis as a catalyst to accelerate our strategy by focusing on the following: prioritizing stronger global brands across various consumer
needs while, at the same time, doing a better job of nurturing and growing regional and scaled local brands; establishing a more disciplined innovation framework and
increasing marketing effectiveness and efficiency; strengthening our revenue growth management capabilities; enhancing our system collaboration and capturing supply chain
efficiencies; and investing in new capabilities and evolving our organization to support the accelerated strategy. Evolving our organization will require a reallocation of
resources and could result in some resource reductions.
33

-- 36 of 89 --

CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Recoverability of Current and Noncurrent Assets
Our Company faces many uncertainties and risks related to various economic, political and regulatory environments in the countries in which we operate, particularly in
developing and emerging markets. Refer to the heading "Item 1A. Risk Factors" in Part I and "Our Business — Challenges and Risks" in Part II of our Annual Report on
Form 10-K for the year ended December 31, 2019. As a result, management must make numerous assumptions which involve a significant amount of judgment when
completing recoverability and impairment tests of current and noncurrent assets in various regions around the world.
Factors that management must estimate include, among others, the economic lives of the assets, sales volume, pricing, cost of raw materials, delivery costs, inflation, cost of
capital, marketing spending, foreign currency exchange rates, tax rates, capital spending, proceeds from the sale of assets and customers' financial condition. These factors are
even more difficult to estimate as a result of uncertainties associated with the duration of the various shelter-in-place orders and reopening plans across the globe related to the
COVID-19 pandemic and the post-pandemic economic recovery. The estimates we use when assessing the recoverability of assets are consistent with those we use in our
internal planning. When performing impairment tests, we estimate the fair values of the assets using management's best assumptions, which we believe would be consistent with
what a market participant would use. The variability of these factors depends on a number of conditions, including uncertainty associated with COVID-19, and thus our
accounting estimates may change from period to period. Our current estimates reflect our belief that the second quarter of 2020 will be the most severely impacted quarter for
the full year 2020; however, we still estimate that the various shelter-in-place orders, reopening plans and social distancing practices across the globe will have a negative
impact on our business in the second half of 2020. We also anticipate that many smaller customers throughout the world may permanently close. The Company has certain
intangible and other long-lived assets that are more dependent on cash flows generated in the away-from-home channels and/or that generate cash flows in geographic areas that
are more heavily impacted by the COVID-19 pandemic and are therefore more susceptible to impairment. In addition, intangible and other long-lived assets we acquired in
recent transactions are naturally more susceptible to impairment, because they are recorded at fair value based on recent operating plans and macroeconomic conditions at the
time of acquisition. We also have certain intangible assets and other longed-lived assets that generate cash flows in a small number of local markets. As we shift our focus
toward prioritizing brands with broad consumer reach, we may choose to reduce or eliminate support for, or discontinue selling, certain brands, which could result in future
impairment charges. If we had used other assumptions and estimates when tests of these assets were performed, impairment charges could have resulted. Furthermore, if
management uses different assumptions or if different conditions exist in future periods, future impairment charges could result. Also, if a customer which has received
advanced funding from the Company permanently closes, we may be required to write off the unamortized balance of the funding. The total future impairment charges and
other asset write-offs we may be required to record could be material. Refer to Note 2 of Notes to Condensed Consolidated Financial Statements for a discussion of recent
acquisitions. Refer to Note 11 of Notes to Condensed Consolidated Financial Statements for the discussion of impairment charges.
We perform recoverability and impairment tests of current and noncurrent assets in accordance with accounting principles generally accepted in the United States ("U.S.
GAAP"). For certain assets, recoverability and/or impairment tests are required only when conditions exist that indicate the carrying value may not be recoverable. For other
assets, impairment tests are required at least annually, or more frequently if events or circumstances indicate that an asset may be impaired.
As of June 26, 2020, the carrying value of our investment in Coca-Cola Bottlers Japan Holdings Inc. ("CCBJHI") exceeded its fair value by $114 million, or 18 percent, and the
carrying value of our investment in Coca-Cola European Partners plc ("CCEP") exceeded its fair value by $365 million, or 11 percent. Based on the length of time and the
extent to which the fair values have been less than our carrying values and our intent and ability to retain the investments for a period of time sufficient to allow for any
anticipated recovery in market value, management determined that the declines in fair values were temporary in nature. Therefore, we did not record an impairment charge
related to either investment.
Our equity method investees also perform such recoverability and/or impairment tests. If an impairment charge is recorded by one of our equity method investees, the Company
records its proportionate share of such charge as a reduction of equity income (loss) — net in our consolidated statement of income. However, the actual amount we record with
respect to our proportionate share of such charge may be impacted by items such as basis differences, deferred taxes and deferred gains.
OPERATIONS REVIEW
Sales of our nonalcoholic ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting for the highest sales volumes. The
volume of sales in the beverage business may be affected by weather conditions.
34

-- 37 of 89 --

Structural Changes, Acquired Brands and Newly Licensed Brands
In order to continually improve upon the Company's operating performance, from time to time, we engage in buying and selling ownership interests in bottling partners and
other manufacturing operations. In addition, we also acquire brands and their related operations or enter into license agreements for certain brands to supplement our beverage
offerings. These items impact our operating results and certain key metrics used by management in assessing the Company's performance.
Unit case volume growth is a metric used by management to evaluate the Company's performance because it measures demand for our products at the consumer level. The
Company's unit case volume represents the number of unit cases (or unit case equivalents) of Company beverage products directly or indirectly sold by the Company and its
bottling partners to customers or consumers and, therefore, reflects unit case volume for both consolidated and unconsolidated bottlers. Refer to the heading "Beverage Volume"
below.
Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or
used in finished products sold by, the Company to its bottling partners or other customers. For Costa Limited ("Costa") non-ready-to-drink beverage products, concentrate sales
volume represents the amount of coffee beans and finished beverages (in all instances expressed in unit case equivalents) sold by the Company to customers or consumers.
Refer to the heading "Beverage Volume" below.
When we analyze our net operating revenues we generally consider the following factors: (1) volume growth (concentrate sales volume or unit case volume, as applicable); (2)
changes in price, product and geographic mix; (3) foreign currency fluctuations; and (4) acquisitions and divestitures (including structural changes defined below), as applicable.
Refer to the heading "Net Operating Revenues" below. The Company sells concentrates and syrups to both consolidated and unconsolidated bottling partners. The ownership
structure of our bottling partners impacts the timing of recognizing concentrate revenue and concentrate sales volume. When we sell concentrates or syrups to our consolidated
bottling partners, we are not able to recognize the concentrate revenue or concentrate sales volume until the bottling partner has sold finished products manufactured from the
concentrates or syrups to a third party or independent customer. When we sell concentrates or syrups to our unconsolidated bottling partners, we recognize the concentrate
revenue and concentrate sales volume when the concentrates or syrups are sold to the bottling partner. The subsequent sale of the finished products manufactured from the
concentrates or syrups to a third party or independent customer does not impact the timing of recognizing the concentrate revenue or concentrate sales volume. When we
account for an unconsolidated bottling partner as an equity method investment, we eliminate the intercompany profit related to these transactions to the extent of our ownership
interest until the equity method investee has sold finished products manufactured from the concentrates or syrups to a third party or independent customer. We typically report
unit case volume when finished products manufactured from the concentrates or syrups are sold to a third party or independent customer regardless of our ownership interest in
the bottling partner.
We generally refer to acquisitions and divestitures of bottling operations as structural changes, which are a component of acquisitions and divestitures. Typically, structural
changes do not impact the Company's unit case volume or concentrate sales volume on a consolidated basis or at the geographic operating segment level. We recognize unit
case volume for all sales of Company beverage products, regardless of our ownership interest in the bottling partner, if any. However, the unit case volume reported by our
Bottling Investments operating segment is generally impacted by structural changes because it only includes the unit case volume of our consolidated bottling operations. Refer
to Note 2 of Notes to Condensed Consolidated Financial Statements for additional information on the Company's acquisitions and divestitures.
"Acquired brands" refers to brands acquired during the past 12 months. Typically, the Company has not reported unit case volume or recognized concentrate sales volume
related to acquired brands in periods prior to the closing of a transaction. Therefore, the unit case volume and concentrate sales volume related to these brands is incremental to
prior year volume. We generally do not consider the acquisition of a brand to be a structural change.
"Licensed brands" refers to brands not owned by the Company but for which we hold certain rights, generally including, but not limited to, distribution rights, and from which
we derive an economic benefit when the products are sold. Typically, the Company has not reported unit case volume or recognized concentrate sales volume related to these
brands in periods prior to the beginning of the term of a license agreement. Therefore, in the year a license agreement is entered into, the unit case volume and concentrate sales
volume related to the brand is incremental to prior year volume. We generally do not consider the licensing of a brand to be a structural change.
In 2020, the Company acquired the remaining interest in fairlife, LLC ("fairlife"). The impact on revenues for fairlife products not previously sold by the Company has been
included in acquisitions and divestitures in our analysis of net operating revenues on a consolidated basis as well as for the North America operating segment.
In 2019, the Company acquired the remaining interest in C.H.I. Limited ("CHI"). The impact of this acquisition has been included in acquisitions and divestitures in our analysis
of net operating revenues on a consolidated basis as well as for the Europe, Middle East and Africa operating segment. Other acquisitions by the Company in 2019 included
controlling interests in
35

-- 38 of 89 --

bottling operations in Zambia, Kenya and Eswatini. The impact of these acquisitions has been included as a structural change in our analysis of net operating revenues on a
consolidated basis as well as for the Bottling Investments and Europe, Middle East and Africa operating segments.
Also in 2019, the Company refranchised certain of its bottling operations in India. The impact of these refranchising activities has been included as a structural change in our
analysis of net operating revenues on a consolidated basis as well as for the Bottling Investments and Asia Pacific operating segments.
Beverage Volume
We measure the volume of Company beverage products sold in two ways: (1) unit cases of finished products and (2) concentrate sales. As used in this report, "unit case" means
a unit of measurement equal to 192 U.S. fluid ounces of finished beverage (24 eight-ounce servings), with the exception of unit case equivalents for Costa non-ready-to-drink
beverage products which are primarily measured in number of transactions; and "unit case volume" means the number of unit cases (or unit case equivalents) of Company
beverage products directly or indirectly sold by the Company and its bottling partners to customers or consumers. Unit case volume primarily consists of beverage products
bearing Company trademarks. Also included in unit case volume are certain products licensed to, or distributed by, our Company, and brands owned by Coca-Cola system
bottlers for which our Company provides marketing support and from the sale of which we derive economic benefit. In addition, unit case volume includes sales by certain joint
ventures in which the Company has an equity interest. We believe unit case volume is one of the measures of the underlying strength of the Coca-Cola system because it
measures trends at the consumer level. The unit case volume numbers used in this report are derived based on estimates received by the Company from its bottling partners and
distributors. Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents)
sold by, or used in finished beverages sold by, the Company to its bottling partners or other customers. For Costa non-ready-to-drink beverage products, concentrate sales
volume represents the amount of coffee beans and finished beverages (in all instances expressed in unit case equivalents) sold by the Company to customers or consumers. Unit
case volume and concentrate sales volume growth rates are not necessarily equal during any given period. Factors such as seasonality, bottlers' inventory practices, supply point
changes, timing of price increases, new product introductions and changes in product mix can create differences between unit case volume and concentrate sales volume growth
rates. In addition to the items mentioned above, the impact of unit case volume from certain joint ventures in which the Company has an equity interest, but to which the
Company does not sell concentrates, syrups, source waters or powders/minerals, may give rise to differences between unit case volume and concentrate sales volume growth
rates.
36

-- 39 of 89 --

Information about our volume growth worldwide and by operating segment is as follows:
Percent Change 2020 versus 2019
Three Months Ended
June 26, 2020
Six Months Ended
June 26, 2020
Unit Cases 1,2,3
Concentrate
Sales4 	Unit Cases 1,2,3
Concentrate
Sales4
Worldwide 	(16) % 	(22) % 	(9) % 	(12) %
Europe, Middle East & Africa 	(17) % 	(26) % 	(10) % 	(15) %
Latin America 	(9) 	(18) 	(5) 	(7)
North America 	(16) 	(17) 	6 	(7) 	(8)
Asia Pacific 	(18) 	(22) 	7 	(13) 	(12) 	7
Global Ventures 	(31) 	(34) 	(17) 	(20)
Bottling Investments 	(36) 5 	N/A 	(22) 5 	N/A
1 Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only.
2 Geographic and Global Ventures operating segment data reflects unit case volume growth for all bottlers, both consolidated and unconsolidated, and distributors in the applicable geographic
areas.
3 Unit case volume percent change is based on average daily sales. Unit case volume growth based on average daily sales is computed by comparing the average daily sales in each of the
corresponding periods. Average daily sales are the unit cases sold during the period divided by the number of days in the period.
4 Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or used in finished
beverages sold by, the Company to its bottling partners or other customers and is not based on average daily sales. For Costa non-ready-to-drink products, concentrate sales volume represents
the amount of coffee beans and finished beverages (in all instances expressed in unit case equivalents) sold by the Company to customers or consumers and is not based on average daily sales.
Each of our interim reporting periods, other than the fourth interim reporting period, ends on the Friday closest to the last day of the corresponding quarterly calendar period. As a result, the
first quarter of 2020 had one less day when compared to the first quarter of 2019, and the fourth quarter of 2020 will have two additional days when compared to the fourth quarter of 2019.
5After considering the impact of structural changes, unit case volume for Bottling Investments declined 33 percent and 19 percent for the three and six months ended June 26, 2020,
respectively.
6After considering the impact of structural changes, concentrate sales volume for North America declined 18 percent for the three months ended June 26, 2020.
7After considering the impact of structural changes, concentrate sales volume for Asia Pacific declined 21 percent and 13 percent for the three and six months ended June 26, 2020, respectively.
Unit Case Volume
Although a significant portion of our Company's revenues is not based directly on unit case volume, we believe unit case
volume is one of the measures of the underlying strength of the Coca-Cola system because it measures trends at the consumer level.
Three Months Ended June 26, 2020 versus Three Months Ended June 28, 2019
Unit case volume in Europe, Middle East and Africa declined 17 percent, which included a 14 percent decline in sparkling soft drinks, a 34 percent decline in water, enhanced
water and sports drinks, a 24 percent decline in juice, dairy and plant-based beverages and a 38 percent decline in tea and coffee. The group's sparkling soft drinks volume
reflected a decline of 11 percent in Trademark Coca-Cola. The group reported declines in unit case volume across all of the business units.
In Latin America, unit case volume declined 9 percent, which included a 7 percent decline in sparkling soft drinks, a 14 percent decline in water, enhanced water and sports
drinks, a 16 percent decline in juice, dairy and plant-based beverages and a 6 percent decline in tea and coffee. The group reported declines in unit case volume of 6 percent in
the Mexico business unit, 7 percent in both the Brazil and Latin Center business units and 23 percent in the South Latin business unit.
Unit case volume in North America declined 16 percent, which included a decline of 19 percent in water, enhanced water and sports drinks, a 12 percent decline in juice, dairy
and plant-based beverages and a 28 percent decline in tea and coffee. The group's sparkling soft drinks volume declined 15 percent, which included an 11 percent decline in
Trademark Coca-Cola.
In Asia Pacific, unit case volume declined 18 percent, which included a 13 percent decline in sparkling soft drinks, a 28 percent decline in water, enhanced water and sports
drinks, a 31 percent decline in juice, dairy and plant-based beverages and a 15 percent decline in tea and coffee. Sparkling soft drinks volume included a 1 percent decline in
Trademark Coca-Cola. The group reported declines in unit case volume of 14 percent in the Japan business unit, 16 percent in the South Pacific business
37

-- 40 of 89 --

unit, 18 percent in the ASEAN business unit and 57 percent in the India & South West Asia business unit. The declines in these business units were partially offset by a 1
percent increase in unit case volume in the Greater China & Korea business unit.
Unit case volume for Global Ventures declined 31 percent, driven by a 53 percent decrease in tea and coffee, a 10 percent decrease in juice, dairy and plant-based beverages and
a decrease in energy drinks.
Unit case volume for Bottling Investments declined 36 percent. The declines in unit case volume in all of our consolidated bottling operations were primarily the result of the
impact of the COVID-19 pandemic.
Six Months Ended June 26, 2020 versus Six Months Ended June 28, 2019
Unit case volume in Europe, Middle East and Africa declined 10 percent, which included a 7 percent decline in sparkling soft drinks, a 17 percent decline in both water,
enhanced water and sports drinks and in juice, dairy and plant-based beverages, and a 25 percent decline in tea and coffee. The group's sparkling soft drinks volume reflected a
decline of 5 percent in Trademark Coca-Cola. The group reported declines in all business units with the exception of the Middle East & North Africa business unit, which was
even.
In Latin America, unit case volume declined 5 percent, which included a 5 percent decline in sparkling soft drinks, a 9 percent decline in juice, dairy and plant-based beverages,
a 3 percent decline in water, enhanced water and sports drinks and a 5 percent decline in tea and coffee. The group reported declines in unit case volume of 4 percent in the
Mexico business unit, 5 percent in the Brazil business unit and 12 percent in the South Latin business unit. The declines in these business units were partially offset by a 2
percent increase in unit case volume in the Latin Center business unit.
Unit case volume in North America declined 7 percent, which included a 17 percent decline in tea and coffee, a 4 percent decline in water, enhanced water and sports drinks,
and a 5 percent decline in juice, dairy and plant-based beverages. The group's sparkling soft drinks volume declined 8 percent, which included a 5 percent decline in Trademark
Coca-Cola.
In Asia Pacific, unit case volume declined 13 percent, which included a 9 percent decline in sparkling soft drinks, a 21 percent decline in water, enhanced water and sports
drinks, a 24 percent decline in juice, dairy and plant-based beverages, and a 10 percent decline in tea and coffee. Trademark Coca-Cola unit case volume was even. The group
reported a 38 percent decline in unit case volume in the India & South West Asia business unit, a 6 percent decline in the Greater China & Korea business unit, a 9 percent
decline in both the Japan and ASEAN business units, and an 8 percent decline in the South Pacific business unit.
Unit case volume for Global Ventures declined 17 percent, driven by a 32 percent decrease in tea and coffee and a 1 percent decrease in juice, dairy and plant-based beverages,
partially offset by growth in energy drinks.
Unit case volume for Bottling Investments declined 22 percent. The declines in unit case volume in all of our consolidated bottling operations were primarily the result of the
impact of the COVID-19 pandemic.
The ultimate impact that the COVID-19 pandemic will have on third quarter and full year 2020 unit case volume is unknown at this time, as it will depend heavily on the
duration of the shelter-in-place orders and the timing, pace and success of reopening plans, as well as the substance and pace of the post-pandemic recovery. While we currently
believe the second quarter of 2020 will be the most severely impacted quarter for the full year, we believe the third quarter will continue to be negatively impacted by the
COVID-19 pandemic. Since the beginning of July, global unit case volume has declined mid single digits, which is an improvement versus unit case volume performance in the
second quarter of 2020.
Concentrate Sales Volume
During the three months ended June 26, 2020, worldwide concentrate sales volume declined 22 percent and unit case volume declined 16 percent compared to the three months
ended June 28, 2019. During the six months ended June 26, 2020, worldwide concentrate sales volume declined 12 percent and unit case volume declined 9 percent compared to
the six months ended June 28, 2019. Concentrate sales volume growth is calculated based on the amount of concentrate sold during the reporting periods, which is impacted by
the number of days. Conversely, unit case volume growth is calculated based on average daily sales, which is not impacted by the number of days in the reporting periods. The
first quarter of 2020 had one less day when compared to the first quarter of 2019, which contributed to the differences between concentrate sales volume and unit case sales
volume growth rates on a consolidated basis and for the individual operating segments during the six months ended June 26, 2020. In addition, the differences between
concentrate sales volume and unit case volume growth rates on a consolidated basis and for the Europe, Middle East and Africa operating segment during the six months ended
June 26, 2020 were impacted by the timing of concentrate shipments related to Brexit in the prior year. The differences between concentrate sales volume and unit case volume
growth rates during the three months ended June 26, 2020 were impacted by a reduction in inventory resulting from higher shipments in the first quarter of 2020 as bottlers built
inventory due to COVID-19 uncertainty and also by the timing of concentrate shipments in Brazil in the prior year.
38

-- 41 of 89 --

Net Operating Revenues
Three Months Ended June 26, 2020 versus Three Months Ended June 28, 2019
During the three months ended June 26, 2020, net operating revenues were $7,150 million compared to $9,997 million during the three months ended June 28, 2019, a decrease
of $2,847 million, or 28 percent.
The following table illustrates, on a percentage basis, the estimated impact of key factors resulting in the increase (decrease) in net operating revenues on a consolidated basis
and for each of our operating segments:
Percent Change 2020 versus 2019
Volume1
Price, Product &
Geographic Mix
Foreign Currency
Fluctuations Acquisitions &
Divestitures2 	Total
Consolidated 	(22) % 	(4) % 	(3) % 	— % 	(28) %
Europe, Middle East & Africa 	(26) % 	(9) % 	(3) % 	— % 	(37) %
Latin America 	(18) 	5 	(11) 	— 	(25)
North America 	(18) 	— 	— 	1 	(16)
Asia Pacific 	(21) 	(1) 	(1) 	— 	(23)
Global Ventures 	(34) 	(17) 	(2) 	— 	(53)
Bottling Investments 	(33) 	3 	(5) 	(3) 	(38)
Note: Certain rows may not add due to rounding.
1 Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our geographic operating segments and our Global Ventures
operating segment (expressed in unit case equivalents) after considering the impact of acquisitions and divestitures. For our Bottling Investments operating segment, this represents the percent
change in net operating revenues attributable to the increase (decrease) in unit case volume computed by comparing the total sales (rather than the average daily sales) in each of the
corresponding periods after considering the impact of structural changes. Our Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only after
considering the impact of structural changes. Refer to the heading "Beverage Volume" above.
2 Includes structural changes. Refer to the heading "Structural Changes, Acquired Brands and Newly Licensed Brands" above.
Refer to the heading "Beverage Volume" above for additional information related to changes in our unit case and concentrate sales volumes.
"Price, product and geographic mix" refers to the change in net operating revenues caused by factors such as price changes, the mix of products and packages sold, and the mix
of channels and geographic territories where the sales occurred. The impact of price, product and geographic mix is calculated by subtracting the change in net operating
revenues resulting from volume increases or decreases, changes in foreign currency exchange rates, and acquisitions and divestitures from the total change in net operating
revenues. Management believes that providing investors with price, product and geographic mix enhances their understanding about the combined impact that the following
items had on the Company's net operating revenues: (1) pricing actions taken by the Company and, where applicable, our bottling partners; (2) changes in the mix of products
and packages sold; and (3) changes in the mix of channels and geographic territories where products were sold. Management uses this measure in making financial, operating
and planning decisions and in evaluating the Company's performance.
Price, product and geographic mix had a 4 percent unfavorable impact on our consolidated net operating revenues. Price, product and geographic mix was impacted by a variety
of factors and events including, but not limited to, the following:
• Europe, Middle East and Africa — unfavorable channel, package and geographic mix;
• Latin America — favorable pricing initiatives in Mexico and the impact of inflationary environments in certain markets, partially offset by unfavorable channel and package
mix;
• North America — favorable price and product mix offset by unfavorable channel and package mix;
• Asia Pacific — unfavorable channel and package mix across a majority of the business units, partially offset by favorable geographic mix;
• Global Ventures — unfavorable product and channel mix primarily due to the impact of the temporary closures of nearly all of the Costa retail stores in Western Europe as a
result of the impact of the COVID-19 pandemic; and
• Bottling Investments — favorable price and geographic mix, partially offset by unfavorable channel and package mix.
Fluctuations in foreign currency exchange rates decreased our consolidated net operating revenues by 3 percent. This unfavorable impact was primarily due to a stronger U.S.
dollar compared to certain foreign currencies, including the euro,
39

-- 42 of 89 --

British pound sterling, Mexican peso, Brazilian real, South African rand and Australian dollar, which had an unfavorable impact on all of our operating segments, except for
North America. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to
certain other foreign currencies, including the Japanese yen, which had a favorable impact on our Asia Pacific operating segment. Refer to the heading "Liquidity, Capital
Resources and Financial Position — Foreign Exchange" below.
"Acquisitions and divestitures" refers to acquisitions and divestitures of brands or businesses, some of which the Company considers to be structural changes. The impact of
acquisitions and divestitures is the difference between the change in net operating revenues and the change in what our net operating revenues would have been if we removed
the net operating revenues associated with an acquisition or divestiture from either the current year or the prior year, as applicable. Management believes that quantifying the
impact that acquisitions and divestitures had on the Company's net operating revenues provides investors with useful information to enhance their understanding of the
Company's net operating revenue performance by improving their ability to compare our period-to-period results. Management considers the impact of acquisitions and
divestitures when evaluating the Company's performance. Refer to the heading "Structural Changes, Acquired Brands and Newly Licensed Brands" above for additional
information related to acquisitions and divestitures.
Six Months Ended June 26, 2020 versus Six Months Ended June 28, 2019
During the six months ended June 26, 2020, net operating revenues were $15,751 million, compared to $18,691 million during the six months ended June 28, 2019, a decrease
of $2,940 million, or 16 percent.
The following table illustrates, on a percentage basis, the estimated impact of key factors resulting in the increase (decrease) in net operating revenues on a consolidated basis
and for each of our operating segments:
Percent Change 2020 versus 2019
Volume1
Price, Product &
Geographic Mix
Foreign Currency
Fluctuations Acquisitions &
Divestitures2 	Total
Consolidated 	(12) % 	(2) % 	(2) % 	— % 	(16) %
Europe, Middle East & Africa 	(15) % 	(4) % 	(3) % 	1 % 	(21) %
Latin America 	(7) 	7 	(11) 	— 	(11)
North America 	(8) 	1 	— 	2 	(6)
Asia Pacific 	(13) 	(2) 	(1) 	1 	(15)
Global Ventures 	(20) 	(8) 	(1) 	— 	(29)
Bottling Investments 	(19) 	1 	(3) 	(2) 	(24)
Note: Certain rows may not add due to rounding.
1 Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our geographic operating segments and our Global Ventures
operating segment (expressed in unit case equivalents) after considering the impact of acquisitions and divestitures. For our Bottling Investments operating segment, this represents the
percent change in net operating revenues attributable to the increase (decrease) in unit case volume computed by comparing the total sales (rather than the average daily sales) in each of the
corresponding periods after considering the impact of structural changes. Our Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only
after considering the impact of structural changes. Refer to the heading "Beverage Volume" above.
2 Includes structural changes. Refer to the heading "Structural Changes, Acquired Brands and Newly Licensed Brands" above.
Refer to the heading "Beverage Volume" above for additional information related to changes in our unit case and concentrate sales volumes.
Price, product and geographic mix had a 2 percent unfavorable impact on our consolidated net operating revenues. Price, product and geographic mix was impacted by a variety
of factors and events including, but not limited to, the following:
• 	Europe, Middle East and Africa — unfavorable channel, package and geographic mix, including the impact of the Brexit inventory build in the prior year;
• 	Latin America — favorable pricing initiatives in Mexico and the impact of inflationary environments in certain markets, partially offset by unfavorable channel and
package mix;
• 	North America — favorable price and product mix, partially offset by unfavorable channel and package mix;
• 	Asia Pacific — unfavorable channel and package mix, partially offset by favorable geographic mix;
• 	Global Ventures — unfavorable product and channel mix primarily due to the impact of the temporary closures of nearly all of the Costa retail stores as a result of the
COVID-19 pandemic; and
40

-- 43 of 89 --

• 	Bottling Investments — favorable geographic mix, partially offset by unfavorable channel and package mix.
The unfavorable channel and package mix for both the three and six months ended June 26, 2020 in all operating segments was primarily a result of the shift in consumer
demand due to the impact of the COVID-19 pandemic. Consumers are purchasing more products in the at-home channels and less in the away-from-home channels. We expect
any shift in consumer demand back to the away-from-home channels during the second half of 2020 to be closely correlated with the easing of the shelter-in-place orders around
the world.
Fluctuations in foreign currency exchange rates decreased our consolidated net operating revenues by 2 percent. This unfavorable impact was primarily due to a stronger U.S.
dollar compared to certain foreign currencies, including the euro, British pound sterling, Mexican peso, Brazilian real, South African rand and Australian dollar, which had an
unfavorable impact on all of our operating segments, except for North America. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was
partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the Japanese yen, which had a favorable impact on our Asia Pacific
operating segment. Refer to the heading "Liquidity, Capital Resources and Financial Position — Foreign Exchange" below.
Net operating revenue growth rates are impacted by sales volume; price, product and geographic mix; foreign currency fluctuations; and acquisitions and divestitures. The size
and timing of acquisitions and divestitures are not consistent from period to period. Based on current spot rates and our hedging coverage in place, we expect foreign currencies
will have an unfavorable impact on our full year 2020 net operating revenues.
Gross Profit Margin
Gross profit margin is a ratio calculated by dividing gross profit by net operating revenues. Management believes gross profit margin provides investors with useful information
related to the profitability of our business prior to considering all of the operating costs incurred. Management uses this measure in making financial, operating and planning
decisions and in evaluating the Company's performance.
Our gross profit margin decreased to 57.9 percent for the three months ended June 26, 2020, compared to 60.8 percent for the three months ended June 28, 2019. Our gross
profit margin decreased to 59.5 percent for the six months ended June 26, 2020, compared to 61.0 percent for the six months ended June 28, 2019. These decreases were
primarily related to volume declines in our more capital-intensive finished goods businesses, unfavorable channel and package mix, and unfavorable manufacturing overhead
absorption, partially offset by the impact of acquisitions and divestitures. Refer to Note 2 of Notes to Condensed Consolidated Financial Statements for additional information
related to acquisitions and divestitures.
Selling, General and Administrative Expenses
The following table sets forth the components of selling, general and administrative expenses (in millions):
Three Months Ended 	Six Months Ended
June 26,
2020
June 28,
2019
June 26,
2020
June 28,
2019
Stock-based compensation expense (income) 	$ 	41 $ 	48 	$ 	36 $ 	88
Advertising expenses 	370 	1,165 	1,272 	2,118
Selling and distribution expenses 	569 	713 	1,267 	1,388
Other operating expenses 	1,003 	1,070 	2,056 	2,169
Selling, general and administrative expenses 	$ 	1,983 $ 	2,996 	$ 	4,631 $ 	5,763
During the three and six months ended June 26, 2020, selling, general and administrative expenses decreased $1,013 million, or 34 percent, and decreased $1,132 million, or 20
percent, respectively, versus the prior year comparable period. The decreases were primarily due to effective cost management and a reduction in marketing spending as a result
of uncertainties related to the impact of the COVID-19 pandemic, the impact of savings from our productivity initiatives and a foreign currency exchange rate impact of 2
percent. The six months ended June 26, 2020 also included a reduction in stock-based compensation expense resulting from a change in estimated payout.
The decrease in advertising expenses for the three and six months ended June 26, 2020 included the impact of a reduction in our estimate of full year advertising expenses that
benefit multiple interim periods. Based on our interim accounting policy for advertising costs, a change in estimate of full year advertising expense is recognized in the interim
period in which the change in estimate occurs. The foreign currency exchange rate impact on advertising expenses was nominal for the three months ended June 26, 2020 and
was a decrease of 1 percent for the six months ended June 26, 2020.
The decrease in selling and distribution expenses during the three months ended June 26, 2020 was primarily due to effective cost management as a result of uncertainties
related to the COVID-19 pandemic. The decrease in selling and distribution
41

-- 44 of 89 --

expenses during the six months ended June 26, 2020 was primarily due to effective cost management as a result of uncertainties related to the COVID-19 pandemic, partially
offset by amortization and depreciation expense in the current year for Coca-Cola Beverages Africa Proprietary Limited ("CCBA"). During the three months ended March 29,
2019, CCBA was classified as held for sale, and therefore amortization and depreciation expense were not recorded.
As of June 26, 2020, we had $326 million of total unrecognized compensation cost related to nonvested stock-based compensation awards granted under our plans, which we
expect to recognize over a weighted-average period of 2.2 years as stock-based compensation expense. This expected cost does not include the impact of any future stock-based
compensation awards granted.
Other Operating Charges
Other operating charges incurred by operating segment and Corporate were as follows (in millions):
Three Months Ended 	Six Months Ended
June 26,
2020
June 28,
2019
June 26,
2020
June 28,
2019
Europe, Middle East & Africa 	$ 	— $ 	— 	$ 	— $ 	1
Latin America 	10 	— 	10 	—
North America 	110 	13 	262 	30
Asia Pacific 	— 	— 	— 	—
Global Ventures 	— 	— 	— 	—
Bottling Investments 	13 	30 	13 	43
Corporate 	40 	49 	90 	145
Total 	$ 	173 $ 	92 	$ 	375 $ 	219
During the three months ended June 26, 2020, the Company recorded other operating charges of $173 million. These charges included an impairment charge of $55 million
related to a trademark in North America, which was primarily driven by the impact of the COVID-19 pandemic, revised projections of future operating results and a change in
brand focus in the Company's portfolio. Also included were charges of $35 million related to discontinuing the Odwalla juice business and an impairment charge of $8 million
related to the Odwalla trademark. Other operating charges also included $22 million related to the Company's productivity and reinvestment program, $18 million related to the
remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition and $12 million related to the restructuring of our water
manufacturing operations in the United States. Refer to Note 2 of Notes to Condensed Consolidated Financial Statements for additional information on the fairlife acquisition.
Refer to Note 12 of Notes to Condensed Consolidated Financial Statements for additional information on the Company's productivity and reinvestment program. Refer to
Note 15 of Notes to Condensed Consolidated Financial Statements for additional information on the impairment charges. Refer to Note 16 of Notes to Condensed Consolidated
Financial Statements for the impact these charges had on our operating segments and Corporate.
During the six months ended June 26, 2020, the Company recorded other operating charges of $375 million. These charges included an impairment charge of $160 million
related to the Odwalla trademark and charges of $35 million related to discontinuing the Odwalla juice business. These charges also included an impairment charge of $55
million related to a trademark in North America, which was primarily driven by the impact of the COVID-19 pandemic, revised projections of future operating results and a
change in brand focus in the Company's portfolio. Other operating charges also included $61 million related to the Company's productivity and reinvestment program, $29
million related to the remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition and $12 million related to the restructuring
of our water manufacturing operations in the United States. Refer to Note 2 of Notes to Condensed Consolidated Financial Statements for additional information on the fairlife
acquisition. Refer to Note 12 of Notes to Condensed Consolidated Financial Statements for additional information on the Company's productivity and reinvestment program.
Refer to Note 15 of Notes to Condensed Consolidated Financial Statements for additional information on the impairment charges. Refer to Note 16 of Notes to Condensed
Consolidated Financial Statements for the impact these charges had on our operating segments and Corporate.
During the three months ended June 28, 2019, the Company recorded other operating charges of $92 million. These charges primarily consisted of $55 million related to the
Company's productivity and reinvestment program. In addition, other operating charges included $29 million for costs incurred to refranchise certain of our North America
bottling operations. Costs related to refranchising include, among other items, internal and external costs for individuals directly working on the refranchising efforts, severance,
and costs associated with the implementation of information technology systems to facilitate consistent data standards and availability throughout our North America bottling
system. Refer to Note 12 of Notes to Condensed Consolidated Financial Statements for additional information on the Company's productivity and reinvestment program. Refer
to Note 16 of
42

-- 45 of 89 --

Notes to Condensed Consolidated Financial Statements for the impact these charges had on our operating segments and Corporate.
During the six months ended June 28, 2019, the Company recorded other operating charges of $219 million. These charges primarily consisted of $123 million related to the
Company's productivity and reinvestment program. In addition, other operating charges included $46 million of transaction costs associated with the purchase of Costa, which
we acquired in January 2019, and $40 million for costs incurred to refranchise certain of our North America bottling operations. Other operating charges also included $2
million related to tax litigation expense. Refer to Note 2 of Notes to Condensed Consolidated Financial Statements for additional information on the acquisition of Costa. Refer
to Note 8 of Notes to Condensed Consolidated Financial Statements for additional information related to the tax litigation. Refer to Note 12 of Notes to Condensed Consolidated
Financial Statements for additional information on the Company's productivity and reinvestment program. Refer to Note 16 of Notes to Condensed Consolidated Financial
Statements for the impact these charges had on our operating segments and Corporate.
Operating Income and Operating Margin
Information about our operating income contribution by operating segment and Corporate on a percentage basis is as follows:
Three Months Ended 	Six Months Ended
June 26,
2020
June 28,
2019
June 26,
2020
June 28,
2019
Europe, Middle East & Africa 	36.1% 	34.7% 	38.4% 	37.2%
Latin America 	25.4 	19.7 	23.9 	20.0
North America 	24.7 	23.8 	20.1 	23.9
Asia Pacific 	32.9 	24.5 	26.7 	23.5
Global Ventures 	(5.1) 	2.4 	(1.9) 	2.6
Bottling Investments 	0.6 	4.0 	1.7 	4.0
Corporate 	(14.6) 	(9.1) 	(8.9) 	(11.2)
Total 	100.0% 	100.0% 	100.0% 	100.0%
Operating margin is a ratio calculated by dividing operating income by net operating revenues. Management believes operating margin provides investors with useful
information related to the profitability of our business after considering all of the operating costs incurred. Management uses this measure in making financial, operating and
planning decisions and in evaluating the Company's performance.
Information about our operating margin on a consolidated basis and by operating segment and Corporate is as follows:
Three Months Ended 	Six Months Ended
June 26,
2020
June 28,
2019
June 26,
2020
June 28,
2019
Consolidated 	27.7% 	29.9% 	27.7% 	29.0%
Europe, Middle East & Africa 	63.0% 	57.5% 	61.8% 	58.6%
Latin America 	66.8 	58.6 	61.9 	57.1
North America 	18.5 	22.5 	15.9 	22.2
Asia Pacific 	61.1 	54.1 	56.5 	52.8
Global Ventures 	(34.5) 	11.5 	(9.5) 	11.4
Bottling Investments 	1.0 	5.9 	2.6 	5.7
Corporate 	* 	* 	* 	*
* Calculation is not meaningful.
Three Months Ended June 26, 2020 versus Three Months Ended June 28, 2019
During the three months ended June 26, 2020, operating income was $1,981 million, compared to $2,988 million during the three months ended June 28, 2019, a decrease of
$1,007 million, or 34 percent. The decrease was primarily driven by a decline in net operating revenues due to the impact of the COVID-19 pandemic, an unfavorable foreign
currency exchange rate impact and higher other operating charges, partially offset by lower selling, general and administrative expenses.
During the three months ended June 26, 2020, fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 5 percent due to a
stronger U.S. dollar compared to certain foreign currencies, including the
43

-- 46 of 89 --

euro, British pound sterling, Mexican peso, Brazilian real and Australian dollar, which had an unfavorable impact on all of our operating segments, except for North America.
The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to certain other
foreign currencies, including the Japanese yen, which had a favorable impact on our Asia Pacific operating segment.
Operating income for all operating segments and Corporate was impacted by a decline in net operating revenues due to the impact of the COVID-19 pandemic. Operating
income was also impacted by lower selling, general and administrative expenses. In addition, operating income for each operating segment and Corporate was impacted by the
following:
• 	Europe, Middle East and Africa — an unfavorable foreign currency exchange rate impact of 4 percent;
• 	Latin America — an unfavorable foreign currency exchange rate impact of 18 percent;
• 	North America — higher other operating charges;
• 	Asia Pacific — an unfavorable foreign currency exchange rate impact of 2 percent;
• 	Global Ventures — the temporary closures of nearly all of the Costa retail stores in Western Europe;
• 	Bottling Investments — a favorable foreign currency exchange rate impact of 16 percent and lower other operating charges; and
• 	Corporate — operating loss in 2020 increased primarily as a result of unfavorable manufacturing overhead variances due to lower volume, the impact of mark-to-market
adjustments of certain economic hedges and a loss on the disposal of certain assets, partially offset by lower stock-based compensation expense, lower annual incentive
expense, lower other operating charges and savings from productivity initiatives.
Six Months Ended June 26, 2020 versus Six Months Ended June 28, 2019
During the six months ended June 26, 2020, operating income was $4,361 million, compared to $5,423 million during the six months ended June 28, 2019, a decrease of $1,062
million, or 20 percent. The decrease in operating income was primarily driven by an unfavorable foreign currency exchange rate impact and higher other operating charges,
partially offset by lower selling, general and administrative expenses.
During the six months ended June 26, 2020, fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 4 percent due to a stronger
U.S. dollar compared to certain foreign currencies, including the euro, British pound sterling, Mexican peso, Brazilian real, South African rand and Australian dollar, which had
an unfavorable impact on all of our operating segments, except for North America. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was
partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the Japanese yen, which had a favorable impact on our Asia Pacific
operating segment.
Operating income for all operating segments and Corporate was impacted by a decline in net operating revenues due to the impact of the COVID-19 pandemic. Operating
income was also impacted by lower selling, general and administrative expenses. In addition, operating income for each operating segment and Corporate was impacted by the
following:
• 	Europe, Middle East and Africa — an unfavorable foreign currency exchange rate impact of 4 percent;
• 	Latin America — an unfavorable foreign currency exchange rate impact of 16 percent;
• 	North America — higher other operating charges;
• 	Asia Pacific — an unfavorable foreign currency exchange rate impact of 1 percent;
• 	Global Ventures — the temporary closures of nearly all of the Costa retail stores;
• 	Bottling Investments — a favorable foreign currency exchange rate impact of 13 percent and lower other operating charges; and
• 	Corporate — Operating loss in 2020 decreased primarily as a result of lower stock-based compensation expense, lower annual incentive expense, lower other operating
charges and savings from productivity initiatives, partially offset by unfavorable manufacturing overhead variances due to lower volume and a loss on the disposal of
certain assets.
Based on current spot rates and our hedging coverage in place, we expect foreign currency fluctuations will have an unfavorable impact on operating income through the end of
the year.
Interest Income
During the three months ended June 26, 2020, interest income was $100 million, compared to $142 million during the three months ended June 28, 2019, a decrease of
$42 million, or 29 percent. During the six months ended June 26, 2020, interest income was $212 million, compared to $275 million during the six months ended June 28, 2019,
a decrease of $63 million, or
44

-- 47 of 89 --

23 percent. These decreases were primarily driven by lower investment balances and lower returns in certain of our international locations, as well as the unfavorable impact of
fluctuations in foreign currency exchange rates.
Interest Expense
During the three months ended June 26, 2020, interest expense was $274 million, compared to $236 million during the three months ended June 28, 2019, an increase of
$38 million, or 16 percent. This increase was primarily driven by our 2020 long-term debt issuances of $11.5 billion, partially offset by lower short-term U.S. interest rates.
During the six months ended June 26, 2020, interest expense was $467 million, compared to $481 million during the six months ended June 28, 2019, a decrease of $14 million,
or 3 percent. This decrease was primarily due to the impact of lower short-term U.S. interest rates and lower debt balances in certain of our international locations, partially
offset by the impact of long-term debt issued in the third quarter of 2019 and the first half of 2020.
Equity Income (Loss) — Net
Three Months Ended June 26, 2020 versus Three Months Ended June 28, 2019
During the three months ended June 26, 2020, equity income was $176 million, compared to equity income of $329 million during the three months ended June 28, 2019, a
decrease of $153 million, or 46 percent. This decrease reflects the impact of the COVID-19 pandemic on operating results reported by our equity method investees and the
unfavorable impact of foreign currency exchange rate fluctuations. In addition, the Company recorded net charges of $63 million and $26 million in the line item equity income
(loss) — net during the three months ended June 26, 2020 and June 28, 2019, respectively. These amounts represent the Company's proportionate share of significant operating
and nonoperating items recorded by certain of our equity method investees.
Six Months Ended June 26, 2020 versus Six Months Ended June 28, 2019
During the six months ended June 26, 2020, equity income was $343 million, compared to equity income of $462 million during the six months ended June 28, 2019, a
decrease of $119 million, or 26 percent. This decrease reflects the impact of the COVID-19 pandemic on operating results reported by our equity method investees and the
unfavorable impact of foreign currency exchange rate fluctuations. In addition, the Company recorded net charges of $101 million and $68 million in the line item equity
income (loss) — net during the six months ended June 26, 2020 and June 28, 2019, respectively. These amounts represent the Company's proportionate share of significant
operating and nonoperating items recorded by certain of our equity method investees.
Other Income (Loss) — Net
Three Months Ended June 26, 2020 versus Three Months Ended June 28, 2019
Other income (loss) — net includes, among other things, dividend income; rental income; gains and losses related to the disposal of property, plant and equipment; gains and
losses related to acquisitions and divestitures; non-service cost components of net periodic benefit cost for pension and other postretirement benefit plans; other charges and
credits related to pension and other postretirement benefit plans; realized and unrealized gains and losses on equity securities and trading debt securities; realized gains and
losses on available-for-sale debt securities; and the impact of foreign currency exchange gains and losses. The foreign currency exchange gains and losses are primarily the
result of the remeasurement of monetary assets and liabilities from certain currencies into functional currencies. The effects of the remeasurement of these assets and liabilities
are partially offset by the impact of our economic hedging program for certain exposures on our consolidated balance sheet. Refer to Note 6 of Notes to Condensed
Consolidated Financial Statements.
During the three months ended June 26, 2020, other income (loss) — net was income of $214 million. The Company recognized a net gain of $247 million related to realized
and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities. The Company also
recorded an other-than-temporary impairment charge of $38 million related to one of our equity method investees in Latin America and a charge of $19 million related to asset
write-offs associated with the restructuring of our water manufacturing operations in the United States. Other income (loss) — net also included income of $42 million related
to the non-service cost components of net periodic benefit cost, $35 million of dividend income and net foreign currency exchange losses of $49 million. None of the other
items included in other income (loss) — net during the three months ended June 26, 2020 was individually significant. Refer to Note 4 of Notes to Condensed Consolidated
Financial Statements for additional information on equity and debt securities. Refer to Note 15 of Notes to Condensed Consolidated Financial Statements for additional
information on the impairment charge and the charge for accelerated depreciation on fixed assets. Refer to Note 16 of Notes to Condensed Consolidated Financial
Statements for the impact these items had on our operating segments and Corporate.
During the three months ended June 28, 2019, other income (loss) — net was a loss of $174 million. The Company recorded an adjustment to reduce the carrying amount of
CCBA's fixed assets and definite-lived intangible assets by $160 million. The Company also recorded an other-than-temporary impairment charge of $49 million related to one
of our equity method
45

-- 48 of 89 --

investees in Latin America and a net gain of $10 million related to realized and unrealized gains and losses on equity securities and trading debt securities as well as realized
gains and losses on available-for-sale debt securities. Other income (loss) — net also included income of $26 million related to the non-service cost components of net periodic
benefit cost, $29 million of dividend income and net foreign currency exchange losses of $39 million. None of the other items included in other income (loss) — net during the
three months ended June 28, 2019 was individually significant. Refer to Note 2 for additional information on the CCBA asset adjustment. Refer to Note 4 of Notes to
Condensed Consolidated Financial Statements for additional information on equity and debt securities. Refer to Note 15 of Notes to Condensed Consolidated Financial
Statements for information on the impairment charge. Refer to Note 16 of Notes to Condensed Consolidated Financial Statements for the impact these items had on our
operating segments and Corporate.
Six Months Ended June 26, 2020 versus Six Months Ended June 28, 2019
During the six months ended June 26, 2020, other income (loss) — net was income of $758 million. The Company recognized a gain of $902 million in conjunction with the
fairlife acquisition, which resulted from the remeasurement of our previously held equity interest in fairlife to fair value, and a gain of $18 million related to the sale of a portion
of our ownership interest in one of our equity method investments. These gains were partially offset by an other-than-temporary impairment charge of $38 million related to one
of our equity method investees in Latin America, a charge of $19 million related to asset write-offs associated with the restructuring of our water manufacturing operations in
the United States, a net loss of $144 million related to realized and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses
on available-for-sale debt securities, and a net loss of $55 million related to economic hedging activities. Other income (loss) — net also included income of $85 million related
to the non-service cost components of net periodic benefit cost, dividend income of $42 million and net foreign currency exchange losses of $33 million. None of the other
items included in other income (loss) — net during the six months ended June 26, 2020 was individually significant. Refer to Note 2 of Notes to Condensed Consolidated
Financial Statements for additional information on the fairlife acquisition. Refer to Note 4 of Notes to Condensed Consolidated Financial Statements for additional information
on equity and debt securities. Refer to Note 6 of Notes to Condensed Consolidated Financial Statements for additional information on our economic hedging activities. Refer to
Note 15 of Notes to Condensed Consolidated Financial Statements for additional information on the impairment charge. Refer to Note 16 of Notes to Condensed Consolidated
Financial Statements for the impact these items had on our operating segments and Corporate.
During the six months ended June 28, 2019, other income (loss) — net was a loss of $405 million. The Company recognized other-than-temporary impairment charges of $286
million related to CCBJHI, an equity method investee, $57 million related to one of our equity method investees in North America, and $49 million related to one of our equity
method investees in Latin America. The Company also recorded an adjustment to reduce the carrying amount of CCBA's fixed assets and definite-lived intangible assets by
$160 million and recognized a $121 million loss in conjunction with our acquisition of the remaining equity ownership interest in CHI. These charges were partially offset by a
net gain of $159 million related to realized and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-
sale debt securities and a gain of $39 million related to the sale of a portion of our equity ownership interest in Embotelladora Andina S.A. ("Andina"). Other income (loss) —
net also included income of $51 million related to the non-service cost components of net periodic benefit cost, $40 million of dividend income and net foreign currency
exchange losses of $61 million. None of the other items included in other income (loss) — net during the six months ended June 28, 2019 was individually significant. Refer to
Note 2 of Notes to Condensed Consolidated Financial Statements for additional information on the CCBA asset adjustment, the acquisition of the remaining equity ownership
interest in CHI and the sale of a portion of our equity ownership interest in Andina. Refer to Note 4 of Notes to Condensed Consolidated Financial Statements for additional
information on equity and debt securities. Refer to Note 15 of Notes to Condensed Consolidated Financial Statements for additional information on the impairment charges and
the loss recognized in conjunction with our acquisition of the remaining equity ownership interest in CHI. Refer to Note 16 of Notes to Condensed Consolidated Financial
Statements for the impact these items had on our operating segments and Corporate.
Income Taxes
The Company recorded income taxes of $438 million (19.9 percent effective tax rate) and $421 million (13.8 percent effective tax rate) during the three months ended June 26,
2020 and June 28, 2019, respectively. The Company recorded income taxes of $653 million (12.5 percent effective tax rate) and $943 million (17.9 percent effective tax rate)
during the six months ended June 26, 2020 and June 28, 2019, respectively.
The Company's effective tax rates for the three and six months ended June 26, 2020 and June 28, 2019 vary from the statutory U.S. federal income tax rate of 21.0 percent
primarily due to the tax impact of significant operating and nonoperating items,
46

-- 49 of 89 --

along with the tax benefits of having significant operations outside the United States and significant earnings generated in investments accounted for under the equity method,
both of which are generally taxed at rates lower than the statutory U.S. rate.
The Company's effective tax rate for the six months ended June 26, 2020 included the favorable impact of a $40 million tax benefit associated with the gain recorded upon the
acquisition of the remaining interest in fairlife and also included the net tax benefit of various discrete tax items. Refer to Note 2 of Notes to Condensed Consolidated Financial
Statements for additional information on the fairlife acquisition.
The Company's effective tax rates for the three and six months ended June 28, 2019 included $199 million of tax benefit recorded as a result of CCBA no longer qualifying as a
discontinued operation. Refer to Note 2 of Notes to Condensed Consolidated Financial Statements.
On September 17, 2015, the Company received a Statutory Notice of Deficiency from the Internal Revenue Service ("IRS") for the tax years 2007 through 2009, after a five-
year audit. The Company contested the proposed adjustments in U.S. Tax Court and is currently awaiting a decision. Refer to Note 8 of Notes to Condensed Consolidated
Financial Statements.
At the end of each interim period, we make our best estimate of the effective tax rate expected to be applicable for the full fiscal year. This estimate reflects, among other items,
our best estimate of operating results and foreign currency exchange rates. Based on current tax laws, the Company's effective tax rate in 2020 is expected to be 19.5 percent
before considering the potential impact of any significant operating and nonoperating items that may affect our effective tax rate.
LIQUIDITY, CAPITAL RESOURCES AND FINANCIAL POSITION
As a result of uncertainties in the near-term outlook for our business caused by the COVID-19 pandemic, we are reevaluating all aspects of our spending. We recognize that
marketing campaigns are often less effective at times like these; therefore, we have taken actions to adjust our marketing spending until we have more clarity and visibility into
the impact of the pandemic on our business. We have reviewed all of our capital projects to ensure that we are only spending on projects that are deemed to be essential in the
current environment. We have taken steps to limit spending on travel, third-party services and other operating expenses, and we continue to focus on cash flow generation. Our
current capital allocation priorities are focused on investing wisely to support our business operations and continuing to prioritize our dividend payment. Currently, we have no
intention of repurchasing shares during the year ending December 31, 2020, and we have no intention on changing our approach toward paying dividends. We also do not
currently expect any significant mergers and acquisitions activity to occur during the remainder of this year. We will review and, when appropriate, adjust our overall approach
to capital allocation as we know more about the length and severity of the COVID-19 pandemic and how the post-pandemic recovery will unfold. The Company does not
typically raise capital through the issuance of stock. Instead, we use debt financing to lower our overall cost of capital and increase our return on shareowners' equity. Refer to
the heading "Cash Flows from Financing Activities" below. We have a history of borrowing funds both domestically and internationally at reasonable interest rates, and we
expect to be able to continue to borrow funds at reasonable rates over the long term. Our debt financing also includes the use of an extensive commercial paper program. While
the COVID-19 pandemic initially caused a disruption in the commercial paper market, we currently still have the ability to borrow funds in this market and expect to continue to
be able to do so in the future. The Company reviews its optimal mix of short-term and long-term debt regularly, and as a result of this review, during the three months
ended June 26, 2020, we decided to issue additional long-term debt with certain tranches having a longer duration than other recent long-term debt issuances. While we intend
to remain active in the commercial paper market, we intend to use a portion of the proceeds from the long-term debt issuances to reduce our commercial paper balance.
On March 20, 2020 and April 29, 2020, we issued $5.0 billion and $6.5 billion, respectively, of long-term debt across various maturities. The Company's cash, cash equivalents,
short-term investments and marketable securities totaled $19.8 billion as of June 26, 2020. In addition to these funds, our commercial paper program and our ability to issue
long-term debt, we had $8.9 billion in unused lines of credit for general corporate purposes as of June 26, 2020. These backup lines of credit expire at various times from 2020
through 2025. On April 6, 2020, we entered into 364-day term loan agreements with a group of financial institutions that provided us with the ability, at our election prior to
August 4, 2020, to borrow $3.0 billion in term loans. On May 11, 2020, we terminated these loan agreements.
Based on all of the aforementioned factors, the Company believes its current liquidity position is strong and will continue to be sufficient to fund our operating activities and
cash commitments for investing and financing activities for the foreseeable future.
47

-- 50 of 89 --

Cash Flows from Operating Activities
As part of our continued efforts to improve our working capital efficiency, we have worked with our suppliers over the past several years to revisit terms and conditions,
including the extension of payment terms. Our current payment terms with the majority of our suppliers are 120 days. Additionally, two global financial institutions offer a
voluntary supply chain finance ("SCF") program which enables our suppliers, at their sole discretion, to sell their receivables from the Company to these financial institutions
on a non-recourse basis at a rate that leverages our credit rating and thus might be more beneficial to them. The SCF program is available to suppliers of goods and services
included in cost of goods sold as well as suppliers of goods and services included in selling, general and administrative expenses in our consolidated statement of income. The
Company and our suppliers agree on commercial terms for the goods and services we procure, including prices, quantities and payment terms, regardless of whether the supplier
elects to participate in the SCF program. The suppliers sell goods or services, as applicable, to the Company and they issue the associated invoices to the Company based on the
agreed-upon contractual terms. Then, if they are participating in the SCF program, our suppliers, at their sole discretion, determine which invoices, if any, they want to sell to
the financial institutions. Our suppliers’ voluntary inclusion of invoices in the SCF program has no bearing on our payment terms. No guarantees are provided by the Company
or any of our subsidiaries under the SCF program. We have no economic interest in a supplier’s decision to participate in the SCF program, and we have no direct financial
relationship with the financial institutions, as it relates to the SCF program. Accordingly, amounts due to our suppliers that elected to participate in the SCF program are included
in the line item accounts payable and accrued expenses in our consolidated balance sheet. All activity related to amounts due to suppliers that elected to participate in the SCF
program is reflected in cash flows from operating activities in our consolidated statement of cash flows. We have been informed by the financial institutions that as of June 26,
2020 and December 31, 2019, suppliers elected to sell $714 million and $784 million, respectively, of our outstanding payment obligations to the financial institutions. The
amount settled through the SCF program was $1,375 million for the six months ended June 26, 2020.
Net cash provided by operating activities for the six months ended June 26, 2020 and June 28, 2019 was $2,786 million and $4,501 million, respectively, a decrease of
$1,715 million, or 38 percent. This decrease was primarily driven by the 20 percent decline in operating income, the extension of payment terms with certain of our suppliers in
the prior year, one less selling day in the current year and the unfavorable impact of foreign currency exchange rate fluctuations. Net cash provided by operating activities
included benefits of approximately $682 million and $869 million for the six months ended June 28, 2019 and the year ended December 31, 2019, respectively, from the
extension of payment terms with certain of our suppliers. We do not believe there is a risk that our payment terms will be shortened in the near future, and we do not currently
expect our net cash provided by operating activities to be significantly impacted by additional extensions of payment terms in 2020.
Cash Flows from Investing Activities
Net cash used in investing activities for the six months ended June 26, 2020 and June 28, 2019 was $6,967 million and $5,362 million, respectively.
Purchases of Investments and Proceeds from Disposals of Investments
During the six months ended June 26, 2020, purchases of investments were $8,294 million and proceeds from disposals of investments were $2,649 million, resulting in a net
cash outflow of $5,645 million. During the six months ended June 28, 2019, purchases of investments were $2,935 million and proceeds from disposals of investments were
$3,395 million, resulting in a net cash inflow of $460 million. This activity primarily represents the purchases of, and proceeds from the disposals of, investments in marketable
securities and short-term investments that were made as part of the Company's overall cash management strategy. Also included in this activity are purchases of, and proceeds
from the disposals of, insurance captive investments. Refer to Note 4 of Notes to Condensed Consolidated Financial Statements for additional information.
Acquisitions of Businesses, Equity Method Investments and Nonmarketable Securities
During the six months ended June 26, 2020, the Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $984 million, which
primarily related to the acquisition of the remaining interest in fairlife. Refer to Note 2 of Notes to Condensed Consolidated Financial Statements for additional information.
During the six months ended June 28, 2019, the Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $5,353 million, which
primarily related to the acquisition of Costa and the remaining interest in CHI. Refer to Note 2 of Notes to Condensed Consolidated Financial Statements for additional
information.
Proceeds from Disposals of Businesses, Equity Method Investments and Nonmarketable Securities
During the six months ended June 26, 2020, proceeds from disposals of businesses, equity method investments and nonmarketable securities were $46 million, which primarily
related to the sale of a portion of our ownership interest in one of our equity method investments.
48

-- 51 of 89 --

During the six months ended June 28, 2019, proceeds from disposals of businesses, equity method investments and nonmarketable securities were $265 million, which primarily
related to the proceeds from the sale of a portion of our equity ownership interest in Andina.
Purchases of Property, Plant and Equipment
Purchases of property, plant and equipment for the six months ended June 26, 2020 and June 28, 2019 were $536 million and $767 million, respectively.
Cash Flows from Financing Activities
Net cash provided by financing activities during the six months ended June 26, 2020 was $8,045 million, and net cash used in financing activities during the six months ended
June 28, 2019 was $1,432 million.
Debt Financing
Issuances and payments of debt included both short-term and long-term financing activities. During the six months ended June 26, 2020, the Company had issuances of debt of
$19,775 million, which included $8,260 million of net issuances related to commercial paper and short-term debt with maturities greater than 90 days and long-term debt
issuances of $11,515 million, net of related discounts and issuance costs.
The Company made payments of debt of $10,304 million during the six months ended June 26, 2020, which included $7,948 million of payments of commercial paper and
short-term debt with maturities greater than 90 days, $1,836 million of payments of commercial paper and short-term debt with maturities of 90 days or less, and payments of
long-term debt of $520 million.
During the six months ended June 26, 2020, the Company issued U.S. dollar-denominated debt of $11,500 million. The carrying value of this debt as of June 26, 2020 was
$11,396 million. The general terms of the notes issued are as follows:
• 	$1,000 million total principal amount of notes due March 25, 2025, at a fixed interest rate of 2.950 percent;
• 	$1,000 million total principal amount of notes due March 25, 2027, at a fixed interest rate of 3.375 percent;
• 	$1,500 million total principal amount of notes due June 1, 2027, at a fixed interest rate of 1.450 percent;
• 	$1,250 million total principal amount of notes due March 25, 2030, at a fixed interest rate of 3.450 percent;
• 	$1,500 million total principal amount of notes due June 1, 2030, at a fixed interest rate of 1.650 percent;
• 	$500 million total principal amount of notes due March 25, 2040, at a fixed interest rate of 4.125 percent;
• 	$1,000 million total principal amount of notes due June 1, 2040, at a fixed interest rate of 2.500 percent;
• 	$1,250 million total principal amount of notes due March 25, 2050, at a fixed interest rate of 4.200 percent;
• 	$1,500 million total principal amount of notes due June 1, 2050, at a fixed interest rate of 2.600 percent; and
• 	$1,000 million total principal amount of notes due June 1, 2060, at a fixed interest rate of 2.750 percent.
During the six months ended June 26, 2020, the Company retired upon maturity:
• 	AUD450 million total principal amount of notes due June 9, 2020, at a fixed interest rate of 2.600 percent; and
• 	$171 million total principal amount of zero coupon notes due June 20, 2020.
49

-- 52 of 89 --

Issuances of Stock
During the six months ended June 26, 2020, the Company received cash proceeds from issuances of stock of $444 million, a decrease of $158 million when compared to cash
proceeds from issuances of stock of $602 million during the six months ended June 28, 2019.
Share Repurchases
During the six months ended June 26, 2020, the Company did not repurchase common stock under the share repurchase plan authorized by our Board of Directors. The
Company's treasury stock activity includes shares surrendered to the Company to pay the exercise price and/or to satisfy tax withholding obligations in connection with so-
called stock swap exercises of employee stock options and/or the vesting of restricted stock issued to employees. The Company's treasury stock activity during the six months
ended June 26, 2020 resulted in a cash outflow of $93 million.
Dividends
During the six months ended June 26, 2020 and June 28, 2019, the Company paid dividends of $1,761 million and $1,709 million, respectively. The Company paid the second
quarter dividend in both 2020 and 2019 during the first week of July.
Our Board of Directors approved the Company's regular quarterly dividend of $0.41 per share at its July 2020 meeting. This dividend is payable on October 1, 2020 to
shareowners of record as of September 15, 2020.
Foreign Exchange
Our international operations are subject to certain opportunities and risks, including currency fluctuations and governmental actions. We closely monitor our operations in each
country and seek to adopt appropriate strategies that are responsive to changing economic and political environments as well as to fluctuations in foreign currencies.
Our Company conducts business in more than 200 countries and territories. Due to the geographic diversity of our operations, weakness in some foreign currencies may be
offset by strength in others. Our foreign currency management program is designed to mitigate, over time, a portion of the potentially unfavorable impact of exchange rate
changes on net income and earnings per share. Taking into account the effects of our hedging activities, the impact of changes in foreign currency exchange rates decreased our
operating income for the three and six months ended June 26, 2020 by 5 percent and 4 percent, respectively.
Based on current spot rates and our hedging coverage in place, we expect foreign currency fluctuations will have an unfavorable impact on operating income and cash flows
from operations through the end of the year.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We have no material changes to the disclosures on this matter made in our Annual Report on Form 10-K for the year ended December 31, 2019.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and the Chief Financial Officer, evaluated the
effectiveness of the design and operation of the Company's "disclosure controls and procedures" (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as
amended (the "Exchange Act")) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer
concluded that the Company's disclosure controls and procedures were effective as of June 26, 2020.
Changes in Internal Control Over Financial Reporting
There have been no changes in the Company's internal control over financial reporting during the quarter ended June 26, 2020 that have materially affected, or are reasonably
likely to materially affect, the Company's internal control over financial reporting.
Part II. Other Information
Item 1. Legal Proceedings
Information regarding reportable legal proceedings is contained in Part I, "Item 3. Legal Proceedings" in our Annual Report on Form 10-K for the year ended December 31,
2019.
50

-- 53 of 89 --

Item 1A. Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on
Form 10-K for the year ended December 31, 2019, as updated and supplemented in Part II, "Item 1A. Risk Factors" in our Quarterly Report on Form 10-Q for the quarter ended
March 27, 2020 and as further updated and supplemented below, which could materially affect our business, financial condition or future results. These risks are not the only
risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our
business, financial condition or future results.
The COVID-19 pandemic has had, and we expect will continue to have, certain negative impacts on our business, and such impacts have had, and may continue to have, a
material adverse effect on our results of operations, financial condition and cash flows.
The public health crisis caused by the COVID-19 pandemic and the measures that have been taken or that may be taken in the future by governments, businesses, including us
and our bottling partners, and the public at large to limit COVID-19's spread have had, and we expect will continue to have, certain negative impacts on our business including,
without limitation, the following:
• 	We have experienced a decrease in sales of certain of our products in markets around the world that have been affected by the COVID-19 pandemic. In particular, sales
of our products in the away-from-home channels have been significantly negatively affected by shelter-in-place regulations or recommendations, closings of restaurants
and cancellations of major sporting and other events that were imposed as a result of the initial COVID-19 outbreak. While some of these restrictions have been lifted or
eased in many jurisdictions as the rates of COVID-19 infections have decreased or stabilized, resurgence of the pandemic in some markets has slowed the reopening
process. If COVID-19 infection trends continue to reverse and the pandemic intensifies and expands geographically, its negative impacts on our sales could be more
prolonged and may become more severe. While we have initially experienced increased sales in the at-home channels from pantry loading as consumers have stocked up
on certain of our products with the expectation of spending more time at home during the crisis, such increased sales levels have not, and we expect will not, fully offset
the sales pressures we have experienced and we expect will continue to experience in the away-from-home channels while social distancing mandates or
recommendations are in effect.
• 	In certain COVID-19 affected markets, consumer demand has shifted away from some of our more profitable beverages and away-from-home consumption to lower-
margin products and at-home consumption, and this shift in consumer purchasing patterns is likely to continue while shelter-in-place and social distancing behaviors are
mandated or encouraged.
• 	Deteriorating economic and political conditions in many of our major markets affected by the COVID-19 pandemic, such as increased unemployment, decreases in
disposable income, declines in consumer confidence, or economic slowdowns or recessions, have caused, and could continue to cause, a decrease in demand for our
products.
• 	We are accelerating our business strategy and are taking certain actions to address challenges posed by the COVID-19 pandemic and deliver on our commitment to
emerge stronger from this crisis. These include focusing investments on a defined growth portfolio by prioritizing brands best positioned for consumer reach;
streamlining the innovation pipeline through initiatives that are scalable regionally or globally as well as a maintaining a disciplined approach to local experimentation;
refreshing our marketing approach, with a focus on improving our marketing investment effectiveness and efficiency; and investing in new capabilities to capitalize on
emerging shifts in consumer behaviors that we anticipate may last beyond this crisis. These actions, which may require substantial additional investment of management
time and financial resources, may not be sufficient to accomplish our goals.
• 	We have experienced temporary disruptions in certain of our concentrate production operations. We have taken measures to protect our employees and facilities around
the world, which have included, but have not been limited to, checking the temperature of employees when they enter our facilities, requiring employees to wear masks
and other protective clothing as appropriate, and implementing additional cleaning and sanitization routines. These measures may not be sufficient to prevent the spread
of COVID-19 among our employees and, therefore, we may face additional concentrate production disruptions in the future, which may place constraints on our ability
to supply concentrates to our bottling partners in a timely manner or may increase our concentrate supply costs.
• 	We have faced, and may continue to face, delays in the delivery of concentrates to our bottling partners as a result of shipping delays due to, among other things,
additional safety requirements imposed by port authorities, closures of or congestion at ports, and capacity constraints experienced by our transportation contractors.
51

-- 54 of 89 --

• 	Some of our bottling partners have experienced, and may experience in the future, temporary plant closures, production slowdowns and disruptions in distribution
operations as a result of the impact of the COVID-19 pandemic on their respective businesses.
• 	Disruptions in supply chains have placed, and may continue to place, constraints on our and our bottling partners’ ability to source beverage containers, such as glass
bottles and cans, which has increased, and in the future may increase, our and their packaging costs.
• 	We have experienced, and expect to continue to experience, adverse fluctuations in foreign currency exchange rates, particularly an increase in the value of the U.S.
dollar against certain key foreign currencies, which negatively affected, and we expect will continue to negatively affect, our reported results of operations and financial
condition.
• 	Our borrowing costs have increased as a result of disruptions and increased volatility and pricing in the commercial paper and debt markets caused by the COVID-19
pandemic and, if the current uncertain conditions in the credit markets continue or worsen, our borrowing costs may continue to increase.
• 	The current uncertain credit market conditions and their actual or perceived effects on our and our major bottling partners' results of operations and financial condition,
along with the current unfavorable economic environment in the United States and much of the world, may increase the likelihood that one or more of the major
independent credit agencies will downgrade our credit ratings, which could have a negative effect on our borrowing costs.
• 	Governmental authorities in the United States and throughout the world may increase or impose new income taxes or indirect taxes, or revise interpretations of existing
tax rules and regulations, as a means of financing the costs of stimulus and other measures enacted or taken, or that may be enacted or taken in the future, to protect
populations and economies from the impact of the COVID-19 pandemic. Such actions could have an adverse effect on our results of operations and cash flows.
• 	We rely on third-party service providers and business partners, such as cloud data storage and other information technology service providers, suppliers, distributors,
contractors, joint venture partners and other external business partners, for certain functions or for services in support of key portions of our operations. These third-party
service providers and business partners are subject to risks and uncertainties related to the COVID-19 pandemic, which may interfere with their ability to fulfill their
respective commitments and responsibilities to us in a timely manner and in accordance with the agreed-upon terms.
• 	The financial impact of the COVID-19 pandemic may cause one or more of our counterparty financial institutions to fail or default on their obligations to us, which
could cause us to incur significant losses.
• 	We may be required to record significant impairment charges with respect to noncurrent assets, including trademarks, bottler franchise rights, goodwill and other
intangible assets, equity method investments, and other long-lived assets, whose fair values may be negatively affected by the effects of the COVID-19 pandemic on our
operations. Also, we may be required to write off obsolete inventory and the unamortized balances of advanced funding provided to customers that permanently close as
a result of the COVID-19 pandemic’s damaging impacts on their respective businesses. In addition, we are required to record impairment charges related to our
proportionate share of impairment charges that may be recorded by equity method investees, and such charges may be significant.
• 	The significant declines in the equity markets and in the valuation of other assets precipitated by the COVID-19 pandemic negatively affected the values of our pension
plan assets during the quarter ended March 27, 2020. While the equity markets and the valuation of other assets have recovered somewhat during the quarter ended June
26, 2020, the fair values of our pension plan assets remain lower than pre-pandemic levels. If pension plan asset values do not continue to recover to pre-pandemic levels
or deteriorate again as a result of uncertainty regarding the timing and pace of economic recovery from the COVID-19 pandemic, we may incur increased pension
expense in future periods.
• 	As a result of the COVID-19 pandemic, including related governmental guidance or directives, we have required most office-based employees, including most
employees based at our global headquarters in Atlanta, to work remotely. We may experience reductions in productivity and disruptions to our business routines while
our remote work policy remains in place.
• 	Actions we have taken or may take, or decisions we have made or may make, as a consequence of the COVID-19 pandemic may result in legal claims or litigation
against us.
The resumption of normal business operations after the disruptions caused by the COVID-19 pandemic may be delayed or constrained by its lingering effects on our bottling
partners, consumers, suppliers and/or third-party service providers.
Any of the negative impacts of the COVID-19 pandemic, including those described above, alone or in combination with others, may have a material adverse effect on our
results of operations, financial condition and cash flows. Any of these negative
52

-- 55 of 89 --

impacts, alone or in combination with others, could exacerbate many of the risk factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the
year ended December 31, 2019. The full extent to which the COVID-19 pandemic will negatively affect our results of operations, financial condition and cash flows will depend
on future developments that are highly uncertain and cannot be predicted, including the scope and duration of the pandemic, the duration of the various shelter-in-place orders
and reopening plans across the globe, and actions taken, or that may be taken in the future, by governmental authorities and other third parties in response to the pandemic.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table presents information with respect to purchases of common stock of the Company made during the three months ended June 26, 2020 by the Company or
any "affiliated purchaser" of the Company as defined in Rule 10b-18(a)(3) under the Exchange Act:
Period
Total Number
of Shares
Purchased1
Average
Price Paid
Per Share
Total Number
of Shares
Purchased as
Part of
Publicly
Announced
Plan2
Maximum
Number of
Shares That May
Yet Be
Purchased Under
Publicly
Announced
Plans3
March 28, 2020 through April 24, 2020 	2,886 $ 	44.70 	— 	161,029,667
April 25, 2020 through May 22, 2020 	1,334 	46.15 	— 	161,029,667
May 23, 2020 through June 26, 2020 	295 	46.67 	— 	161,029,667
Total 	4,515 $ 	45.26 	—
1 The total number of shares purchased includes: (1) shares purchased pursuant to the 2012 Plan described in footnote 2 below, if any, and (2) shares surrendered to the Company to pay the
exercise price and/or to satisfy tax withholding obligations in connection with so-called stock swap exercises of employee stock options and/or the vesting of restricted stock issued to
employees.
2 On October 18, 2012, the Company publicly announced that our Board of Directors had authorized a plan ("2012 Plan") for the Company to purchase up to 500 million shares of our common
stock. This column discloses the number of shares purchased pursuant to the 2012 Plan during the indicated time periods (including shares purchased pursuant to the terms of preset trading
plans meeting the requirements of Rule 10b5-1 under the Exchange Act).
3 On February 21, 2019, the Company publicly announced that our Board of Directors had authorized a new plan ("2019 Plan") for the Company to purchase up to 150 million shares of our
common stock following the completion of the 2012 Plan. This column discloses the number of shares available for purchase under the 2012 Plan and the number of shares authorized for
purchase under the 2019 Plan.
Item 6. Exhibits
In reviewing the agreements included as exhibits to this report, please remember they are included to provide you with information regarding their terms and are not intended to
provide any other factual or disclosure information about the Company or the other parties to the agreements. The agreements contain representations, warranties, covenants
and conditions by or of each of the parties to the applicable agreement. These representations, warranties, covenants and conditions have been made solely for the benefit of the
other parties to the applicable agreement and:
• should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be
inaccurate;
• may have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not
necessarily reflected in the agreement;
• may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and
• were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.
Accordingly, these representations, warranties, covenants and conditions may not describe the actual state of affairs as of the date they were made or at any other time.
Additional information about the Company may be found elsewhere in this report and the Company's other public filings, which are available without charge through the
Securities and Exchange Commission's website at http://www.sec.gov.
53

-- 56 of 89 --

EXHIBIT INDEX
Exhibit No.
(With regard to applicable cross-references in the list of exhibits below, the Company's Current, Quarterly and Annual Reports are filed with the Securities and Exchange
Commission (the "SEC") under File No. 001-02217; and Coca-Cola Refreshments USA, Inc.'s (formerly known as Coca-Cola Enterprises Inc.) Current, Quarterly and Annual
Reports are filed with the SEC under File No. 001-09300).
3.1 	Certificate of Incorporation of the Company, including Amendment of Certificate of Incorporation, dated July 27, 2012 — incorporated herein by reference to
Exhibit 3.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 28, 2012.
3.2 	By-Laws of the Company, as amended and restated through April 22, 2020 — incorporated herein by reference to Exhibit 3.2 to the Company's Quarterly
Report on Form 10-Q for the quarter ended March 27, 2020.
4.1 	Intentionally omitted.
4.2 	As permitted by the rules of the SEC, the Company has not filed certain instruments defining the rights of holders of long-term debt of the Company or
consolidated subsidiaries under which the total amount of securities authorized does not exceed 10 percent of the total assets of the Company and its consolidated
subsidiaries. The Company agrees to furnish to the SEC, upon request, a copy of any omitted instrument.
4.3 	Amended and Restated Indenture, dated as of April 26, 1988, between the Company and Deutsche Bank Trust Company Americas, as successor to Bankers
Trust Company, as trustee — incorporated herein by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on May 25, 2017.
4.4 	First Supplemental Indenture, dated as of February 24, 1992, to Amended and Restated Indenture, dated as of April 26, 1988, between the Company and
Deutsche Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee — incorporated herein by reference to Exhibit 4.2 to the
Company's Current Report on Form 8-K filed on May 25, 2017.
4.5 	Second Supplemental Indenture, dated as of November 1, 2007, to Amended and Restated Indenture, dated as of April 26, 1988, as amended, between the
Company and Deutsche Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee — incorporated herein by reference to Exhibit 4.3
of the Company's Current Report on Form 8-K filed on May 25, 2017.
4.6 	Form of Note for 3.150% Notes due November 15, 2020 — incorporated herein by reference to Exhibit 4.7 to the Company's Current Report on Form 8-K filed
on November 18, 2010.
4.7 	Form of Note for 3.30% Notes due September 1, 2021 — incorporated herein by reference to Exhibit 4.14 to the Company's Quarterly Report on Form 10-Q for
the quarter ended September 30, 2011.
4.8 	Form of Note for 2.500% Notes due 2023 — incorporated herein by reference to Exhibit 4.6 to the Company's Current Report on Form 8-K filed on March 5,
2013.
4.9 	Form of Note for 2.450% Notes due 2020 — incorporated herein by reference to Exhibit 4.7 to the Company's Current Report on Form 8-K filed on November
1, 2013.
4.10 	Form of Note for 3.200% Notes due 2023 — incorporated herein by reference to Exhibit 4.8 to the Company's Current Report on Form 8-K filed on November
1, 2013.
4.11 	Form of Note for 1.875% Notes due 2026 — incorporated herein by reference to Exhibit 4.4 to the Company's Registration Statement on Form 8-A filed on
September 19, 2014.
4.12 	Form of Note for 1.125% Notes due 2022 — incorporated herein by reference to Exhibit 4.5 to the Company's Registration Statement on Form 8-A filed on
September 19, 2014.
4.13 	Form of Note for 0.75% Notes due 2023 — incorporated herein by reference to Exhibit 4.6 to the Company's Registration Statement on Form 8-A filed on
March 6, 2015.
4.14 	Form of Note for 1.125% Notes due 2027 — incorporated herein by reference to Exhibit 4.7 to the Company's Registration Statement on Form 8-A filed on
March 6, 2015.
4.15 	Form of Note for 1.625% Notes due 2035 — incorporated herein by reference to Exhibit 4.8 to the Company's Registration Statement on Form 8-A filed on
March 6, 2015.
4.16 	Form of Note for 1.875% Notes due 2020 — incorporated herein by reference to Exhibit 4.5 to the Company's Current Report on Form 8-K filed on October 27,
2015.
4.17 	Form of Note for 2.875% Notes due 2025 — incorporated herein by reference to Exhibit 4.6 to the Company's Current Report on Form 8-K filed on October 27,
2015.
4.18 	Form of Note for 2.55% Notes due 2026 — incorporated herein by reference to Exhibit 4.6 to the Company's Current Report on Form 8-K filed on May 31,
2016.
4.19 	Form of Note for 1.550% Notes due 2021 — incorporated herein by reference to Exhibit 4.4 to the Company's Current Report on Form 8-K filed on September
1, 2016.
4.20 	Form of Note for 2.250% Notes due 2026 — incorporated herein by reference to Exhibit 4.5 to the Company's Current Report on Form 8-K filed on September
1, 2016.
54

-- 57 of 89 --

4.21 	Form of Note for 1.100% Notes due 2036 — incorporated herein by reference to Exhibit 4.4 to the Company’s Registration Statement on Form 8-A filed on
September 2, 2016.
4.22 	Form of Note for 0.000% Notes due 2021 — incorporated herein by reference to Exhibit 4.5 to the Company’s Registration Statement on Form 8-A filed on
March 9, 2017.
4.23 	Form of Note for 0.500% Notes due 2024 — incorporated herein by reference to Exhibit 4.6 to the Company’s Registration Statement on Form 8-A filed on
March 9, 2017.
4.24 	Form of Note for 2.200% Notes due 2022 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 25,
2017.
4.25 	Form of Note for 2.900% Notes due 2027 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 25,
2017.
4.26 	Form of Note for Floating Rate Notes due 2021 — incorporated herein by reference to Exhibit 4.4 to the Company's Registration Statement on Form 8-A filed
on March 8, 2019.
4.27 	Form of Note for 0.125% Notes due 2022 — incorporated herein by reference to Exhibit 4.5 to the Company's Registration Statement on Form 8-A filed on
March 8, 2019.
4.28 	Form of Note for 0.750% Notes due 2026 — incorporated herein by reference to Exhibit 4.6 to the Company's Registration Statement on Form 8-A filed on
March 8, 2019.
4.29 	Form of Note for 1.250% Notes due 2031 — incorporated herein by reference to Exhibit 4.7 to the Company's Registration Statement on Form 8-A filed on
March 8, 2019.
4.30 	Form of Note for 1.750% Notes due 2024 — incorporated herein by reference to Exhibit 4.4 to the Company's Current Report on Form 8-K filed on September
9, 2019.
4.31 	Form of Note for 2.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.5 to the Company's Current Report on Form 8-K filed on September
9, 2019.
4.32 	Form of Note for 2.950% Notes due 2025 — incorporated herein by reference to Exhibit 4.4 to the Company's Current Report on Form 8-K filed on March 25,
2020.
4.33 	Form of Note for 3.375% Notes due 2027 — incorporated herein by reference to Exhibit 4.5 to the Company's Current Report on Form 8-K filed on March 25,
2020.
4.34 	Form of Note for 3.450% Notes due 2030 — incorporated herein by reference to Exhibit 4.6 to the Company's Current Report on Form 8-K filed on March 25,
2020.
4.35 	Form of Note for 4.125% Notes due 2040 — incorporated herein by reference to Exhibit 4.7 to the Company's Current Report on Form 8-K filed on March 25,
2020.
4.36 	Form of Note for 4.200% Notes due 2050 — incorporated herein by reference to Exhibit 4.8 to the Company's Current Report on Form 8-K filed on March 25,
2020.
4.37 	Form of Note for 1.450% Notes due 2027 — incorporated herein by reference to Exhibit 4.4 to the Company's Current Report on Form 8-K filed on May 4,
2020.
4.38 	Form of Note for 1.650% Notes due 2030 — incorporated herein by reference to Exhibit 4.5 to the Company's Current Report on Form 8-K filed on May 4,
2020.
4.39 	Form of Note for 2.500% Notes due 2040 — incorporated herein by reference to Exhibit 4.6 to the Company's Current Report on Form 8-K filed on May 4,
2020.
4.40 	Form of Note for 2.600% Notes due 2050 — incorporated herein by reference to Exhibit 4.7 to the Company's Current Report on Form 8-K filed on May 4,
2020.
4.41 	Form of Note for 2.750% Notes due 2060 — incorporated herein by reference to Exhibit 4.8 to the Company's Current Report on Form 8-K filed on May 4,
2020.
4.42 	Indenture, dated as of July 30, 1991, between Coca-Cola Refreshments USA, Inc. and Deutsche Bank Trust Company Americas, as trustee — incorporated herein
by reference to Exhibit 4.1 to Coca-Cola Refreshments USA, Inc.'s Current Report on Form 8-K dated July 30, 1991.
4.43 	First Supplemental Indenture, dated as of January 29, 1992, to the Indenture, dated as of July 30, 1991, between Coca-Cola Refreshments USA, Inc. and Deutsche
Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.01 to Coca-Cola Refreshments USA, Inc.'s Current Report on Form 8-
K dated January 29, 1992.
4.44 	Second Supplemental Indenture, dated as of June 22, 2017, to the Indenture, dated as of July 30, 1991, as amended, among Coca-Cola Refreshments USA, Inc.,
the Company and Deutsche Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.1 to the Company's Current Report on
Form 8-K filed on June 23, 2017.
4.45 	Third Supplemental Indenture, dated as of July 5, 2017, to the Indenture, dated as of July 30, 1991, as amended, among Coca-Cola Refreshments USA, Inc., the
Company and Deutsche Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.3 to the Company's Current Report on
Form 8-K filed on July 6, 2017.
55

-- 58 of 89 --

10.1 	Amendment One to The Coca-Cola Company Severance Pay Plan, as Amended and Restated Effective January 1, 2020, dated May 29, 2020.
31.1 	Rule 13a-14(a)/15d-14(a) Certification, executed by James Quincey, Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola
Company.
31.2 	Rule 13a-14(a)/15d-14(a) Certification, executed by John Murphy, Executive Vice President and Chief Financial Officer of The Coca-Cola Company.
32.1 	Certifications required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. Section 1350),
executed by James Quincey, Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola Company, and by John Murphy, Executive Vice
President and Chief Financial Officer of The Coca-Cola Company.
101 	The following financial information from The Coca-Cola Company's Quarterly Report on Form 10-Q for the quarter ended June 26, 2020, formatted in iXBRL
(Inline Extensible Business Reporting Language): (i) Condensed Consolidated Statements of Income for the three and six months ended June 26, 2020 and June
28, 2019, (ii) Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 26, 2020 and June 28, 2019, (iii) Condensed
Consolidated Balance Sheets as of June 26, 2020 and December 31, 2019, (iv) Condensed Consolidated Statements of Cash Flows for the six months ended June
26, 2020 and June 28, 2019, and (v) Notes to Condensed Consolidated Financial Statements.
104 	Cover Page Interactive Data File (the cover page XBRL tags are embedded within the iXBRL document).
56

-- 59 of 89 --

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
THE COCA-COLA COMPANY
(Registrant)
/s/ KATHY LOVELESS
Date: 	July 22, 2020 	Kathy Loveless
Vice President and Controller
(On behalf of the Registrant)
/s/ MARK RANDAZZA
Date: 	July 22, 2020 	Mark Randazza
Vice President, Assistant Controller and Chief Accounting Officer
(Principal Accounting Officer)
57

-- 60 of 89 --

Exhibit 3.2
BY-LAWS OF THE COCA-COLA COMPANY
AS AMENDED AND RESTATED THROUGH APRIL 22, 2020
ARTICLE I
SHAREHOLDERS:
Section 1. Place, Date and Time of Holding Annual Meetings. Annual meetings of shareholders shall be held at such place, date and time as
shall be designated from time to time by the Board of Directors. In the absence of a resolution adopted by the Board of Directors establishing
such place, date and time, the annual meeting shall be held at 1209 Orange Street, Wilmington, Delaware, on the third Wednesday in April of
each year at 9:00 A.M. (local time).
Section 2. Voting. Each outstanding share of common stock of the Company is entitled to one vote on each matter submitted to a vote. Except
as provided below, all actions shall be authorized by a majority of the votes cast unless a greater vote is required by the laws of Delaware. A
shareholder may vote in person or by proxy authorized by an instrument in writing or by a transmission permitted by law filed in accordance
with the procedures established for the meeting. Any copy, facsimile telecommunication or other reliable reproduction of the writing or
transmission created pursuant to this section may be substituted or used in lieu of the original writing or the transmission that could be used,
provided that such copy, facsimile telecommunication or other reproduction shall be a complete reproduction of the entire original writing or
transmission. A nominee for director election shall be elected by the affirmative vote of a majority of the votes cast with respect to such
nominee at any meeting for the election of directors at which a quorum is present, provided that if the number of nominees exceeds the
number of directors to be elected, the directors shall be elected by a plurality of the votes of the shares represented in person or by proxy at any
such meeting and entitled to vote on the election of directors. In an election of directors, a majority of the votes cast means that the number of
votes cast “for” a nominee must exceed 50% of the votes cast with respect to such nominee (excluding abstentions). If a director is not elected,
the director shall promptly tender his or her resignation to the Board of Directors. The Committee on Directors and Corporate Governance will
make a recommendation to the Board of Directors on whether to accept or reject the resignation, or whether other action should be taken. The
Board of Directors will act on the resignation taking into account the recommendation of the Committee on Directors and Corporate
Governance and publicly disclose its decision and the rationale behind it within 100 days from the date of the certification of the election
results. The director who tenders his or her resignation will not participate in the decisions of the Committee on Directors and Corporate
Governance or the Board of Directors that concern such resignation. If a director’s resignation is accepted by the Board of Directors pursuant to
this By-Law, or if a nominee for director is not elected and the nominee is not an incumbent director, then the Board of Directors, in its sole
discretion, may fill any resulting vacancy pursuant to the provisions of Article VI, Section 2 or may decrease the size of the Board of Directors
pursuant to the provisions of Article II, Section 1.

-- 61 of 89 --

Section 3. Quorum. The holders of a majority of the issued and outstanding shares of capital stock of the Company, present in person or
represented by proxy, shall constitute a quorum at all meetings of shareholders. Where a separate vote by a class or classes or series is required,
a majority of the shares of such class or classes or series present in person or represented by proxy shall constitute a quorum entitled to take
action with respect to that vote on that matter.
Section 4. Adjournment of Meetings. In the absence of a quorum or for any other reason, the chairman of the meeting may adjourn the meeting
from time to time. If the adjournment is not for more than thirty days, the adjourned meeting may be held without notice other than an
announcement at the meeting. If the adjournment is for more than thirty days, or if a new record date is fixed for the adjourned meeting, a
notice of the adjourned meeting shall be given to each shareholder of record entitled to vote at such meeting. At any such adjourned meeting at
which a quorum is present, any business may be transacted which might have been transacted at the meeting originally called.
Section 5. Special Meetings.
(a) General. Special meetings of the shareholders for any purpose or purposes may be called by, and only by, (i) the Board of Directors, (ii) the
Chairman of the Board of Directors, (iii) the Chief Executive Officer or (iv) solely to the extent required by Section 5(b), the Secretary of the
Company. Each special meeting shall be held at such date, time and place either within or without the State of Delaware as may be stated in the
notice of the meeting.
(b) Shareholder Requested Special Meetings.
(i) Special meetings of the shareholders (each a “Shareholder Requested Special Meeting”) shall be called by the Secretary upon the
written request of a shareholder (or a group of shareholders formed for the purpose of making such request) who or which has Net Long
Beneficial Ownership (as defined below) of 25% or more of the outstanding common stock of the Company (the “Requisite Percent”) as of the
date of submission of the request. Compliance by the requesting shareholder or group of shareholders with the requirements of this section and
related provisions of these By-Laws shall be determined in good faith by the Board of Directors, which determination shall be conclusive and
binding on the Company and the shareholders.
“Net Long Beneficial Ownership” (and its correlative terms), when used to describe the nature of a shareholder’s ownership of common
stock of the Company, shall mean those shares of common stock of the Company as to which the shareholder in question possesses (x) the sole
power to vote or direct the voting, (y) the sole economic incidents of ownership (including the sole right to profits and the sole risk of loss),
and (z) the sole power to dispose of or direct the disposition. The number of shares calculated in accordance with clauses (x), (y) and (z) shall
not include any shares (1) sold by such shareholder in any transaction that has not been settled or closed, (2) borrowed by such shareholder for
any purposes or purchased by such shareholder pursuant to an agreement to resell or (3) subject to any option, warrant, derivative or other
agreement or understanding, whether any such arrangement is to be settled with shares of common stock of the Company or with cash based on
the notional amount of shares subject
2

-- 62 of 89 --

thereto, in any such case which has, or is intended to have, the purpose or effect of (A) reducing in any manner, to any extent or at any time in
the future, such shareholder’s rights to vote or direct the voting and full rights to dispose or direct the disposition of any of such shares or (B)
offsetting to any degree gain or loss arising from the sole economic ownership of such shares by such shareholder.
(ii) A request for a Shareholder Requested Special Meeting must be signed by the Net Long Beneficial Owners of the Requisite Percent of
the Company’s common stock (or their duly authorized agents) and be delivered to the Secretary at the principal executive offices of the
Company by registered mail, return receipt requested.
Such request shall (A) set forth a statement of the specific purpose or purposes of the meeting and the matters proposed to be acted on
at such special meeting, (B) bear the date of signature of each shareholder (or duly authorized agent) signing the request, (C) set forth (w) the
name and address, as they appear in the Company’s books, of each shareholder signing such request (or on whose behalf the request is signed),
(x) the number of shares of common stock of the Company as to which such shareholder has Net Long Beneficial Ownership, (y) include
evidence of the fact and duration of such shareholder’s beneficial ownership of such stock consistent with that which is required under
Regulation 14A under the Securities Exchange Act of 1934, as amended (the "1934 Act") and (z) a certification from each such shareholder
that the shareholders signing the request in the aggregate satisfy the Net Long Beneficial Ownership requirement of these By-Laws, (D) set
forth all information relating to each such shareholder that must be disclosed in solicitations of proxies for election of directors in an election
contest (even if an election contest is not involved), or is otherwise required, in each case, pursuant to Regulation 14A under the 1934 Act, (E)
describe any material interest of each such shareholder in the specific purpose or purposes of the meeting, and (F) include an acknowledgment
by each shareholder and any duly authorized agent that any disposition of shares of common stock of the Company as to which such
shareholder has Net Long Beneficial Ownership as of the date of delivery of the special meeting request and prior to the record date for the
proposed meeting requested by such shareholder shall constitute a revocation of such request with respect to such shares. In addition, the
shareholder and any duly authorized agent shall promptly provide any other information reasonably requested by the Company to allow it to
satisfy its obligations under applicable law.
Any requesting shareholder may revoke a request for a special meeting at any time by written revocation delivered to the Secretary at
the principal executive offices of the Company. If, following such revocation at any time before the date of the Shareholder Requested Special
Meeting, the remaining requests are from shareholders holding in the aggregate less than the Requisite Percent, the Board of Directors, in its
discretion, may cancel the Shareholder Requested Special Meeting.
(iii) Notwithstanding the foregoing, the Secretary shall not be required to call a special meeting of shareholders if (A) the request for
such special meeting does not comply with this Section 5(b), (B) the Board of Directors, the Chairman of the Board of Directors or the Chief
Executive Officer has called or calls an annual or special meeting of shareholders to be held not later than ninety (90) days after the date on
which a valid
3

-- 63 of 89 --

request has been delivered to the Secretary (the “Delivery Date”), (C) the request is received by the Secretary during the period commencing
ninety (90) days prior to the first anniversary of the date of the immediately preceding annual meeting and ending on the date of the next
annual meeting, (D) the request contains an identical or substantially similar item (a “Similar Item”) to an item that was presented at any
meeting of shareholders held within one hundred and twenty (120) days prior to the Delivery Date (and, for purposes of this clause (D) the
election of directors shall be deemed a “Similar Item” with respect to all items of business involving the election or removal of directors), (E)
the request relates to an item of business that is not a proper subject for action by the shareholders of the Company under applicable law or (F)
the request was made in a manner that involved a violation of Regulation 14A under the 1934 Act or other applicable law.
(iv) Any Shareholder Requested Special Meeting shall be held at such date, time and place within or without the state of Delaware as
may be fixed by the Board of Directors; provided, however, that the date of any Shareholder Requested Special Meeting shall be not more than
sixty (60) days after the record date for such meeting (the “Meeting Record Date”), which shall be fixed in accordance with Article I, Section 9
of these By-Laws. In fixing a date and time for any Shareholder Requested Special Meeting, the Board of Directors may consider such factors
as it deems relevant within the good faith exercise of business judgment, including, without limitation, the nature of the matters to be
considered, the facts and circumstances surrounding any request for the special meeting and any plan of the Board of Directors to call an
annual meeting or a special meeting.
(v) Business transacted at any Shareholder Requested Special Meeting shall be limited to the purpose(s) stated in the request; provided,
however, that nothing herein shall prohibit the Company from submitting matters to a vote of the shareholders at any Shareholder Requested
Special Meeting.
Section 6. Notice of Shareholders Meeting. Notice, stating the place, date, hour and purpose of the annual or special meeting shall be given by
the Secretary not less than ten nor more than sixty days before the date of the meeting to each shareholder entitled to vote at such meeting.
Section 7. Organization. The Chairman of the Board of Directors shall preside at all meetings of shareholders. In the absence of, or in case of a
vacancy in the office of, the Chairman of the Board of Directors, the Chief Executive Officer, the President, or in the President’s absence or in
the event that the Board of Directors has not selected a President, any Senior Executive Vice President, Executive Vice President, Senior Vice
President or Vice President in order of seniority as specified in this sentence, and, within each classification of office in order of seniority in
time in that office, shall preside. The Secretary of the Company shall act as secretary at all meetings of the shareholders and in the Secretary’s
absence, the chairman of the meeting may appoint a secretary.
The Board of Directors of the Company shall be entitled to make such rules or regulations for the conduct of meetings of shareholders as it
shall deem necessary, appropriate or convenient. Subject to such rules and regulations of the Board of Directors,
4

-- 64 of 89 --

if any, the chairman of the meeting shall have the right and the authority to prescribe such rules, regulations and procedures and to do all such
acts as, in the judgment of such chairman, are necessary, appropriate or convenient for the proper conduct of the meeting, including, without
limitation, establishing (i) an agenda or order of business for the meeting, (ii) rules and procedures for maintaining order at the meeting and the
safety of those present, (iii) limitations on participation in such meetings to shareholders of record of the Company and their duly authorized
and constituted proxies, and such other persons as the chairman of the meeting shall permit, (iv) restrictions on entries to the meeting after the
time affixed for the commencement thereof, (v) limitations on the time allotted to the questions or comments by participants and (vi) regulation
of the opening and closing of the polls for balloting and matters which are to be voted on by ballot. Unless and to the extent determined by the
Board of Directors or the chairman of the meeting, meetings of shareholders shall not be required to be held in accordance with rules of
parliamentary procedure.
Section 8. Inspectors of Election. All votes by ballot at any meeting of shareholders shall be conducted by such number of inspectors of
election as are appointed for that purpose by the Company. The Company may designate one or more alternate inspectors to replace any
inspector who fails to act. If no inspector or alternate is able to act at a meeting of shareholders, the person presiding at the meeting may, and
to the extent required by law, shall, appoint one or more inspectors to act at the meeting. Each inspector, before entering upon the discharge of
his or her duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best of his
or her ability. Every vote taken by ballots shall be counted by a duly appointed inspector or inspectors.
Section 9. Record Date. The Board of Directors, in order to determine the shareholders entitled to notice of or to vote at any meeting of
shareholders or any adjournment thereof, or entitled to take action by written consent, or entitled to receive payment of any dividend or other
distribution or allotment of any rights or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the
purpose of any other lawful action, shall fix in advance a record date which shall not be more than sixty nor less than ten days before the date
of such meeting, nor more than sixty days prior to any other action and in such case only such shareholders as shall be shareholders of record
on the date so fixed, shall be entitled to such notice of or to vote at such meeting or any adjournment thereof, or entitled to take action by
written consent, or be entitled to receive payment of any such dividend or other distribution or allotment of any rights or be entitled to exercise
any such rights in respect of stock or to take any such other lawful action, as the case may be, notwithstanding any transfer of any stock on the
books of the Company after any such record date fixed as aforesaid.
Section 10. Nature of Business; Notice of Shareholder Business. At any annual or special meeting of shareholders, only such business shall be
conducted as shall have been properly brought before the meeting. To be properly brought before an annual or special meeting, business must
be: (A) specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Board of Directors, (B) otherwise
properly
5

-- 65 of 89 --

brought before the meeting by or at the direction of the Board of Directors, or (C) otherwise properly brought before the meeting by a
shareholder.
In order for business to be properly brought before an annual meeting by a shareholder, the shareholder must have given timely notice thereof
in writing to the Secretary of the Company, and such business must be a proper matter for shareholder action under the General Corporation
Law of the State of Delaware. With respect to nominations of persons for election to the Board of Directors of the Company, the shareholder
(or group of shareholders) must comply with the notice and other requirements set forth in Article I, Section 11 and Section 12 of these By-
Laws, as applicable. In order for business to be properly brought before a Shareholder Requested Special Meeting by a shareholder, such
shareholder must comply with the notice and other requirements set forth in Article I, Section 5 of these By-Laws.
To be timely, a shareholder’s notice with respect to an annual meeting, other than with respect to nominations of persons for election to the
Board of Directors of the Company pursuant to Article I, Section 12 of these By-Laws, must be delivered to or mailed and received at the
principal executive offices of the Company not later than the close of business on the one hundred twentieth (120th) day prior to the first
anniversary of the preceding year’s annual meeting; provided, however, that in the event no annual meeting was held in the previous year or
the date of the annual meeting has been changed by more than thirty (30) days, notice by the shareholder to be timely must be so received not
later than the close of business on the later of one hundred and twenty (120) days in advance of such annual meeting or ten (10) days following
the date on which public announcement of the date of the meeting is first made. A shareholder’s notice to the Secretary shall set forth as to
each matter the shareholder proposes to bring before the annual meeting: (i) a brief description of the business desired to be brought before the
annual meeting (including the text of any resolutions proposed for consideration and in the event that such business includes a proposal to
amend the Company’s By-Laws, the language of the proposed amendment) and the reasons for conducting such business at the annual
meeting, (ii) the name and address, as they appear on the Company’s books, of the shareholder proposing such business, (iii) the class and
number of shares of the Company which are beneficially owned and owned of record by the shareholder, (iv) any material interest of the
shareholder or the shareholder’s affiliates or associates in such business, (v) a description of any agreement, arrangement or understanding
(including any derivative or short positions, profit interests, options, warrants, convertible securities, stock appreciation or similar rights,
hedging transactions, and borrowed or loaned shares) that has been entered into as of the date of the shareholder’s notice by, or on behalf of,
such shareholder and, whether or not such instrument or right shall be subject to settlement in underlying shares of capital stock of the
Company, the effect or intent of which is to mitigate loss to, manage risk or benefit of share price changes for, or increase or decrease the
voting power of, such shareholder, with respect to securities of the Company and (vi) any other information that is required to be provided by
the shareholder pursuant to Regulation 14A under the1934 Act, in his capacity as a proponent to a shareholder proposal and any other
information reasonably requested by the Company to allow it to satisfy its obligations under applicable law. Notwithstanding
6

-- 66 of 89 --

the foregoing, in order to include information with respect to a shareholder proposal in the proxy statement and form of proxy for a
shareholders’ meeting, shareholders must provide notice as required by the regulations promulgated under the 1934 Act. Notwithstanding
anything in these By-Laws to the contrary, no business (other than the nominations for the election of directors) shall be conducted at any
annual meeting except in accordance with the procedures set forth in this Section 10. The chairman of the meeting shall, if the facts warrant,
determine and declare at the meeting that business was not properly brought before the meeting and in accordance with the provisions of this
Section 10, and, if he should so determine, he shall so declare at the meeting that any such business not properly brought before the meeting
shall not be transacted.
Section 11. Election of Directors. Only persons who are nominated in accordance with the procedures set forth in this Section 11 or the
procedures set forth in Section 12 of this Article I shall be eligible for election as directors. Nominations of persons for election to the Board of
Directors of the Company may be made at an annual meeting of shareholders or at a special meeting of shareholders called for the purpose of
electing directors. Nominations may be made (i) by or at the direction of the Board of Directors, (ii) at an annual meeting by any shareholder
of the Company entitled to vote in the election of directors at the meeting who complies with the notice procedures set forth in this Section 11,
(iii) at an annual meeting by a shareholder or group of shareholders of the Company who complies with the notice and other requirements set
forth in Article I, Section 12 of these By-Laws or (iv) at a Shareholder Requested Special Meeting by a shareholder or group of shareholders of
the Company who complies with the notice and other requirements set forth in Article I, Section 5 of these By-Laws.
Nominations by a shareholder or a group of shareholders at an annual meeting pursuant to this Section 11, other than with respect to
nominations of persons for election to the Board of Directors of the Company pursuant to Article I, Section 12 of these By-Laws, shall be made
pursuant to timely notice in writing to the Secretary of the Company in accordance with the provisions of Section 10. Such shareholder’s notice
shall set forth (i) as to each person, if any, whom the shareholder proposes to nominate for election or re-election as a director: (A) the name,
age, business address and residence address of such person, (B) the principal occupation or employment of such person, (C) the class and
number of shares of the Company which are beneficially owned by such person, (D) a description of all arrangements or understandings
between the shareholder and each nominee or any other person or persons (naming such person or persons) pursuant to which the nominations
are to be made by the shareholder, and (E) any other information relating to such person that is required to be disclosed in solicitations of
proxies for elections of directors, or is otherwise required, in each case pursuant to Regulation 14A under the 1934 Act (including, without
limitation, such person’s written consent to being named in the proxy statement, if any, as a nominee and to serving as a director if elected);
and (ii) as to such shareholder giving notice, the information required to be provided pursuant to Section 10. At the request of the Board of
Directors, any person nominated by a shareholder for election as a director shall furnish to the Secretary of the Company that information
required to be set forth in the shareholder’s notice of nomination which pertains to the nominee. The chairman of the meeting shall, if the facts
warrant,
7

-- 67 of 89 --

determine and declare at the meeting that nomination was not made in accordance with the procedures prescribed by these By-Laws, and if he
should so determine, he shall so declare at the meeting, and the defective nomination shall be disregarded.
Section 12. Proxy Access for Director Nominations.
(a) The Company shall include in its proxy statement for an annual meeting of shareholders the name, together with the Required Information
(as defined below), of any person nominated for election (a “Shareholder Nominee”) to the Board of Directors by a shareholder that satisfies,
or by a group of no more than twenty (20) shareholders that satisfy, the requirements of this Section 12 (an “Eligible Shareholder”), and that
expressly elects at the time of providing the notice required by this Section 12 (the “Nomination Notice”) to have its nominee included in the
Company’s proxy materials pursuant to this Section 12.
(b) To be timely, a shareholder’s Nomination Notice must be delivered to or mailed and received by the Secretary at the principal executive
offices of the Company not less than one hundred and twenty (120) days nor more than one hundred and fifty (150) days prior to the
anniversary of the date the Company commenced mailing of its proxy materials in connection with the most recent annual meeting of
shareholders; provided, however, that in the event that the annual meeting is called for a date that is more than thirty (30) days before or
seventy (70) days after the anniversary of the preceding year’s annual meeting, in order to be timely the Nomination Notice must be so
received not later than the close of business on the later of one hundred and twenty (120) days in advance of such annual meeting or ten (10)
days following the day on which public disclosure of the date of the annual meeting was made. In no event shall the public announcement of
an adjournment or postponement of an annual meeting commence a new time period (or extend any time period) for the giving of a
Nomination Notice as described above.
(c) For purposes of this Section 12, the “Required Information” that the Company will include in its proxy statement is (i) the information
concerning the Shareholder Nominee and the Eligible Shareholder that is required to be disclosed in the Company’s proxy statement by the
regulations promulgated under the 1934 Act; and (ii) if the Eligible Shareholder so elects, a Statement (as defined below). To be timely, the
Required Information must be delivered to or mailed and received by the Secretary within the time period specified in this Section 12 for
providing the Nomination Notice,
(d) The number of Shareholder Nominees (including Shareholder Nominees that were submitted by an Eligible Shareholder for inclusion in the
Company’s proxy materials pursuant to this Section 12 but either are subsequently withdrawn or that the Board of Directors decides to
nominate as Board of Director nominees) appearing in the Company’s proxy materials with respect to an annual meeting of shareholders shall
not exceed the greater of (i) two or (ii) twenty percent (20%) of the number of directors in office as of the last day on which a Nomination
Notice may be delivered pursuant to this Section 12, or if such amount is not a whole number, the closest whole number below twenty percent
(20%). In the event that the number of Shareholder Nominees submitted by Eligible Shareholders pursuant to this Section 12 exceeds this
maximum number, each Eligible Shareholder will select one Shareholder Nominee for inclusion in the Company’s
8

-- 68 of 89 --

proxy materials until the maximum number is reached, going in order of the amount (largest to smallest) of shares of the capital stock of the
Company each Eligible Shareholder disclosed as owned in its respective Nomination Notice submitted to the Company and confirmed by the
Company. If the maximum number is not reached after each Eligible Shareholder has selected one Shareholder Nominee, this selection process
will continue as many times as necessary, following the same order each time, until the maximum number is reached.
(e) For purposes of this Section 12, an Eligible Shareholder shall be deemed to “own” only those outstanding shares of the capital stock of the
Company as to which the shareholder possesses both (i) the full voting and investment rights pertaining to the shares and (ii) the full economic
interest in (including the opportunity for profit and risk of loss on) such shares; provided that the number of shares calculated in accordance
with clauses (i) and (ii) shall not include any shares (x) sold by such shareholder or any of its affiliates in any transaction that has not been
settled or closed, (y) borrowed by such shareholder or any of its affiliates for any purposes or purchased by such shareholder or any of its
affiliates pursuant to an agreement to resell or (z) subject to any option, warrant, forward contract, swap, contract of sale, or other derivative or
similar agreement entered into by such shareholder or any of its affiliates, whether any such instrument or agreement is to be settled with shares
or with cash based on the notional amount or value of shares of outstanding capital stock of the Company, in any such case which instrument or
agreement has, or is intended to have, the purpose or effect of (1) reducing in any manner, to any extent or at any time in the future, such
shareholder’s or its affiliates’ full right to vote or direct the voting of any such shares, and/or (2) hedging, offsetting or altering to any degree
gain or loss arising from the full economic ownership of such shares by such shareholder or affiliate. A shareholder shall “own” shares held in
the name of a nominee or other intermediary so long as the shareholder retains the right to instruct how the shares are voted with respect to the
election of directors and possesses the full economic interest in the shares. A person’s ownership of shares shall be deemed to continue during
any period in which (i) the person has loaned such shares, provided that the person has the power to recall such loaned shares on three (3)
business days’ notice; or (ii) the person has delegated any voting power by means of a proxy, power of attorney or other instrument or
arrangement that is revocable at any time by the person. The terms “owned,” “owning” and other variations of the word “own” shall have
correlative meanings. Whether outstanding shares of the capital stock of the Company are “owned” for these purposes shall be determined by
the Board of Directors, which determination shall be conclusive and binding on the Company and its shareholders.
(f) An Eligible Shareholder must have owned (as defined above) continuously for at least three (3) years that number of shares of capital stock
as shall constitute three percent (3%) or more of the outstanding capital stock of the Company (the “Required Shares”) as of both (i) a date
within seven (7) days prior to the date of the Nomination Notice and (ii) the record date for determining shareholders entitled to vote at the
annual meeting. For purposes of satisfying the foregoing ownership requirement under this Section 12, (i) the shares of the capital stock of the
Company owned by one or more shareholders, or by the person or persons who own shares of the capital stock of the Company and on whose
9

-- 69 of 89 --

behalf any shareholder is acting, may be aggregated, provided that the number of shareholders and other persons whose ownership of shares of
capital stock of the Company is aggregated for such purpose shall not exceed twenty (20), and (ii) a group of funds under common
management and investment control shall be treated as one shareholder or person for this purpose. No person may be a member of more than
one group of persons constituting an Eligible Shareholder under this Section 12. For the avoidance of doubt, if a group of shareholders
aggregates ownership of shares in order to meet the requirements under this Section 12, all shares held by each shareholder constituting their
contribution to the foregoing 3% threshold must be held by that shareholder continuously for at least three (3) years, and evidence of such
continuous ownership shall be provided as specified in this Section 12(f).
Within the time period specified in this Section 12 for providing the Nomination Notice, an Eligible Shareholder must provide the following
information in writing to the Secretary of the Company:
(i) one or more written statements from the record holder of the shares (and from each intermediary through which the shares are or
have been held during the requisite three (3)-year holding period) verifying that, as of a date within seven (7) days prior to the date of the
Nomination Notice, the Eligible Shareholder owns, and has owned continuously for the preceding three (3) years, the Required Shares, and the
Eligible Shareholder’s agreement to provide, within five (5) business days after the record date for the annual meeting, written statements from
the record holder and intermediaries verifying the Eligible Shareholder’s continuous ownership of the Required Shares through the record
date;
(ii) the written consent of each Shareholder Nominee to being named in the proxy statement as a nominee and to serving as a director if
elected, together with the information and representations that would be required to be set forth in a shareholder’s notice of a nomination
pursuant to Section 11 of this Article I;
(iii) a copy of the Schedule 14N that has been filed with the Securities and Exchange Commission as required by Rule 14a-18 under the
1934 Act, as such rule may be amended;
(iv) a representation that the Eligible Shareholder (including each member of any group of shareholders that together is an Eligible
Shareholder under this Section 12) (A) acquired the Required Shares in the ordinary course of business and not with the intent to change or
influence control at the Company, and does not presently have such intent, (B) has not nominated and will not nominate for election to the
Board of Directors at the annual meeting any person other than the Shareholder Nominee(s) being nominated pursuant to this Section 12, (C)
has not engaged and will not engage in, and has not and will not be a “participant” in another person’s, “solicitation” within the meaning of
Rule 14a-1(l) under the 1934 Act in support of the election of any individual as a director at the annual meeting other than its Shareholder
Nominee or a nominee of the Board of Directors, (D) will not distribute to any shareholder any form of proxy for the annual meeting other than
the form distributed by the Company and (E) in the case of a nomination by a group of shareholders that together is an Eligible Shareholder,
the
10

-- 70 of 89 --

designation by all group members of one group member that is authorized to act on behalf of all such members with respect to the nomination
and matters related thereto, including any withdrawal of the nomination; and
(v) an undertaking that the Eligible Shareholder agrees to (A) own the Required Shares through the date of the annual meeting, (B)
assume all liability stemming from any legal or regulatory violation arising out of the Eligible Shareholder’s communications with the
shareholders of the Company or out of the information that the Eligible Shareholder provided to the Company, (C) indemnify and hold
harmless the Company and each of its directors, officers and employees individually against any liability, loss or damages in connection with
any threatened or pending action, suit or proceeding, whether legal, administrative or investigative, against the Company or any of its directors,
officers or employees arising out of any nomination, solicitation or other activity by the Eligible Shareholder in connection with its efforts to
elect the Shareholder Nominee pursuant to this Section 12, (D) comply with all other laws and regulations applicable to any solicitation in
connection with the annual meeting and (E) provide to the Company prior to the annual meeting such additional information as necessary with
respect thereto.
(g) The Eligible Shareholder may provide to the Secretary of the Company, at the time the information required by this Section 12 is provided,
a written statement for inclusion in the Company’s proxy statement for the annual meeting, not to exceed five hundred (500) words, in support
of the Shareholder Nominee’s candidacy (the “Statement”). Notwithstanding anything to the contrary contained in this Section 12, the
Company may omit from its proxy materials any information or Statement (or portion thereof) that it, in good faith, believes would violate any
applicable law or regulation.
(h) Within the time period specified in this Section 12 for delivering the Nomination Notice, a Shareholder Nominee must deliver to the
Secretary of the Company a written representation and agreement that the Shareholder Nominee (i) is not and will not become a party to any
agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how such person,
if elected as a director of the Company, will act or vote on any issue or question that has not been disclosed to the Company, (ii) is not and will
not become a party to any agreement, arrangement or understanding with any person or entity other than the Company with respect to any
direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director that has not been disclosed
to the Company, and (iii) will comply with all the Company’s corporate governance, conflict of interest, confidentiality and stock ownership
and trading policies and guidelines, and any other Company policies and guidelines applicable to directors, as well as any applicable law, rule
or regulation or listing requirement. At the request of the Company, the Shareholder Nominee must submit all completed and signed
questionnaires required of the Company’s directors and officers. The Company may request such additional information as necessary to permit
the Board of Directors to determine if each Shareholder Nominee is independent under the listing standards of the principal U.S. exchange
upon which the Company’s capital stock is listed, any applicable rules of the Securities and Exchange Commission and any publicly disclosed
standards used by the Board of Directors in determining and disclosing the independence of the Company’s
11

-- 71 of 89 --

directors (the “Applicable Independence Standards”). If the Board of Directors determines that the Shareholder Nominee is not independent
under the Applicable Independence Standards, the Shareholder Nominee will not be eligible for inclusion in the Company’s proxy materials.
(i) Any Shareholder Nominee who is included in the Company’s proxy materials for a particular annual meeting of shareholders but either (i)
withdraws from or becomes ineligible or unavailable for election at the annual meeting, or (ii) does not receive at least twenty-five percent
(25%) of the votes cast “for” the Shareholder Nominee’s election, will be ineligible to be a Shareholder Nominee pursuant to this Section 12
for the next two (2) annual meetings.
(j) The Company shall not be required to include, pursuant to this Section 12, any Shareholder Nominees in its proxy materials for any meeting
of shareholders (i) for which the Secretary of Company receives a notice that a shareholder has nominated a person for election to the Board of
Directors pursuant to the advance notice requirements for shareholder nominees for director set forth in Section 11 of this Article I and such
shareholder does not expressly elect at the time of providing the notice to have its nominee included in the Company’s proxy materials
pursuant to this Section 12, (ii) if the Eligible Shareholder who has nominated such Shareholder Nominee has engaged in or is currently
engaged in, or has been or is a “participant” in another person’s, “solicitation” within the meaning of Rule 14a-1(l) under the 1934 Act in
support of the election of any individual as a director at the meeting other than its Shareholder Nominee(s) or a nominee of the Board of
Directors, (iii) who is not independent under the Applicable Independence Standards, as determined by the Board of Directors, (iv) whose
election as a member of the Board of Directors would cause the Company to be in violation of these By-Laws, the Certificate of Incorporation,
the listing standards of the principal exchange upon which the Company’s capital stock is traded, or any applicable law, rule or regulation, (v)
who is or has been, within the past three years, an officer or director of a competitor, as defined in Section 8 of the Clayton Antitrust Act of
1914, (vi) who is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses) or has been
convicted in such a criminal proceeding within the past ten (10) years, (vii) who is subject to any order of the type specified in Rule 506(d) of
Regulation D promulgated under the Securities Act of 1933, as amended, (viii) if such Shareholder Nominee or the applicable Eligible
Shareholder shall have provided information to the Company in respect to such nomination that was untrue in any material respect or omitted to
state a material fact necessary in order to make the statement made, in light of the circumstances under which it was made, not misleading, as
determined by the Board of Directors, or (ix) if the Eligible Shareholder or applicable Shareholder Nominee otherwise contravenes any of the
agreements or representations made by such Eligible Shareholder or Shareholder Nominee or fails to comply with its obligations pursuant to
this Section 12.
(k) Notwithstanding anything to the contrary set forth herein, the Board of Directors or the person presiding at the meeting shall declare a
nomination by an Eligible Shareholder to be invalid, and such nomination shall be disregarded notwithstanding that proxies in respect of such
vote may have been received by the Company, if (i) the Shareholder
12

-- 72 of 89 --

Nominee(s) and/or the applicable Eligible Shareholder shall have breached its or their obligations, agreements or representations under this
Section 12, as determined by the Board of Directors or the person presiding at the annual meeting of shareholders, or (ii) the Eligible
Shareholder (or a qualified representative thereof) does not appear at the annual meeting of shareholders to present any nomination pursuant to
this Section 12.
(l) The Eligible Shareholder (including any person who owns shares of capital stock of the Company that constitute part of the Eligible
Shareholder’s ownership for purposes of satisfying Section 12(f) hereof) shall file with the Securities and Exchange Commission any
solicitation or other communication with the Company’s shareholders relating to the meeting at which the Shareholder Nominee will be
nominated, regardless of whether any such filing is required under Regulation 14A of the 1934 Act or whether any exemption from filing is
available for such solicitation or other communication under Regulation 14A of the 1934 Act.
ARTICLE II
DIRECTORS:
Section 1. Number and Term and Classes of Directors. The whole Board of Directors shall consist of not less than ten (10) nor more than
twenty (20) members, the exact number to be set from time to time by the Board of Directors. No decrease in the number of directors shall
shorten the term of any incumbent director. In absence of the Board of Directors setting the number of directors, the number shall be 20. The
Board of Directors shall be elected each year, at the annual meeting of shareholders, to hold office until the next annual meeting and until their
successors are elected and qualified.
Section 2. Regular Meetings. Regular meetings of the Board of Directors shall be held at such times as the Board of Directors may determine
from time to time.
Section 3. Special Meetings. Special meetings of the Board of Directors may be called by the Chairman of the Board of Directors, the
Secretary or by a majority of the directors by written request to the Secretary.
Section 4. Notice of Meetings. The Secretary shall give notice of all meetings of the Board of Directors by mailing the notice at least three days
before each meeting or by telegraphing or telephoning the directors, or sending notice to the directors by facsimile or other electronic
transmission, not later than one day before the meeting. The notice shall state the time, date and place of the meeting, which shall be
determined by the Chairman of the Board of Directors, or, in absence of the Chairman, by the Secretary of the Company, unless otherwise
determined by the Board of Directors by action taken prior to the meeting.
Section 5. Quorum and Voting. A majority of the directors holding office shall constitute a quorum for the transaction of business. Except as
otherwise specifically required by Delaware law or by the Certificate of Incorporation of the Company or by these By-Laws, any action
required to be taken shall be authorized by a majority of the directors present at any meeting at which a quorum is present.
Section 6. Participation in Meetings; Action by Unanimous Consent. Members of the Board of Directors, or any committee thereof, may
participate in a meeting of the Board
13

-- 73 of 89 --

of Directors or any committee thereof by means of conference telephone or other communications equipment by means of which all persons
participating in the meeting can hear each other and such participation shall constitute presence in person at such meeting. Action may be
taken by the Board of Directors without a meeting if all members thereof consent thereto in writing or by electronic transmission, and the
writing or writings or electronic transmission or transmissions are filed with the minutes of the proceedings of the Board of Directors. Such
filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in
electronic form.
Section 7. General Powers of Directors. The business and affairs of the Company shall be managed under the direction of the Board of
Directors.
Section 8. Chairman. At all meetings of the Board of Directors, the Chairman of the Board of Directors shall preside and in the absence of, or
in the case of a vacancy in the office of, the Chairman of the Board of Directors, a chairman selected by the Chairman of the Board of Directors
or, if he fails to do so, by the directors, shall preside.
Section 9. Compensation of Directors. Directors and members of any committee of the Board of Directors shall be entitled to such reasonable
compensation and fees for their services as shall be fixed from time to time by resolution of the Board of Directors and shall also be entitled to
reimbursement for any reasonable expenses incurred in attending meetings of the Board of Directors and any committee thereof, except that a
director who is an officer or employee of the Company shall receive no compensation or fees for serving as a director or a committee member.
Section 10. Qualification of Directors. Any director who was elected or re-elected because he or she was an officer of the Company at the time
of that election or the most recent re-election shall resign as a member of the Board of Directors simultaneously when he or she ceases to be an
officer of the Company.
ARTICLE III
COMMITTEES OF THE BOARD OF DIRECTORS:
Section 1. Committees of the Board of Directors. The Board of Directors shall designate an Audit Committee, a Compensation Committee and
a Committee on Directors and Corporate Governance, and whatever other committees the Board of Directors deems advisable, each of which
shall have and may exercise the powers and authority of the Board of Directors to the extent provided in the charters of each committee
adopted by the Board of Directors in one or more resolutions.
The Chairman of the Board shall have the power and authority of a committee of the Board of Directors for purposes of taking any action
which the Chairman of the Board is authorized to take under the provisions of this Article.
Section 2. Election of Committee Members. The members of each committee shall be elected by the Board of Directors and shall serve until the
first meeting of the Board of Directors after the annual meeting of shareholders and until their successors are elected and qualified or until the
members’ earlier resignation or removal. The Board of
14

-- 74 of 89 --

Directors may designate the Chairman and Vice Chairman of each committee. Vacancies may be filled by the Board of Directors at any
meeting.
The Chairman of the Board may designate one or more directors to serve as an alternate member or members at any committee meeting to
replace any absent or disqualified member, such alternate or alternates to serve for that committee meeting only, and the Chairman of the Board
may designate a committee member as acting chairman of that committee, in the absence of the elected committee chairman, to serve for that
committee meeting only.
Section 3. Procedure/Quorum/Notice. The Committee Chairman, Vice Chairman or a majority of any committee may call a meeting of that
committee. A quorum of any committee shall consist of a majority of its members unless otherwise provided by resolution of the Board of
Directors. The majority vote of a quorum shall be required for the transaction of business. The secretary of the committee or the chairman of
the committee shall give notice of all meetings of the committee by mailing the notice to the members of the committee at least three days
before each meeting or by telegraphing or telephoning the members or sending the notice to members by facsimile or other electronic
transmission, not later than one day before the meeting. The notice shall state the time, date and place of the meeting. Each committee shall fix
its other rules of procedure. Action may be taken by any committee without a meeting if all members thereof consent thereto in writing or by
electronic transmission, and the writing or writings or electronic transmission or transmissions are filed with the minutes of the proceedings of
such committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes
are maintained in electronic form.
ARTICLE IV
NOTICE AND WAIVER OF NOTICE:
Section 1. Notice. Any notice required to be given to shareholders or directors under these By-Laws, the Certificate of Incorporation or by law
may be given by mailing the same, addressed to the person entitled thereto, at such person’s last known post office address and such notice
shall be deemed to be given at the time of such mailing. Without limiting the manner by which notice otherwise may be given effectively to
shareholders, any notice to shareholders may be given by electronic transmission in the manner provided in Section 232 of the Delaware
General Corporation Law.
Section 2. Waiver of Notice. Whenever any notice is required to be given under these By‑Laws, the Certificate of Incorporation or by law, a
written waiver thereof, signed by the person entitled to notice, or a waiver given by such person by electronic transmission, whether before or
after the time stated therein, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of notice of
such meeting, except when the person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the
transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of
any regular or special meeting of the shareholders, directors or a committee of directors need be specified in any written waiver of notice.
15

-- 75 of 89 --

ARTICLE V
OFFICERS:
Section 1. Officers of the Company. The officers of the Company shall be selected by the Board of Directors and shall be a Chairman of the
Board of Directors, a Chief Executive Officer, one or more Vice Presidents, a Secretary and a Treasurer. The Board of Directors may elect one
or more Vice Chairmen, President and a Controller and one or more of the following: Senior Executive Vice President, Executive Vice
President, Senior Vice President, Assistant Vice President, Assistant Secretary, Associate Treasurer, Assistant Treasurer, Associate Controller
and Assistant Controller. Two or more offices may be held by the same person.
The Company may have a General Counsel who shall be appointed by the Board of Directors and shall have general supervision of all matters
of a legal nature concerning the Company, unless the Board of Directors has also appointed a General Tax Counsel, in which event the General
Tax Counsel shall have general supervision of all tax matters of a legal nature concerning the Company.
The Company may have a Chief Financial Officer who shall be appointed by the Board of Directors and shall have general supervision over
the financial affairs of the Company. The Company may also have a Chief of Internal Audits who shall be appointed by the Board of Directors.
Section 2. Election of Officers. At the first meeting of the Board of Directors after each annual meeting of shareholders, the Board of Directors
shall elect the officers. From time to time the Board of Directors may elect other officers.
Section 3. Tenure of Office; Removal. Each officer shall hold office until the first meeting of the Board of Directors after the annual meeting of
shareholders following the officer’s election and until the officer’s successor is elected and qualified or until the officer’s earlier resignation or
removal. Each officer shall be subject to removal at any time, with or without cause, by the affirmative vote of a majority of the entire Board of
Directors.
Section 4. Chairman of the Board of Directors. The Chairman of the Board of Directors shall preside over meetings of the Board of Directors
and shall consult and advise with the Board of Directors and committees thereof on the business and the affairs of the Company. The Chairman
of the Board of Directors shall have such other duties as may be assigned by the Board of Directors.
Section 5. Chief Executive Officer. The Chief Executive Officer, subject to the overall direction and supervision of the Board of Directors and
committees thereof, shall be in general charge of the affairs of the Company, and shall consult and advise with the Board of Directors and
committees thereof on the business and the affairs of the Company. The Chief Executive Officer shall have the power to make and execute
contracts and other instruments, including powers of attorney, on behalf of the Company and to delegate such power to others.
Section 6. President. The Board of Directors may select a President who shall have such powers and perform such duties, including those of
Chief Operating Officer, as may be
16

-- 76 of 89 --

assigned by the Board of Directors or by the Chief Executive Officer. In the absence or disability of the President, his or her duties shall be
performed by the Chief Executive Officer or such persons as the Board of Directors or the Chief Executive Officer may designate. The
President shall also have the power to make and execute contracts on the Company’s behalf and to delegate such power to others.
Section 7. Vice Presidents. Each Senior Executive Vice President, Executive Vice President, Senior Vice President and Vice President shall
have such powers and perform such duties as may be assigned to the officer by the Board of Directors or by the Chief Executive Officer.
Section 8. Secretary. The Secretary shall keep minutes of all meetings of the shareholders and of the Board of Directors, and shall keep, or
cause to be kept, minutes of all meetings of committees of the Board of Directors, except where such responsibility is otherwise fixed by the
Board of Directors. The Secretary shall issue all notices for meetings of the shareholders and Board of Directors and shall have charge of and
keep the seal of the Company and shall affix the seal attested by the Secretary’s signature to such instruments as may properly require same.
The Secretary shall cause to be kept such books and records as the Board of Directors, the Chairman of the Board of Directors, the Chief
Executive Officer or the President may require; and shall cause to be prepared, recorded, transferred, issued, sealed and cancelled certificates
of stock as required by the transactions of the Company and its shareholders. The Secretary shall attend to such correspondence and such other
duties as may be incident to the office of the Secretary or assigned by the Board of Directors, the Chairman of the Board of Directors, the Chief
Executive Officer or the President.
In the absence of the Secretary, an Assistant Secretary is authorized to assume the duties herein imposed upon the Secretary.
Section 9. Treasurer. The Treasurer shall perform all duties and acts incident to the position of Treasurer, shall have custody of the Company
funds and securities, and shall deposit all money and other valuable effects in the name and to the credit of the Company in such depositories as
may be designated by the Board of Directors. The Treasurer shall disburse the funds of the Company as may be authorized, taking proper
vouchers for such disbursements, and shall render to the Board of Directors, whenever required, an account of all the transactions of the
Treasurer and of the financial condition of the Company. The Treasurer shall vote all of the stock owned by the Company in any corporation
and may delegate this power to others. The Treasurer shall perform such other duties as may be assigned to the Treasurer and shall report to the
Chief Financial Officer or, in the absence of the Chief Financial Officer, to the Chief Executive Officer.
In the absence of the Treasurer, an Assistant Treasurer is authorized to assume the duties herein imposed upon the Treasurer.
Section 10. Controller. The Board of Directors may select a Controller who shall keep or cause to be kept in the books of the Company
provided for that purpose a true account of all transactions and of the assets and liabilities of the Company. The Controller shall prepare and
submit to the Chief Financial Officer or, in the absence of the Chief Financial Officer, to the Chief Executive Officer, such financial statements
and schedules as may
17

-- 77 of 89 --

be required to keep the Chief Financial Officer and the Chief Executive Officer currently informed of the operations and financial condition of
the Company, and perform such other duties as may be assigned by the Chief Financial Officer or the Chief Executive Officer.
In the absence of the Controller, an Assistant Controller is authorized to assume the duties herein imposed upon the Controller.
Section 11. Chief of Internal Audits. The Board of Directors may select a Chief of Internal Audits, who shall cause to be performed, and have
general supervision over, auditing activities of the financial transactions of the Company, including the coordination of such auditing activities
with the independent accountants of the Company and who shall perform such other duties as may be assigned to him from time to time. The
Chief of Internal Audits shall report to the Chief Financial Officer or, in the absence of the Chief Financial Officer, to the Chief Executive
Officer. From time to time at the request of the Audit Committee, the Chief of Internal Audits shall inform that committee of the auditing
activities of the Company.
Section 12. Assistant Vice Presidents. The Company may have Assistant Vice Presidents who shall be appointed by a committee whose
membership shall include one or more executive officers of the Company (the "Committee"). Each such Assistant Vice President shall have
such powers and shall perform such duties as may be assigned from time to time by the Committee, the Chief Executive Officer, the President
or any Vice President, and which are not inconsistent with the powers and duties granted and assigned by these By-Laws or the Board of
Directors. Assistant Vice Presidents appointed by the Committee shall be subject to removal at any time, with or without cause, by the
Committee. Annually the Committee shall report to the Board of Directors who it has appointed to serve as Assistant Vice Presidents and their
respective responsibilities.
ARTICLE VI
RESIGNATIONS: FILLING OF VACANCIES:
Section 1. Resignations. Any director, member of a committee, or officer may resign at any time. Such resignation shall be made by notice to
the Chairman of the Board of Directors or the Secretary given in writing or by electronic transmission and shall take effect at the time specified
therein, and, if no time be specified, at the time of its receipt by the Chairman of the Board of Directors or the Secretary. The acceptance of a
resignation shall not be necessary to make it effective.
Section 2. Filling of Vacancies. If the office of any director becomes vacant, the directors in office, although less than a quorum, or, if the
number of directors is increased, the directors in office, may elect any qualified person to fill such vacancy. In the case of a vacancy in the
office of a director caused by an increase in the number of directors, the person so elected shall hold office until the next annual meeting of
shareholders, or until his successor shall be elected and qualified. In the case of a vacancy in the office of a director resulting otherwise than
from an increase in the number of directors, the person so elected to fill such vacancy shall hold office for the unexpired term of the director
whose office became vacant. If the office of any officer becomes vacant, the Chairman of
18

-- 78 of 89 --

the Board of Directors may appoint any qualified person to fill such vacancy temporarily until the Board of Directors elects any qualified
person for the unexpired portion of the term. Such person shall hold office for the unexpired term and until the officer’s successor shall be duly
elected and qualified or until the officer’s earlier resignation or removal.
ARTICLE VII
INDEMNIFICATION:
Section 1. Indemnification of Directors, Officers, Employees and Agents. The Company shall indemnify any person who was or is a party or is
threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or
investigative (other than an action by or in the right of the Company) by reason of the fact that he is or was a director, officer, employee or
agent of the Company, or is or was serving at the request of the Company as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in
settlement actually and reasonably incurred by him in connection with such action, suit or proceeding if he acted in good faith and in a manner
he reasonably believed to be in or not opposed to the best interest of the Company, and, with respect to any criminal action or proceeding, had
no reasonable cause to believe his conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement,
conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith
and in a manner which he reasonably believed to be in or not opposed to the best interest of the Company, and with respect to any criminal
action or proceeding, had reasonable cause to believe that his conduct was unlawful.
The Company shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed
action or suit by or in the right of the Company to procure a judgment in its favor by reason of the fact that he is or was a director, officer,
employee or agent of the Company, or is or was serving at the request of the Company, as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys’ fees) actually and reasonably incurred by
him in connection with the defense or settlement of such action or suit if he acted in good faith and in a manner he reasonably believed to be in
or not opposed to the best interests of the Company and except that no indemnification shall be made in respect of any claim, issue or matter as
to which such person shall have been adjudged to be liable to the Company unless and only to the extent that the Court of Chancery or the court
in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the
circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such
other court shall deem proper.
Notwithstanding the foregoing, except with respect to a proceeding to enforce rights to indemnification or advancement of expenses under this
Article VII, the Company shall be required to indemnify a person under this Article VII in connection with a proceeding (or
19

-- 79 of 89 --

part thereof) initiated by such person only if such proceeding (or part thereof) was authorized by the Board of Directors.
Section 2. Expenses. To the extent that a director, officer, employee or agent of the Company has been successful on the merits or otherwise, in
whole or in part, in defense of any action, suit or proceeding referred to in Section 1 or in defense of any claim, issue or matter therein, he shall
be indemnified against expenses (including attorneys’ fees) actually and reasonably incurred by him in connection therewith. The entitlement
to expenses under this Section 2 shall include any expenses incurred by a director, officer, employee or agent of the Company in connection
with any action, suit or proceeding brought by such director, officer, employee or agent to enforce a right to indemnification or payment of
expenses under this Article. If successful in whole or in part in any such action, suit or proceeding, or in any action, suit or proceeding brought
by the Company to recover a payment of expenses pursuant to the terms of an undertaking provided in accordance with Section 4, the director,
officer, employee or agent also shall be entitled to be paid the expense of prosecuting or defending such action, suit or proceeding.
Section 3. Procedure for Receiving Indemnification. To receive indemnification under this By-Law, a director, officer, employee or agent of
the Company shall submit to the Company a written request, including therein or therewith such documentation and information as is
reasonably available to him and reasonably necessary to determine his entitlement to indemnification. Upon receipt by the Company of a
written request for indemnification, a determination, if required by applicable law, with respect to a claimant’s request shall be made: (1) by the
Board of Directors by a majority vote of a quorum consisting of directors who were not parties to such action, suit or proceeding, even though
less than a quorum; or (2) by a committee of such directors designated by majority vote of such directors, even though less than a quorum; or
(3) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion; or (4) by the shareholders.
The determination of a claimant’s entitlement to indemnification shall be made within a reasonable time, and in any event within no more than
60 days, after receipt by the Company of a written request for indemnification, together with the supporting documentation required by this
Section. The burden of establishing that a claimant is not entitled to be indemnified under this Article or otherwise shall be on the Company.
Section 4. Payment of Expenses. Expenses incurred in defending a civil or criminal action, suit or proceeding shall be paid by the Company in
advance of the final disposition of such action, suit or proceeding within 30 days after receipt by the Company of a statement requesting
payment of such expenses. Such statement shall evidence the expenses incurred by the claimant and shall include an undertaking by or on
behalf of the claimant to repay such expenses if it shall ultimately be determined, by final judicial decision from which there is no further right
to appeal, that he is not entitled to be indemnified by the Company as authorized by this Article. The burden of establishing that a claimant is
not entitled to payment of expenses under this Article or otherwise shall be on the Company. Any such payment shall not be deemed to be a
loan or extension or arrangement of credit by or on behalf of the Company.
20

-- 80 of 89 --

Section 5. Provisions Non-Exclusive; Survival of Rights. The indemnification and payment of expenses provided by or granted pursuant to this
Article shall not be deemed exclusive of any other rights to which those indemnified or those who receive payment of expenses may be entitled
under any By-Law, agreement, vote of shareholders or disinterested directors or otherwise, both as to action in an official capacity and as to
action in another capacity while holding such office, and shall continue as to a person who has ceased to be a director, officer, employee or
agent and shall inure to the benefit of the heirs, executors and administrators of such a person.
Section 6. Insurance. The Company shall have power to purchase and maintain insurance on behalf of any person who is or was a director,
officer, employee or agent of the Company, or is or was serving at the request of the Company as a director, officer, employee or agent of
another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against him and incurred by him in any
such capacity, or arising out of his status as such, whether or not the Company would have the power to indemnify him against such liability
under the provisions of this Article.
Section 7. Authority to Enter into Indemnification Agreements. The Company shall have the power to enter into contracts with any director,
officer, employee or agent of the Company in furtherance of the provisions of this Article to provide for the payment of such amounts as may
be appropriate, in the discretion of the Board of Directors, to effect indemnification and payment of expenses as provided in this Article.
Section 8. Effect of Amendment. Any amendment, repeal or modification of this Article shall not adversely affect any right or protection
existing at the time of such amendment, repeal or modification in respect of any act or omission occurring prior to such amendment, repeal or
modification.
Section 9. No Duplication of Payments. The Company’s obligation, if any, to indemnify or pay expenses to any person under this Article shall
be reduced to the extent such person has otherwise received payment (under any insurance policy, indemnity clause, bylaw, agreement, vote or
otherwise).
ARTICLE VIII
CAPITAL STOCK:
Section 1. Form and Execution of Certificates. The certificates of shares of the capital stock of the Company shall be in such form as shall be
approved by the Board of Directors. The certificates shall be signed by the Chairman of the Board of Directors or the Chief Executive Officer
or the President, or a Vice President, and by the Secretary or an Assistant Secretary or the Treasurer or an Assistant Treasurer. Each certificate
of stock shall certify the number of shares owned by the shareholder in the Company.
A facsimile of the seal of the Company may be used in connection with the certificates of stock of the Company, and facsimile signatures of
the officers named in this Section may be used in connection with said certificates. In the event any officer whose facsimile signature has been
placed upon a certificate shall cease to be such officer before the certificate is issued, the certificate may be issued with the same effect as if
such person was an officer at the date of issue.
21

-- 81 of 89 --

Section 2. Record Ownerships. All certificates shall be numbered appropriately and the names of the owners, the number of shares and the date
of issue shall be entered in the books of the Company. The Company shall be entitled to treat the holder of record of any share of stock as the
holder in fact thereof and accordingly shall not be bound to recognize any equitable or other claim to or interest in any share on the part of any
other person, whether or not it shall have express or other notice thereof, except as required by the laws of Delaware.
Section 3. Transfer of Shares. Upon surrender to the Company or to a transfer agent of the Company of a certificate for shares duly endorsed or
accompanied by proper evidence of succession, assignment, or authority to transfer, it shall be the duty of the Company, if it is satisfied that all
provisions of law regarding transfers of shares have been duly complied with, to issue a new certificate to the person entitled thereto, cancel the
old certificate and record the transaction upon its books.
Section 4. Lost, Stolen or Destroyed Stock Certificates. Any person claiming a stock certificate in lieu of one lost, stolen or destroyed shall
give the Company an affidavit as to such person’s ownership of the certificate and of the facts which go to prove that it was lost, stolen or
destroyed. The person shall also, if required by the Board of Directors, give the Company a bond, sufficient to indemnify the Company against
any claims that may be made against it on account of the alleged loss, theft or destruction of any such certificate or the issuance of such new
certificate. Any Vice President or the Secretary or any Assistant Secretary of the Company is authorized to issue such duplicate certificates or
to authorize any of the transfer agents and registrars to issue and register such duplicate certificates.
Section 5. Regulations. The Board of Directors from time to time may make such rules and regulations as it may deem expedient concerning
the issue, transfer and registration of shares.
Section 6. Transfer Agent and Registrar. The Board of Directors may appoint such transfer agents and registrars of transfers as may be deemed
necessary, and may require all stock certificates to bear the signature of either or both.
ARTICLE IX
SEAL:
Section 1. Seal. The Board of Directors shall provide a suitable seal containing the name of the Company, the year of its creation, and the
words, "CORPORATE SEAL, DELAWARE," or other appropriate words. The Secretary shall have custody of the seal.
ARTICLE X
FISCAL YEAR:
Section 1. Fiscal Year. The fiscal year of the Company shall be the calendar year.
ARTICLE XI
EXCLUSIVE FORUM FOR ADJUDICATION OF DISPUTES:
22

-- 82 of 89 --

Section 1. Exclusive Forum for Adjudication of Disputes. Unless the Company consents in writing to the selection of an alternative forum, the
sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company; (ii) any action asserting a claim for or
based on a breach of a fiduciary duty owed by any current or former director or officer or other employee of the Company to the Company or
to the Company’s shareowners, including a claim alleging the aiding and abetting of such a breach of fiduciary duty; (iii) any action asserting a
claim against the Company or any current or former director or officer or other employee of the Company arising pursuant to any provision of
the General Corporation Law of the State of Delaware or the Certificate of Incorporation or these By-laws (as either may be amended from
time to time); (iv) any action asserting a claim related to or involving the Company that is governed by the internal affairs doctrine; or (iv) any
action asserting an “internal corporate claim” as that term is defined in Section 115 of the General Corporation Law of the State of Delaware,
shall be a state court located within the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction, the federal
court for the District of Delaware).
ARTICLE XII
AMENDMENTS:
Section 1. Directors May Amend By-Laws. The Board of Directors shall have the power to make, amend and repeal the By-laws of the
Company.
Section 2. By-laws Subject to Amendment by Shareholders. All By-Laws shall be subject to amendment, alteration, or repeal by the
shareholders entitled to vote at any annual meeting or at any special meeting.
ARTICLE XIII
EMERGENCY BY-LAWS:
Section 1. Emergency By-laws. This Article XIII shall be operative during any emergency resulting from an attack on the United States or on a
locality in which the Company conducts its business or customarily holds meetings of its Board of Directors or its shareholders, or during any
nuclear or atomic disaster or during the existence of any catastrophe or other similar emergency condition, as a result of which a quorum of the
Board of Directors or, if one has been constituted, the Executive Committee thereof cannot be readily convened (an "emergency"),
notwithstanding any different or conflicting provision in the preceding Articles of these By-laws or in the Certificate of Incorporation of the
Company. To the extent not inconsistent with the provisions of this Article, the By-laws provided in the preceding Articles and the provisions
of the Certificate of Incorporation of the Company shall remain in effect during such emergency, and upon termination of such emergency, the
provisions of this Article XIII shall cease to be operative.
Section 2. Meetings. During any emergency, a meeting of the Board of Directors, or any committee thereof, may be called by any officer or
director of the Company. Notice of the time and place of the meeting shall be given by any available means of communication by the person
calling the meeting to such of the directors and/or
23

-- 83 of 89 --

Designated Officers, as defined in Section 3 hereof, as it may be feasible to reach. Such notice shall be given at such time in advance of the
meeting as, in the judgment of the person calling the meeting, circumstances permit.
Section 3. Quorum. At any meeting of the Board of Directors, or any committee thereof, called in accordance with Section 2 of this Article
XIII, the presence or participation of two directors, one director and a Designated Officer or two Designated Officers shall constitute a quorum
for the transaction of business.
The Board of Directors or the committees thereof, as the case may be, shall, from time to time but in any event prior to such time or times as an
emergency may have occurred, designate the officers of the Company in a numbered list (the "Designated Officers") who shall be deemed, in
the order in which they appear on such list, directors of the Company for purposes of obtaining a quorum during an emergency, if a quorum of
directors cannot otherwise be obtained.
Section 4. By-laws. At any meeting called in accordance with Section 2 of this Article XIII, the Board of Directors or the committees thereof,
as the case may be, may modify, amend or add to the provisions of this Article XIII so as to make any provision that may be practical or
necessary for the circumstances of the emergency.
Section 5. Liability. No officer, director or employee of the Company acting in accordance with the provisions of this Article XIII shall be
liable except for willful misconduct.
Section 6. Repeal or Change. The provisions of this Article XIII shall be subject to repeal or change by further action of the Board of Directors
or by action of the shareholders, but no such repeal or change shall modify the provisions of Section 5 of this Article XIII with regard to action
taken prior to the time of such repeal or change.
24

-- 84 of 89 --

Exhibit 10.1
FIRST AMENDMENT
THE COCA-COLA COMPANY SEVERANCE PAY PLAN
(As Amended and Restated Effective January 1, 2020)
This Amendment to The Coca-Cola Company Severance Pay Plan is hereby adopted by The Coca-Cola Company Benefits Committee
(“Benefits Committee”), effective as of May 29, 2020.
1. The definition of Participant shall be amended to read as follows:
Participant means:
(a) 	a regular full-time or regular part-time (working at least 30 hours per week) employee of the Company or a Participating Affiliate
who works primarily within the United States (one of the fifty states or the District of Columbia) and who is actively at work or on an
Approved Leave of Absence, or
(b) 	a regular, full-time salaried Global Mobility Assignee who is actively at work or on an Approved Leave of Absence.
Notwithstanding the foregoing, the term “Participant” shall not include any employee of The Coca-Cola Company or an Affiliate who is
performing services for Costa USA LLC and who ultimately reports up to the CEO, Costa in accordance with the personnel and
organizational systems of the Company. Furthermore, the term "Participant" shall not include any employee covered by a collective
bargaining agreement between an employee representative and the Company or any Affiliate, unless the collective bargaining agreement
provides for the employee’s participation in this Plan.
An individual shall be treated as an "employee" for purposes of this Plan for any period only if (i) he is actually classified during such
period by the Company (or to the extent applicable, any Affiliate) on its payroll, personnel and benefits system as an employee, and
(ii) he is paid for services rendered during such period through the payroll system, as distinguished from the accounts payable
department, of the Company or the Affiliate. No other individual shall be treated as an employee under this Plan for any period,
regardless of his or her status during such period as an employee under common law or under any statute. In addition, an individual shall
be treated as an exempt or nonexempt employee for purposes of this Plan only if he is actually classified during such period by the
Company or an Affiliate on its payroll, personnel and benefits system as an exempt or nonexempt employee.
2. Appendix B is amended to add Grand Prairie Plant (TX) to the Thermal (Hot-fill/Juice/Water) Plants list.

-- 85 of 89 --

3. Appendix B is further amended to add the following:
Other facilities
Odwalla Chilled Distribution Centers
IN WITNESS WHEREOF, the Benefits Committee has caused this Amendment to be adopted and signed by its duly authorized
member on May 29, 2020.
THE COCA-COLA COMPANY
BENEFITS COMMITTEE
BY: /s/ Silvina Kippke
Silvina Kippke

-- 86 of 89 --

Exhibit 31.1
CERTIFICATIONS
I, James Quincey, Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola Company, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of The Coca-Cola Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;
(b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
(c) 	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) 	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the
registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal
control over financial reporting; and
5. 	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's
auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial
reporting.
Date: 	July 22, 2020
/s/ JAMES QUINCEY
James Quincey
Chairman of the Board of Directors and Chief Executive Officer of
The Coca-Cola Company

-- 87 of 89 --

Exhibit 31.2
CERTIFICATIONS
I, John Murphy, Executive Vice President and Chief Financial Officer of The Coca-Cola Company, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of The Coca-Cola Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;
(b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
(c) 	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) 	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the
registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal
control over financial reporting; and
5. 	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's
auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial
reporting.
Date: 	July 22, 2020
/s/ JOHN MURPHY
John Murphy
Executive Vice President and Chief Financial Officer of
The Coca-Cola Company

-- 88 of 89 --

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of The Coca-Cola Company (the "Company") on Form 10-Q for the period ended June 26, 2020 (the "Report"), I, James Quincey,
Chairman of the Board of Directors and Chief Executive Officer of the Company and I, John Murphy, Executive Vice President and Chief Financial Officer of the Company,
each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) 	to my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) 	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ JAMES QUINCEY
James Quincey
Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola Company
July 22, 2020
/s/ JOHN MURPHY
John Murphy
Executive Vice President and Chief Financial Officer of The Coca-Cola Company
July 22, 2020

-- 89 of 89 --